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Preface
Reports of verified cases of tuberculosis 
(RVCT) are submitted to the Division of Tu-
berculosis Elimination (DTBE), Centers for 
Disease Control and Prevention (CDC), by 60 
reporting areas (the 50 states, the District of 
Columbia, New York City, Puerto Rico, and 
seven other jurisdictions in the Pacific and 
Caribbean).  In January 1993, an expanded 
system was developed to collect additional in-
formation for each reported TB case in order to 
better monitor trends in TB and TB control.  A 
software package (SURVS-TB) for data entry, 
analysis, and transmission of case reports to 
CDC was designed and implemented as part of 
the expanded TB surveillance system.  In 1998, 
the Tuberculosis Information Management Sys-
tem (TIMS) replaced SURVS-TB. 
This publication, Reported Tuberculosis in the 
United States, 2007, presents the summary 
data for TB cases reported to CDC, verified, 
and counted for 2007.  It is similar to previous 
publications (see page xi, #19) and contains six 
major sections.  The first section presents trends 
in the overall TB case counts and case rates by 
selected demographic and clinical characteris-
tics.  The second section presents overall case 
counts and case rates for the United States by 
selected demographic characteristics for 2007.  
In the third section, TB case counts and case 
rates are presented by state and other jurisdic-
tions with tables of selected demographic and 
clinical characteristics.  In the fourth section, 
data collected as part of the expanded system 
(e.g., initial drug resistance, HIV status) are 
presented by reporting area.  Select tables 
report data from the Pacific and Caribbean ju-
risdictions.  The fifth section provides TB case 
counts and case rates by metropolitan statistical 
areas (MSAs: see Technical Notes, page 9, for 
further details) with tables of selected demo-
graphic and clinical characteristics.  Finally, the 
sixth section presents figures from the annual 
surveillance slide set, which emphasize key 
recent trends in TB epidemiology in the United 
States.  The slides with accompanying text can 
also be viewed and downloaded from the DTBE 
home page, which is accessible via the Internet at 
http://www.cdc.gov/tb/.
To help interpret the data, an Executive Com-
mentary (page 3) and Technical Notes (page 9) 
have been included.  In addition, the current case 
definition (MMWR 1997;46 [No. RR 10]:40-41) 
and “Recommendations for Counting Reported 
Tuberculosis Cases” are provided in Appendices 
A and B, respectively (page 119).  The recommen-
dations for counting TB cases, which update the 
original January 1977 recommendations, were first 
published in Reported Tuberculosis in the United 
States, 1996.  
After the publication of updated Guidelines for 
Targeted Tuberculin Testing and Treatment of La-
tent Tuberculosis Infection in April 20001, DTBE, 
CDC, began receiving reports of serious adverse 
events (i.e., hospitalization or death) related to the 
use of a 2-month course of rifampin and pyrazin-
amide (RZ) for treatment of latent tuberculosis in-
fection (TLTBI).  Subsequently, DTBE requested 
and received reports and conducted on-site inves-
tigations of liver injury in persons on TLTBI, and 
treatment guidelines were revised accordingly.2 
Severe adverse events among persons receiving 
TLTBI continue to be a public health concern, 
and data on the annual number and trends of such 
events are needed.  To this end, DTBE organized a 
working group on TLTBI adverse events in Sep-
tember 2003.  This working group was charged 
with the development of a national surveillance 
system with the following objectives:
To assist public health officials, policy 
makers, and healthcare providers in the 
prevention of adverse events, and
To serve as the basis for periodic evalua-
tion of guidelines for TLTBI and revision 
of these guidelines as needed.
Development of the National System for Severe 
Adverse Events Associated with Treatment of 
•
•
xLTBI has been implemented, and will include 
formal collaborations among CDC, FDA, and 
other participating agencies to ensure inter-
agency notification of serious adverse events.  
Mechanisms for quality assurance and timely 
dissemination of data are also under develop-
ment. 
At present, DTBE urges hospices, hospitals, 
jails, prisons, and private medical offices to 
report, through their local health departments, 
all severe adverse events (e.g., liver injury, 
metabolic acidosis, anaphylaxis, seizure, severe 
dermatitis) leading to hospitalization or death 
of a person receiving TLTBI that occurred after 
January 1, 2004, to DTBE by telephone (404-
639-8401) or e-mail (LManangan@cdc.gov).
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State TB Statistics on the Internet*
AL http://www.adph.org/tb/
AK http://www.epi.alaska.gov/id/tb.stm
AR None
AZ http://www.azdhs.gov/phs/oids/tuberculosis
CA http://ww2.cdph.ca.gov/programs/tb/Pages/default.aspx
CO http://www.cdphe.state.co.us/dc/tb/tbhome.html
CT http://www.dph.state.ct.us/bch/infectiousdise/tbstatis.htm
DC None
DE http://www.dhss.delaware.gov/dph/dpc/tuberculosis.html
FL http://www.doh.state.fl.us/disease_ctrl/tb/
GA http://health.state.ga.us/epi/tuber.asp
HI http://www.hawaii.gov/health/tb
IA http://www.idph.state.ia.us/adper/tb_control.asp
ID None
IL http://www.idph.state.il.us/health/infect/reportdis/tb.htm
IN http://www.in.gov/isdh/19662.htm
KS http://www.kdheks.gov/tb/statistical_information.html
KY http://chfs.ky.gov/dph/tb.htm
LA http://www.dhh.louisiana.gov/offices/?ID=273
MA http://www.mass.gov/dph/cdc/tb/index.htm
MD http://www.edcp.org/tb/index.html
ME http://www.maine.gov/dhhs/boh/ddc/tuberculosis_control.htm
MI http://www.michigan.gov/tb
MN http://www.health.state.mn.us/divs/idepc/diseases/tb/stats.html
MO http://www.ddhss.mo.gov/Tuberculosis.index.html
MT http://www.dphhs.mt.gov/PHSD/epidemiology/commun-disease-epi-tuberculosis.shtml
MS http://www.msdh.state.ms.us/msdhsite/_static/14,0,125.html 
ND http://www.health.state.nd.us/disease/tb/
NC http://www.epi.state.nc.us/epi/tb
NE http://www.dhhs.ne.gov/cod/Tuberculosis/tbindex.htm
NH http://www.dhhs.nh.gov/DHHS/CDCS/LIBRARY/ Fact+Sheet/tb-reference.htm
NJ http://www.state.nj.us/health/cd/tbhome.htm
NM http://www.health.state.nm.us/PHD/Infectious_Diseases/TB/2007_NM_TB_CaseRates.pdf
NYC http://www.nyc.gov/html/doh/html/tb/tb-reports.shtml
NV http://health.nv.gov/index.php?option=com_content&task= view&id=208&Itemid=348
NY None
OH http://www.odh.ohio.gov/healthstats/disease/tb/tb1.aspx
OK http://www.health.ok.gov/program/tb/index.html
OR http://oregon.gov/DHS/ph/tb/
PA http://www.health.state.pa.us/PHP/TB/tb.htm
RI http://www.health.ri.gov/disease/communicable/tb/index.php
PR http://www.salud.gov.pr/Programas/ProgramaTuberculosis/ Pages/DatosEstadisticosTuberculosis.aspx 
SC http://www.scdhec.net/health/disease/tb/index.htm
SD http://doh.sd.gov/tb
TN http://health.state.tn.us/ceds/TB/index.htm 
TX http://www.dshs.state.tx.us/idcu/disease/tb/statistics/
UT http://www.health.utah.gov/cdc/tb_home.htm
VA http://www.vdh.virginia.gov/epidemiology/DiseasePrevention/Programs/Tuberculosis/Epidemiology/
VT None
WA http://www.doh.wa.gov/cfh/tb
WI http://www.dhfs.wisconsin.gov/tb
WV http://www.wvtb.org
WY http://www.health.wyo.gov/PHSD/tb/index.html
*As reported to CDC by U.S. reporting area TB programs as of July 2008. Includes responses from the reporting areas of New York City 
(NYC) and Puerto Rico (PR).
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Executive Commentary
Highlights of 2007 Report
Since 1953, in cooperation with state and local health departments, the Centers for Disease Control 
and Prevention (CDC) have collected information on each newly reported case of tuberculosis (TB) 
disease in the United States.  Currently, each individual TB case report (Report of Verified Case of 
Tuberculosis, or RVCT) is submitted electronically to CDC’s Division of Tuberculosis Elimination.  
The following are the highlights of the 2007 report:
1. Updated case counts for each year from 1993 through 2006.
2. Case counts:  13,299 TB cases were reported to CDC from the 50 states and the District of Co-
lumbia (DC) for 2007, representing a 3.3% decrease from 2006 (Table 1).
• Twenty-one states reported increased case counts from 2006 (Table 28).
• California, Texas, New York, and Florida accounted for 48% of the national case total (Table 
28). 
• For the fourth consecutive year, Hispanics (29%) exceeded all other racial or ethnic groups 
with the largest percentage of total cases (Table 2).
• For the first time, Asians (26%) matched non-Hispanic blacks or African-Americans1 (26%) 
as the second largest racial or ethnic group.
• Blacks or African-Americans born in the United States represented 45% of TB cases in U.S.-
born persons and accounted for approximately 18% of the national case total (Tables 17, 18).
• Asians born outside the United States represented 43% of TB cases in foreign-born persons 
and accounted for approximately 25% of the national case total (Tables 17, 18).
3. Case rates:  In 2007, the TB case rate declined from 4.6 to 4.4 per 100,000 persons, representing 
a 4.2% decrease from 2006. 
• Fifteen states and DC reported rates above the national average (Table 20).
• Twenty-six states met the definition for low incidence, or ≤3.5 cases per 100,000 population 
(Table 20).
• The TB case rate was 2.1 per 100,000 for U.S.-born persons and 20.7 for foreign-born per-
sons (Table 5). 
• Asians continued to have the highest case rate (26.3 per 100,000 persons) among all racial or 
ethnic groups (Table 2).
4. Burden among the foreign-born:  The percentage of cases occurring in foreign-born persons con-
tinued to increase and was 58% of the national case total.
• Foreign-born Hispanics and Asians together represented 81% of TB cases in foreign-born 
persons, and accounted for 47% of the national case total (Tables 17, 18).
• In 29 states, ≥50% of TB cases occurred among foreign-born persons (Table 23).
• In 13 states, ≥70% of TB cases occurred among foreign-born persons (Table 23).
• The top five countries of origin of foreign-born persons with TB were Mexico, Philippines, 
India, Vietnam, and China (Table 6).
5. Drug resistance:  1.1% of reported cases, compared to 1.0% in 2006, had primary multidrug re-
sistance, which is defined as no previous history of TB disease and resistance to at least isoniazid 
and rifampin (Table 10).
1Hispanic and non-Hispanic are ethnicities. All races are non-Hispanic. The category “non-Hispanic blacks or African-Americans” 
includes U.S.- born and foreign-born persons unless otherwise specified.   
Tuberculosis in the United States
In 2007, the number of TB cases reported 
(13,299) and case rate (4.4 cases per 100,000) 
both decreased; this represented declines of 
3.3% and 4.2%, respectively, compared to 2006.  
Since the 1992 TB resurgence peak in the United 
States, the number of TB cases reported annu-
ally has decreased by 50%.  However, the trend 
of the declining annual case rate has slowed, 
from an annual average decline of 7.3% for 1993 
through 2000 to an annual average decline of 
3.8% for 2000 through 2007 (Table 1).
The proportion of total cases occurring in for-
eign-born persons has been increasing since 
1993.  In 2007, 58% of TB cases occurred in 
foreign-born persons.  Foreign-born persons 
have accounted for the majority of TB cases in 
the United States every year since 2001.  More-
over, the case rate among foreign-born persons 
in 2007 was nearly 10 times higher than among 
U.S.-born persons (Table 5).
Tuberculosis deaths decreased by 0.6%, from 
648 deaths in 2005 to 644 deaths in 2006, the 
latest year for which complete data are available 
(Table 1).
Age
Since 1993, TB case rates have declined annu-
ally for all age groups.  TB case rates vary by 
well-known factors such as age, race and ethnic-
ity, and country of origin.  In 2007, TB case rates 
declined or remained constant for all age groups 
except adults aged 15 to 24 years, which in-
creased slightly compared to 2006.  The highest 
burden of disease continues to be among older 
adults.  In 2007, adults aged 65 years and older 
had a case rate of 6.8 cases per 100,000, while 
children aged <14 years had the lowest rate at 
1.3 cases per 100,000 (Table 4).  
Race and Ethnicity
In 2003, the race and ethnicity category, “non-
Hispanic, Asian or Pacific Islander,” was split 
into “non-Hispanic Asian” and “non-Hispanic 
Native Hawaiian or Other Pacific Islander.”  In 
2007, Asians had the highest TB case rate at 26.3 
cases per 100,000, which was a slight increase 
from 25.9 in 2006.  In 2007, Native Hawaiians 
or Other Pacific Islanders had the second-highest 
TB case rate at 23.0 cases per 100,000, which is 
a marked increase compared to 13.4 cases per 
100,000 reported in 2006 (Table 2).
Since 1993, TB case rates have declined be-
tween 57% and 69% in these racial and ethnic 
groups:  among Hispanic or Latinos from 19.9 to 
8.5 cases per 100,000; among blacks or African-
Americans from 28.5 to 9.4 cases per 100,000; 
and among non-Hispanic whites from 3.6 to 1.1 
cases per 100,000.  In 2007, the TB case rate for 
Asians was nearly three times higher than that 
for Hispanics or blacks or African-Americans 
(Table 2).
Origin of Birth
Since 1993, the TB case rate among U.S.-born 
persons has declined annually.  In 2007, the TB 
case rate for U.S.-born persons was 2.1 cases 
per 100,000, representing a 72% decrease from 
7.4 cases per 100,000 in 1993.  The TB case 
rate among foreign-born persons also declined 
during the same interval but was less substantial.  
In 2007, the TB case rate among foreign-born 
persons was 20.7 cases per 100,000 representing 
a 39% decrease from 34.0 cases per 100,000 in 
1993 (Table 5). 
The proportion of TB cases among persons born 
in the United States also has declined annually 
since 1993.  In 2007, 42% of TB cases were 
among U.S-born persons compared to 69% in 
1993 (Table 5).  In 29 states, ≥50% of TB cases 
occurred among foreign-born persons.  In 13 
states (California, Colorado, Delaware, Massa-
chusetts, Minnesota, Nebraska, New Hampshire, 
New Jersey, New York, Oregon, Rhode Island, 
Virginia, and Washington), ≥70% of TB cases 
occurred among foreign-born persons (Table 23).
Country of Origin and World Region
From 2001 through 2007, the top five countries 
of origin of foreign-born persons with TB were 
Mexico, Philippines, India, Vietnam, and China 
(Table 6).  However, the changes in the distribu-
tion of TB cases by world region of origin reflect 
the changing immigration patterns among per-
sons settling in the United States2.  Of the 7,750 
TB cases reported among foreign-born persons 
in 2007, 43% occurred among persons born in 
the Americas region, and 31% occurred among 
persons born in the Western Pacific region (Table 
19).  From 1993 to 2007, the proportion of cases 
increased among persons born in the Eastern 
Mediterranean region (3% in 1993 to 4.5% in 
2007), the Southeast Asia region (6% in 1993 
to 12% in 2007), and the African region (2% in 
1993 and 7% in 2007) (Table 19).
Multidrug-Resistant Tuberculosis
Since 1993, when the RVCT was expanded to 
include drug-susceptibility results, the propor-
tion of patients with primary multidrug-resistant 
TB (MDR TB), which is defined as no previous 
history of TB disease and resistance to at least 
isoniazid and rifampin, has decreased from 2.5% 
to 1.1% in 2007.  Since 1998, the percentage of 
U.S.-born patients with MDR TB has remained 
≤ 0.7%.  However, of the total number of re-
ported primary MDR TB cases, the proportion 
occurring in foreign-born persons increased from 
25.5% (103 of 407) in 1993 to 80% (78 of 98) in 
2007 (Table 10).
Extensively Drug-Resistant Tuberculosis
CDC has included an updated case count of 
extensively drug-resistant TB (XDR TB) cases 
from 1993 to 2007 in the slide set that accompa-
nies this report.  XDR TB is defined as resistance 
to isoniazid and rifampin plus resistance to any 
fluoroquinolone and at least one of three inject-
able second-line anti-TB drugs (i.e., amikacin, 
2World Health Organization (WHO).  Global Tuberculosis 
Control 2008:  Surveillance, Planning, and Finance.  Geneva, 
Switzerland:  World Health Organization, 2008 (WHO/HTM/
TB/2008.393).
kanamycin, or capreomycin)3,4.  Two cases of 
XDR TB were reported during 2007, compared 
to four cases in 2006.
Tuberculosis Therapy
The proportion of TB patients prescribed an 
initial treatment regimen of three or more anti-
TB drugs increased annually from 72% in 1993 
to 88% in 2007.  The proportion of patients who 
completed therapy within 1 year increased from 
64% in 1993 to 83% in 2005. The proportion of 
persons receiving directly observed therapy at 
least for a portion of the treatment duration also 
increased from 35% in 1993 to 86% in 2005, the 
latest year for which complete outcome data are 
available (Table 12).
Summary 
Essential elements for controlling TB in the 
United States include sufficient resources, in-
terventions targeted to populations at high risk 
for TB, and collaborative efforts with the inter-
national community to reduce the burden of TB 
globally.
During 1993 through 2007, TB case rates in the 
United States decreased for U.S.-born and for-
eign-born persons; however, the decrease among 
foreign-born persons continues to be less sub-
stantial.  Despite the decreasing case rate among 
foreign-born persons, well over half of the TB 
cases in the United States in 2007 occurred in 
this population, and the case rate was more than 
10 times higher than among U.S.-born persons.  
To address the high TB case rates among for-
eign-born persons, CDC is collaborating with 
other national and international public health 
organizations to: 1) improve overseas screening 
of immigrants and refugees by systematically 
monitoring and evaluating the screening process; 
2) strengthen the current notification system that 
alerts local health departments about the arrival 
of immigrants or refugees who have suspected 
3Centers for Disease Control and Prevention (CDC).  Notice to 
readers:  revised definition of XDR-TB.  Morbid Mortal Weekly 
Report 2006; 55:1176.
4WHO.  Extensively drug-resistant tuberculosis (XDR-TB):  
recommendations for prevention and control.  Weekly Epidemiol 
Record 2006; 81:  430–432.
TB in order to enhance the evaluation and treat-
ment of such persons; 3) improve coordination 
of TB control activities between the United 
States and Mexico to ensure completion of treat-
ment among TB patients who cross the border; 
4) test recent arrivals from high-incidence coun-
tries for latent TB infection and monitor treat-
ment completion; and 5) survey foreign-born TB 
patients in the United States to determine op-
portunities for improving prevention and control 
interventions.  In addition, CDC continues to 
strengthen collaborations with international part-
ners, including the World Health Organization’s 
Stop TB Partnership, to improve TB control in 
high-incidence countries.
Accelerating progress in national TB elimination 
activities will require broader prevention ef-
forts among high-risk population groups such as 
black or African-American and Asian communi-
ties, persons who are incarcerated, persons with 
excess alcohol and drug use, persons with human 
immunodeficiency virus infection, and persons 
living in poverty with limited access to medical 
care and stable housing.  
In addition, low-incidence areas in the United 
States require continued support to maintain 
the capacity and expertise needed to respond to 
future TB cases5 especially in light of chang-
ing immigration patterns.  CDC has updated the 
comprehensive national action plan to reflect 
the alignment of CDC priorities with the 2000 
Institute of Medicine report on TB and to ensure 
that priority prevention activities are undertaken 
with optimal collaboration and coordination 
among national and international public health 
partners6,7.  
5CDC.  Progressing toward tuberculosis elimination in low-in-
cidence areas of the United States:  Recommendations of the 
Advisory Council for the Elimination of Tuberculosis.  Morbid 
Mortal Weekly Report 2002; 51 (No. RR-5): 1–20.
6Institute of Medicine.  Ending Neglect:  The Elimination of 
Tuberculosis in the United States.  Washington, DC:  National 
Academy Press, 2000.
7CDC.  CDC’s Response to Ending Neglect:  The Elimination of 
Tuberculosis from the United States.  Atlanta, GA:  U.S. Depart-
ment of Health and Human Services, CDC, 2000.
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1Other U.S. jurisdictions include American Samoa, the Commonwealth of the Northern Mariana Islands, the Federated States of Mi-
cronesia, Guam, the Republic of the Marshall Islands, the Republic of Palau, and U.S. Virgin Islands.
Technical Notes
National Surveillance for Tuberculosis
All reporting areas (i.e., the 50 states, the District 
of Columbia, New York City, Puerto Rico, and 
other U.S. jurisdictions in the Pacific and Carib-
bean) report tuberculosis (TB) cases to CDC 
using a standard case report form, Report of 
Verified Case of Tuberculosis (RVCT).1 Reported 
TB cases are verified according to the TB case 
definition for public health surveillance (MMWR 
1997;46[No. RR-10]:40–41).
Cases may be verified using the laboratory case 
definition, the clinical case definition, or a pro-
vider diagnosis.  A case may be verified by the 
laboratory case definition either by: 1) isolation 
of Mycobacterium tuberculosis from a clinical 
specimen, OR 2) detection of M. tuberculosis 
nucleic acid using an FDA approved nucleic acid 
amplification test, OR 3) demonstration of acid-
fast bacilli (AFB) in a clinical specimen when a 
culture has not been or cannot be obtained.
A case may be verified by the clinical case defi-
nition in the presence of ALL of the following 
clinical criteria: 1) a positive tuberculin skin test 
(TST) result, 2) other signs and symptoms com-
patible with TB, such as an abnormal, unstable 
(worsening or improving) chest radiograph, or 
clinical evidence of current disease, 3) treatment 
with two or more antituberculosis medications, 
and 4) a completed diagnostic evaluation.  
When cases of TB are diagnosed but do not meet 
the clinical case definition, reporting areas also 
have the option of verifying TB cases based on 
provider diagnosis.  Currently, the RVCT does 
not collect information on results from interferon 
gamma release assays such as the QuantiF-
ERON-TB Gold test.  If this test is performed 
in lieu of the TST, then the RVCT should reflect 
that the TST was not performed.  Cases without 
a TST that are diagnosed by a positive Quan-
tiFERON-TB Gold result should be considered 
to have been confirmed by provider diagnosis.  
Another example of a provider diagnosis would 
be in the case of anergic patients with a clinical 
picture consistent with TB but without laboratory 
evidence of M. tuberculosis.
In January 1993, in conjunction with state and 
local health departments, CDC implemented 
an expanded surveillance system for TB that 
would collect additional data to better moni-
tor and target groups at risk for TB disease, to 
estimate and follow the extent of drug-resistant 
TB, and to evaluate outcomes of TB cases.  The 
RVCT form for reporting TB cases was revised 
to collect information on occupation, the initial 
drug regimen, human immunodeficiency virus 
(HIV) test results, history of substance abuse and 
homelessness, and residence in correctional or 
long term-care facilities at the time of diagnosis.  
RVCT Follow Up Report-1 was added to collect 
drug susceptibility results for the initial M. tuber-
culosis isolate from patients with culture-positive 
disease.
To evaluate the outcomes of TB therapy, RVCT 
Follow Up Report-2 was added to collect in-
formation on the reason and date therapy was 
stopped, the type of health care provider, sputum 
culture conversion, the use of directly observed 
therapy (DOT), and the results of drug-suscepti-
bility testing for the final M. tuberculosis isolate 
from patients with culture-positive disease.
Since 1993, RVCT data have been reported to 
CDC using software specifically developed for 
expanded TB surveillance (i.e., SURVS-TB, 
1993–1997; TIMS, 1998–present).  The instruc-
tions for completing the RVCT forms and the 
definitions for all data items were included in the 
software user’s guide.  The summary data pre-
sented in this publication for 2007 (and for 2005, 
Tables 39–44) and the trend data for 1993–2007 
(Tables 1–14) were received at CDC by April 23, 
2008.
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Completion of Tuberculosis Therapy
Tables 12, 41, 43, and 44 present rates of com-
pletion of TB therapy (COT).  Data collected by 
RVCT Follow Up Report-2 on date and reason 
therapy stopped (e.g., patient completed therapy, 
moved, was lost) were used to calculate rates 
of COT.  Cases were stratified by the indicated 
length of therapy, based on American Thoracic 
Society/CDC/Infectious Diseases Society of 
America treatment guidelines2 in effect dur-
ing the period covered, and the patient’s initial 
drug susceptibility test results, age, and site of 
disease.  The adequacy of the treatment regimen 
(e.g., the sufficiency of the duration of therapy, 
the appropriateness of the prescribed TB drugs) 
was not evaluated in this analysis. Acquired drug 
resistance during therapy with the need for a lon-
ger duration of therapy was also not considered 
in this analysis.
In Table 41, the first column shows the total 
number of cases reported during 2005.  The 
remaining columns are grouped under three 
headings: therapy of 1 year or less indicated, 
therapy greater than 1 year indicated, and over-
all. Patients eligible to complete therapy within 
one year had to have been alive at diagnosis and 
initiated therapy with at least one drug. Eligible 
patients did not have rifampin resistance, did not 
die during therapy, and did not have meningeal 
tuberculosis, regardless of age.  In addition, tu-
berculosis cases under the age of 15 were not eli-
gible to complete therapy within one year if they 
had disseminated disease (disseminated disease 
is defined as miliary tuberculosis and/or a posi-
tive tuberculosis blood culture). Patients with 
culture-negative disease, those with an unknown 
culture status, and those with culture-positive 
disease but unknown initial drug-susceptibility 
test results, data were included under the catego-
ry of 1 year or less of therapy indicated. Table 12 
presents data only for cases where therapy of 1 
year or less was indicated.   
In Table 41, each group under an indicated 
length of therapy has an initial column showing 
2CDC.  Treatment of Tuberculosis, American Thoracic Society, CDC, and the Infectious Diseases Society of America.  MMWR 
2003;52(No.RR-11):1-77.  
the number of cases in persons who were alive 
at diagnosis and prescribed an initial regimen of 
one or more drugs, and who did not die during 
therapy.  This number was used as the denomina-
tor in COT rate calculations.
COT rates, shown as percentages, were only 
calculated for areas reporting reason therapy 
stopped for at least 90% of cases shown in the 
overall column. For the group with an indi-
cated length of therapy of 1 year or less, rates 
are shown for both COT in 1 year or less (COT 
<1 year) and for COT, regardless of duration 
(i.e., duration of therapy <1 year, >1 year, or 
unknown).  For COT <1 year, the numerator 
included only those patients completing therapy 
in <365 days (based on the dates therapy started 
and stopped).  Patients with missing dates were 
classified as “treatment not completed” for this 
calculation.
Rates of COT, regardless of duration, were 
calculated by dividing the number of patients 
reported as having completed therapy by the 
number of total eligible patients.  Patients with 
an outcome other than completed therapy (i.e., 
moved, lost, refused treatment, and other) were 
classified as “treatment not completed.”  Patients 
with an unknown outcome were also classified 
as “treatment not completed.”  For the remaining 
two groups of indicated therapy length (greater 
than 1 year and overall), only rates of COT, 
regardless of duration, are presented.  Table 12 
provides rates for COT <1 year and for COT, 
regardless of duration, only for the group with 
an indicated therapy of 1 year or less.  Table 
43 presents rates of COT by ethnicity and non-
Hispanic race, and by state for those in whom 
therapy less than 1 year was indicated.
Site of TB Disease
Miliary disease is classified as both an extrapul-
monary and a pulmonary form of TB (Tables 8, 
9, 26, 27, and 47).  In publications prior to 1997, 
miliary disease was classified as extrapulmonary 
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TB unless pulmonary disease was reported as the 
major site of TB disease. 
Reporting of HIV Status 
Table 37 shows information on HIV status for 
persons with TB aged 25–44 years, the age 
group in which 73% of AIDS cases occur (CDC. 
HIV/AIDS Surveillance Report 2003; 15).  The 
information on HIV status for TB cases reported 
in 2007 is incomplete.  Reasons for incomplete 
reporting of HIV test results to the national TB 
surveillance system include concerns about 
confidentiality, which may limit the exchange 
of data between TB and HIV/AIDS programs; 
laws and regulations in certain states and local 
jurisdictions that have been interpreted as pro-
hibiting the HIV/AIDS program from sharing the 
HIV status of TB patients with the TB program, 
or from reporting patients with TB and AIDS to 
the TB program; and reluctance by health care 
providers to report HIV test results to the TB 
surveillance program staff.  In addition, health 
care providers may not offer HIV counseling, 
testing, and referral to some TB patients because 
of a lack of resources or of appropriately trained 
staff, or due to the perception that selected pa-
tients (e.g., foreign-born persons) are not at risk 
for HIV infection.
Data on the HIV-infection status of reported TB 
cases should be interpreted with caution.  These 
data are not representative of all TB patients with 
HIV infection.  HIV testing is performed after a 
patient receives counseling and gives informed 
consent.  Since testing is voluntary, some TB 
patients may decline HIV testing.  TB patients 
who are tested anonymously may choose not 
to share the results of HIV testing with their 
health care provider.  TB patients managed in 
the private sector may receive confidential HIV 
testing, but results may not be reported to the TB 
program in the health department.  In addition, 
many factors may influence HIV testing of TB 
patients, including the extent to which testing is 
targeted or routinely offered to specific groups 
(e.g., 25- to 44-year-old males, injecting drug 
users, homeless persons), and the availability of 
and access to HIV testing services.  These data 
may overrepresent or underrepresent the propor-
tion of TB patients known to be HIV infected in 
a reporting area.
 
Tabulation and Presentation of TB Data  
This report primarily presents summary data for 
TB cases reported to CDC in 2007.  Data from 
the RVCT Follow Up Report-2 (i.e., completion 
of therapy, use of directly observed therapy, and 
type of health care provider) are presented for 
cases reported in 2005.  In addition, trend data 
are presented in Tables 1 through 14.  TB cases 
are tabulated by the year in which the reporting 
area verified that the patient had TB and included 
the patient in its official annual TB case count.  
In contrast to previous annual summaries, in 
which TB case counts for preceding years were 
not updated, the current summary reflects up-
dated information on the numbers of cases of 
confirmed TB for each year from 1993 to 2006.  
Therefore, case counts for these years differ from 
those reported in the annual summaries previ-
ously published.  Totals for the United States 
only include data from the 50 states, the District 
of Columbia, and New York City.  Age group 
tabulations are based on the patient’s age in the 
month and year the patient was reported to the 
health department as a suspected TB case.  State 
or metropolitan area data tabulations are based 
on the patient’s residence at diagnosis of TB (see 
Appendix B: “Recommendations for Counting 
Reported Tuberculosis Cases”).
Tables 46 through 50 present data by metropoli-
tan statistical areas (MSAs) with an estimated 
2007 population of 500,000 or more.  MSAs are 
defined by the federal Office of Management and 
Budget (OMB), and the definitions effective as 
of December 2006 were used for this publica-
tion (http://www.whitehouse.gov/omb/bulle-
tins/fy2007/b07-01.pdf).  On June 6, 2003, the 
OMB announced new MSA definitions based on 
Census 2000 data and the information has been 
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updated annually. Some MSAs added or dropped 
counties and some MSAs merged.  The MSA 
definitions apply to all areas except the six New 
England states; for these states, the New Eng-
land County Metropolitan Areas (NECMAs) are 
used.  MSAs are named for a central city in the 
MSA or NECMA, may include several cities and 
counties, and may cross state boundaries.  For 
example, the TB cases and case rates presented 
for the District of Columbia in Table 20 include 
only persons residing within the geographic 
boundaries of the District.  However, the TB 
cases and case rates for the Washington, D.C., 
MSA (Table 46) include persons residing within 
the several counties in the metropolitan area, 
including counties in Maryland, Virginia, and 
West Virginia.
 
Rates
Rates are expressed as the number of cases 
reported each calendar year per 100,000 popula-
tion.  Population denominators used in calculat-
ing TB rates were based on official census and 
midyear (July 1) postcensal estimates from the 
U.S. Census Bureau.  Specifically, in Tables 1 
and 20, the U.S. total populations for 2000 to 
2007 were obtained from the Annual Estimates 
of the Population for the United States, Regions, 
States, and Puerto Rico (July 1, 2000– July 1, 
2007).3 In 2003, two modifications were made 
to the RVCT form: 1) entries for multiple race 
(two or more races reported for a person) were 
allowed, and 2) the previous category of Asian/
Pacific Islander was divided into “Asian” and 
“Native Hawaiian or Other Pacific Islander.”  To 
calculate rates in Tables 2 and 3, denominators 
for 2000 to 2007 were obtained from the Annual 
Estimates of the Population by Sex, Race, and 
Hispanic or Latino Origin for the United States: 
April 1, 2000, to July 1, 2007.4 To calculate rates 
for Table 4, denominators were obtained from 
the Annual Estimates of the Population by Sex 
and Five-Year Age Groups for the United States: 
April 1, 2000, to July 1, 2007.5  Denomina-
tors for computing 2007 rates in Table 16 were 
obtained from U.S. Census Bureau Monthly 
Postcensal Resident Population, by single year of 
age, sex, race, and Hispanic origin: July 1, 2007.6 
In 2004, the method for calculating the annual 
percentage change in the TB case rate was modi-
fied.  In contrast to methods used in previous 
summaries, unrounded figures are now applied 
to calculate the percentage change in the case 
rate, providing a greater degree of precision and 
accuracy than in the past.
In Table 5, the populations for U.S.-born and 
foreign-born persons for 1993 and 1994 were 
obtained from Quarterly Estimates of the United 
States Foreign-born and Native Resident Popula-
tions: April 1, 1990, to July 1, 1999.7  Denomi-
nators for computing the 1995–2007 rates were 
based on extrapolations from the U.S. Census 
Current Population Survey (March Supplement). 
 
Mortality Data
Official TB mortality statistics for the United 
States are compiled by the National Center for 
Health Statistics (NCHS), CDC.  The annual 
mortality rate is calculated as the number of 
deaths due to TB in that year, divided by the 
estimated population for the year, multiplied by 
100,000 (Table 1).  The number of deaths for 
2006 (preliminary) was obtained from the Na-
tional Center for Health Statistics, National Vital 
Statistics Report, Vol. 56, No. 16, June 11, 2008.  
The number of deaths for 2007 was not available 
at the time of this publication.
3 http://www.census.gov/popest/states/tables/NST-EST2007-01.xls
4 http://www.census.gov/popest/national/asrh/NC-EST2007/NC-EST2007-03.xls
5 http://www.census.gov/popest/national/asrh/NC-EST2007/NC-EST2007-01.xls
6 http://www.census.gov/popest/national/asrh/files/NC-EST2007-ALLDATA-R-Files16.csv
7 http://www.census.gov/popest/archives/1990s/nat-nativity-sum.txt
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Morbidity Trend Tables
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00 , . -. -.  0. -. 0.0
00 ,0 . -. -.  0. +. 0.0
00 , . -. -.  0. -0. -.
00 ,0 . -. -.  0. -. 0.0
00 ,0 . -.0 -.  0. -. 0.0
00 , . -. -.  0. -0. 0.0
00 , . -. -. … … … …
Table 1. Tuberculosis Cases, Case Rates per 100,000 Population, Deaths, and Death Rates 
per 100,000 Population, and Percent Change:  United States, 1953–2007
Tuberculosis Cases Tuberculosis Deaths
Percent ChangePercent Change
Number Rate Number RateNumber NumberRate RateYear
 Official tuberculosis mortality statistics were compiled by the National Center for Health Statistics, CDC, National Vital Statistics 
Reports. 
 The large decrease in death rate in 1979 occurred because late effects of tuberculosis (e.g., bronchiectasis or fibrosis) and pleu-
risy with effusion (without mention of cause) are no longer included in tuberculosis deaths.
Percent change in tuberculosis death rates is calculated with rounded figures. See Technical Notes (page 9). 
Note: 1993 to 2007 tuberculosis case counts and rates updated as of April 23, 2008, using Bridged-Race 1990–1999 Intercensal 
Population Estimates for 1990–1999 (ftp://ftp.cdc.gov/pub/health_statistics/nchs/datasets/nvss/bridgepop/documentationbridged-
intercena1.doc) (accessed July 7, 2008) and Annual Estimates of the Population for the United States and States, and for Puerto 
Rico (July 1, 2000– July 1, 2007)  (www.census.gov/popest/states/tables/NST-EST2007-01.xls) (accessed July 7, 2008).  Percent-
age change results reported to one decimal. Ellipses indicate data not available. Case data after 1974 are not comparable to prior 
years due to changes in the surveillance case definition that became effective in 1975.  See Surveillance Slides #2 and #3.
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 Table 4.  Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Age 
Group: United States, 1993–2007 
Year
Total
Cases
0–14 15–24 25–44 45–64 > Unk..
No. No. No. No. No. No. (%)(%)(%)(%)(%)(%) Rate Rate Rate Rate Rate
Includes unknown and missing.
Note: Previously published rates for 1993–1999 have been updated using Bridged-Race 1990–1999 Intercensal Population Estimates  
(http://www.cdc.gov/nchs/about/major/dvs/popbridge/popbridge.htm) (accessed June 24, 2008). Denominators for computing 2000–2007 
case rates were obtained from the Annual Estimates of the Population by Sex and Five-Year Age Groups for the United States: April 1, 
2000, to July 1, 2007  (http://www.census.gov/popest/national/asrh/NC-EST2007/NC-EST2007-03.xls) (accessed June 24, 2008).
Data for all years updated through April 23, 2008.
See Technical Notes (page 9).
Zero % (0) denotes <0.5%.
See Surveillance Slides #5 and #6.
Table 5.  Tuberculosis Cases, Percentages, and Case Rates per 100,000 
Population by Origin of Birth: United States, 1993–2007
Year
Total
Cases
U.S.-born Persons Foreign-born Persons Unknown or Missing
No. (%)No. (%) RateNo. (%) Rate
Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the 
Republic of the Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, 
the Republic of Palau, the U.S. Virgin Islands, and U.S. minor and outlying Pacific islands.
Note:  Denominators for computing rates for years 1993–1994 were obtained from Quarterly Estimates of the 
United States Foreign-born and Native Resident Populations: April 1, 1990–July 1, 1999, located at http://www.
census.gov/population/estimates/nation/nativity/fbtab001.txt (accessed June 24, 2008). Denominators for comput-
ing the 1995–2007 rates are based on the U.S. Census Bureau, Current Population Survey (March Supplement).  
Data for all years updated through April 23, 2008.
 See Technical Notes (page 9).
Zero % (0) denotes <0.5%.
See Surveillance Slides #11, #12, #15, and #16.

 Table 6. Tuberculosis Cases and Percentages Among Foreign-born Persons1 by 
the Top 30 Countries2 of Origin of Birth: United States, 2003–2007
Country of Origin
00 00 00 00 00
Year
No. No. No. No. No.(%) (%) (%) (%) (%)
Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the 
Republic of the Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the 
Republic of Palau, the U.S. Virgin Islands, and U.S. minor and outlying Pacific islands.
The top 30 countries were selected based on their ranked 5-year average number of TB cases.
 Includes Not Specified for Country of Origin. Excludes missing.
Note: Zero (0) denotes <0.5%.
Data for all years updated through April 23, 2008.
Total Cases 7,750 (100) 7,817 (100) 7,722 (100) 7,845 (100) 7,931 (100)
Mexico , (24) , (25) , (25) ,00 (26) ,0 (26)
Philippines  (12) 0 (11) 0 (11) 0 (11)  (12)
Vietnam  (7)  (8)  (7)  (8)  (8)
India  (8)  (7)  (7)  (7) 0 (8)
China  (5)  (5)  (5)  (4)  (5)
Haiti  (2)  (3)  (3)  (3)  (3)
Guatemala  (3) 0 (3)  (3) 0 (2)  (2)
Korea, Republic of  (2) 0 (3)  (2)  (3)  (2)
Ethiopia  (2) 0 (3) 0 (2) 0 (2)  (2)
Peru  (2) 0 (2)  (2)  (2)  (2)
Somalia  (2)  (3)  (2) 0 (2) 0 (1)
Honduras 0 (2)  (2)  (2)  (1)  (2)
Ecuador  (1)  (1)  (2)  (2)  (2)
El Salvador  (2)  (2)  (2)  (2)  (1)
Cambodia  (1)  (1) 0 (1) 0 (1)  (1)
Dominican Republic 0 (1)  (1)  (1) 0 (1)  (1)
Pakistan  (1) 0 (1)  (1)  (1)  (1)
Lao, PDR  (1) 0 (1)  (1)  (1)  (1)
Kenya  (1)  (1)  (1)  (1)  (1)
Thailand  (1)  (1)  (1) 0 (1)  (1)
Colombia  (1)  (1)  (0)  (1)  (1)
Liberia  (1)  (1)  (1)  (1) 0 (0)
Indonesia  (1)  (1)  (1)  (0)  (1)
Cuba  (1)  (1)  (1)  (1)  (1)
Nigeria  (1)  (0)  (0)  (1)  (1)
Nepal  (1)  (1)  (0)  (1)  (0)
Burma  (1) 0 (1)  (1)  (1)  (0)
Bangladesh  (1)  (1)  (0)  (0)  (0)
Russia  (1)  (1)  (1)  (0) 0 (0)
Taiwan  (1)  (0)  (0)  (0)  (0)
All Others  (12)  (13)  (12) 0 (13)  (12)
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 Table 9.  Pulmonary Tuberculosis Cases and Percentages by Sputum Smear and Sputum 
Culture Results: United States, 1993–2007
Year
Total 
Pulmonary 
Cases
Sputum Smear Result Sputum Culture Result
Positive Negative
Not Done or 
Unknown Positive Negative
Not Done or  
Unknown
No. (%) No. (%) No. No. No. No.(%) (%) (%) (%)
 Includes cases among persons with both pulmonary and extrapulmonary disease and cases of miliary TB.
Note:   See Technical Notes (page 9).
Data for all years updated through April 23, 2008.
	Table	8.		Tuberculosis	Cases	and	Percentages	by	Case	Verification	Criterion	and	Site	of	
Disease: United States, 1993–2007
Year
Total
Cases
Verification Criterion Site of Disease
Positive
Culture
Positive
Smear
Clinical
Case Definition
Provider
Diagnosis Pulmonary
Extra-
pulmonary
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Based on the public health surveillance case definition for tuberculosis:  CDC. Case definitions for infectious conditions under public 
health surveillance.  MMWR 1997:46(No. RR-10):40–41.  See Appendix A.
Includes cases among persons with both pulmonary and extrapulmonary disease and cases of miliary TB.
Includes cases among persons with extrapulmonary TB disease only.
Excludes missing and unknowns.
Note: See Technical Notes (page 9) for a description of national TB surveillance.
Data for all years updated through April 23, 2008.
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  (17.0)  (11.7)  (27.9)  (7.2)  (5.1)  (11.3)
  (17.5)  (13.0)  (25.1) 0 (7.3)  (4.7)  (11.6)
  (16.5)  (12.0)  (24.4)  (5.0) 0 (3.6)  (7.3)
 0 (14.7)  (7.7)  (25.9)  (5.9)  (2.6)  (11.2)
  (13.0)  (7.8) 0 (22.8)  (3.1)  (1.2)  (6.5)
  (12.3)  (6.5)  (19.4)  (4.2)  (1.6)  (7.8)
000  (13.0)  (6.1) 0 (22.2)  (3.8)  (0.6)  (8.1)
00  (13.6)  (8.6)  (19.0)  (4.9)  (2.2)  (8.0)
00  (13.9)  (7.6)  (21.3)  (4.4)  (1.0)  (8.4)
00  (12.5)  (6.4)  (18.1) 0 (3.8)  (0.8)  (6.6)
00  (11.6)  (5.5)  (18.0)  (4.7)  (1.5)  (8.0)
00 0 (13.8)  (8.0)  (19.0)  (4.4)  (0.8) 0 (7.5)
00  (13.9)  (4.5)  (20.2)  (4.5)  (0.5)  (7.3)
00  (14.2)  (7.1)  (19.3)  (4.0)  (1.5)  (5.7)
 Table 10. Tuberculosis Cases and Percentages, by Resistance to INH or Multidrug 
Resistance1 in Persons with No Previous History of TB, by Origin of Birth: United 
States, 1993–2007
Resistance to at least isoniazid and rifampin. 
Isolates may be resistant to other drugs.
All cases were culture positive, and initial drug susceptibility testing done.
Includes persons of unknown country of birth.
Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacific islands.
Includes Not Specified for Country of Origin.  Excludes missing.
Note:  Data for all years updated through April 23, 2008.
Percentages are of total cases for given year with no previous history of TB, culture positive, and initial drug susceptibility testing done 
(total cases not shown). More than 95% of all persons in each group had drug-susceptibility test results reported for an initial isolate.
See Surveillance Slides #19 through #22.
Year
Resistance to Isoniazid Resistance to Isoniazid and Rifampin
Total Cases, Foreign-born,U.S.-born Total Cases, U.S.-born Foreign-born,
No. No. No. No. No. No.(%) (%) (%) (%) (%) (%)
Resistance to at least isoniazid and rifampin
Isolates may be resistant to other drugs.
All cases were culture positive, and initial drug susceptibility testing done.
Includes persons of unknown country of birth.
Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacific islands.
 Includes Not Specified for Country of Origin.  Excludes missing.
Note:  Data for all years updated through April 23, 2008.
Percentages are of total cases for given year with previous history of TB, culture positive, and initial drug susceptibility testing done (total 
cases not shown). More than 95% of all persons in each group had drug-susceptibility test results reported for an initial isolate.
Table 11. Tuberculosis Cases and Percentages, by Resistance to INH or Multidrug 
Resistance1 in Persons with Previous History of TB, by Origin of Birth: United 
States, 1993–2007
Year
Resistance to Isoniazid Resistance to Isoniazid and Rifampin
Total Cases, Foreign-born,U.S.-born Total Cases, U.S.-born Foreign-born,
No. No. No. No. No. No.(%) (%) (%) (%) (%) (%)

 (12.9) (31.2) (40.9) (40.3) (21.3) (14.1) (64.1) (87.5)
 (7.0) (23.3) (56.3) (55.7) (26.8) (19.6) (69.0) (87.9)
 (5.2) (20.3) (63.4) (62.7) (36.1) (20.8) (73.9) (89.6)
 (4.2) (17.5) (67.9) (67.3) (41.5) (21.9) (76.4) (90.5)
 (3.2) (15.1) (72.4) (71.9) (45.9) (23.3) (78.2) (91.3)
 (2.6) (12.9) (74.7) (74.3) (46.8) (26.1) (80.6) (92.5)
 (2.2) (11.2) (77.2) (76.9) (48.5) (27.1) (80.8) (92.3)
000 (2.0) (10.4) (78.6) (78.5) (51.8) (25.5) (81.5) (92.6)
00 (1.7) (9.6) (80.1) (79.8) (52.7) (27.0) (81.5) (92.5)
00 (1.8) (8.9) (80.5) (80.3) (54.4) (27.3) (82.1) (92.3)
00 (1.4) (8.1) (81.5) (81.3) (55.8) (28.1) (82.8) (92.7)
00 (1.5) (6.3) (82.5) (82.4) (57.5) (27.0) (82.8) (91.7)
00 (1.2) (5.5) (83.8) (83.7) (56.8) (29.4) (82.7) (91.9)
00 (1.2) (4.8) (83.2) (83.1) … … … …
00 (1.1) (4.7) (83.3) (83.3) … … … …
 Table 13.  Tuberculosis Cases and Percentages in Persons with HIV Test Results1 and with 
HIV Coinfection by Age Group: United States, 1993–2006
Year
25–44 Years Old All Ages
HIV Test
Results HIV Positive
HIV Test
Results HIV Positive
No. No. No. No.(%) (%) (%) (%)
Includes persons with positive, negative, or indeterminate HIV test results and persons from California with co-diagnosis of TB and 
AIDS. In California, the number of patients testing negative, indeterminate, refusing testing, not offered testing, test performed but status 
unknown, unknown, or missing HIV data is not reported to CDC. California did not report AIDS test results for 2005. Rhode Island did not 
report HIV test results for years 1993–1997.
Note:  Data for all years updated through April 23, 2008.
See Surveillance Slides #24 and #25. 
 Table 12.  Percentages of Tuberculosis Cases by Initial Drug Regimen, Use of Directly  
Observed Therapy (DOT), and Completion of Therapy (COT): United States, 1993–2007
Year
Initial Drug Regimen,
Directly Observed Therapy
Therapy <1 Year Indicated
IRZ IRZ, E/S DOT Only
Both DOT and Self-
Administered COT < Year COTI R
 Includes persons alive at diagnosis.
I=isoniazid; R=rifampin; Z=pyrazinamide; E=ethambutol; S=streptomycin.  Excludes cases with no information on initial drug regimen; 
0.74% received no initial drug therapy, 0.16% were started on one drug, and 9.65% had an initial multidrug regimen other than IR, IRZ, or 
IRZ,E/S.
Includes persons alive at diagnosis with initial drug regimen of one or more drugs prescribed.
Includes persons alive at diagnosis, with initial drug regimen of one or more drugs prescribed, who did not die during therapy.  Excludes 
persons with initial isolate resistant to rifampin and pediatric (aged <15) cases with meningeal, bone or joint, or miliary disease.  See 
Technical Notes (page 9) for description of COT calculation.
Note: Ellipses indicate data not available.
Data for all years updated through April 23, 2008.
See Surveillance Slides #25 and #26.
IRZE
  (46) 0 (29)  (30)  (15)
  (49)  (30)  (33) 0 (15)
  (52)  (26)  (36) 0 (13)
  (58)  (25)  (42)  (12)
  (60)  (21)  (44) 0 (11)
  (61) 0 (20)  (45)  (10)
  (63)  (19) 0 (48)  (10)
000  (63)  (17)  (50)  (9)
00  (64)  (16) 0 (50) 0 (9)
00  (66)  (16)  (53)  (9)
00  (67) 0 (16) 0 (55) 0 (9)
00  (68)  (14)  (57)  (8)
00  (69)  (13)  (58) 0 (7)
00  (69)  (12)  (60) 0 (7)

Table 14.  Tuberculosis Cases and Percentages by Reason Tuberculosis Therapy Stopped: 
United States, 1993–2005
Year
Total
Cases Completed Therapy Moved Lost Refused Died Unknown
Includes all cases in persons reported as alive at diagnosis and taking one or more TB drugs.
Died = died of any cause (not only TB).
Includes cases in persons reporting reason therapy stopped = Other, Missing, or Unknown. 
Note: Data for all years are updated through April 23, 2008.
Data complete through 2005 only.  See Technical Notes (page 9) for details.
No. (%) No. No. No. No. No.(%) (%) (%) (%) (%)No.
  0 (76.0) 0 (4.7) 0 (4.6)  (0.9) 0 (12.9)  (0.9)
 0  (77.1)  (5.2)  (3.2)  (0.8)  (11.9)  (1.9)
   (79.6)  (4.5)  (2.6)  (0.7)  (11.0)  (1.6)
 0 0 (81.3)  (3.9) 0 (2.6)  (0.8)  (9.8)  (1.7)
 0  (82.7)  (3.5)  (2.3)  (0.6)  (9.3) 00 (1.6)
   (84.0)  (3.0) 00 (2.3) 0 (0.6)  (9.0) 0 (1.2)
   (84.3)  (2.7)  (2.1) 0 (0.6)  (8.5)  (1.7)
000   (84.9) 0 (2.6)  (2.5)  (0.7)  (8.2)  (1.1)
00 0  (85.6)  (2.4)  (2.4)  (0.6)  (7.2)  (1.7)
00  0 (85.4)  (2.3)  (2.5)  (0.6) 0 (7.4)  (1.9)
00   (86.2)  (2.2)  (2.5)  (0.6)  (6.9)  (1.7)
00 0  (85.2)  (2.4)  (2.4)  (0.6) 0 (6.8)  (2.6)
00   (85.1)  (2.5)  (2.3)  (0.6)  (7.1)  (2.3)

Morbidity Tables
United States, 2007


Table 15.  Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race, Sex, and Age 
Group: United States, 2007
Persons of Hispanic or Latino ethnicity may be of any race or multiple race.             
Indicates two or more races reported for a person. Category first reported in 2003.        
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other 
Pacific Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple Race does 
not include persons of Hispanic ethnicity.
See Technical Notes (page 9).                 
See Surveillance Slide #10.
Age Group
Race/Ethnicity and Sex All Ages Under 5 5–14 15–24 25–44 45–64 >
Not 
Stated
Total Cases ,   , , ,0 , 
  Male ,    , , ,0 
  Female ,  0  , , ,0 0
  Unknown  0 0 0   0 0
Hispanic or Latino ,  0  ,  0 
  Male ,   0 ,0 0  
  Female ,   0   0 0
  Unknown  0 0 0   0 0
Non-Hispanic
American Indian or Alaska Native        0
  Male 0       0
  Female      0  0
  Unknown 0 0 0 0 0 0 0 0
Asian ,   0 , ,0  0
  Male , 0    0  0
  Female ,       0
  Unknown 0 0 0 0 0 0 0 0
Black or African American ,0    , ,  0
  Male ,0      0 0
  Female ,   0   0 0
  Unknown 0 0 0 0 0 0 0 0
Native Hawaiian or Other Pacific Islander        0
  Male        0
  Female 0      0 0
  Unknown 0 0 0 0 0 0 0 0
White ,  0     
  Male ,  0     
  Female   0     0
  Unknown 0 0 0 0 0 0 0 0
Multiple Race   0     0
  Male   0     0
  Female   0     0
  Unknown 0 0 0 0 0 0 0 0
Unknown  0      0
  Male 0 0 0     0
  Female  0      0
  Unknown 0 0 0 0 0 0 0 0

Table 16.  Tuberculosis Case Rates per 100,000 Population by Hispanic Ethnicity and Non-
Hispanic Race, Sex, and Age Group: United States, 2007
Persons of Hispanic or Latino origin may be of any race or multiple race.             
Indicates two or more races reported for a person. Category first reported in 2003.        
Note: Denominators for computing case rates were obtained from the U.S. Census Bureau Monthly Postcensal Resident Population, by 
single year of age, sex, race, and Hispanic origin: July 1, 2007 (http://www.census.gov/popest/national/asrh/files/NC-EST2007-ALLDATA-
R-File16.csv) (Accessed May 5, 2008).
Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other Pacific 
Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple Race does not 
include persons of Hispanic ethnicity.
See Technical Notes (page 9).                 
See Surveillance Slides #7 and #10.                 
Age Group
Race/Ethnicity and Sex All Ages Under 5 5–14 15–24 25–44 45 –64 >
Total Rate . . 0. . . . .
Male . . 0. . .0 . .
Female . . 0. . . . .
Hispanic or Latino . . . . . . .
Male 0. . . . . . .
Female . . . . . . .
American Indian or Alaska Native . . . . . 0. .
Male . . . . .0 . .
Female . . . .0 . . .
Asian . . . . . . .
Male . . . . . . .0
Female . . . . . . .
Black or African American . . . . 0. . .
Male . . . . . . .
Female . .0 . . . . 0.
Native Hawaiian or Other Pacific Islander .0 .0 . . . . .
Male . . . 0. . 0. .0
Female . . . . .0 . 0.
White . 0. 0. 0. 0. . .
Male . 0. 0. 0. .0 . .
Female 0. 0. 0. 0. 0. 0. .
Multiple Race 0. 0. 0.0 0. 0. . .
Male 0. 0. 0.0 0. 0. .0 .
Female 0. 0. 0.0 0. 0. 0. .

Age Group
Race/Ethnicity and Sex All Ages Under 5 5–14 15–24 25–44 45–64 >
Not 
Stated
Table 17.  Tuberculosis Cases in U.S.-born Persons by Hispanic Ethnicity and Non-Hispanic 
Race, Sex, and Age Group: United States, 2007
Persons of Hispanic or Latino origin may be of any race or multiple race.             
Indicates two or more races reported for a person. Category first reported in 2003.        
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other 
Pacific Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple race does 
not include persons of Hispanic ethnicity.
See Technical Notes (page 9).
See Surveillance Slide #13.
Total Cases ,    , , , 
  Male ,0 0    ,  
  Female ,    0  0 0
  Unknown 0 0 0 0 0 0 0 0
Hispanic or Latino  0   0   
  Male  0  0    
  Female  00      0
  Unknown 0 0 0 0 0 0 0 0
Non-Hispanic
American Indian or Alaska Native 0       0
  Male        0
  Female      0  0
  Unknown 0 0 0 0 0 0 0 0
Asian  0   0   0
  Male 0      0 0
  Female        0
  Unknown 0 0 0 0 0 0 0 0
Black or African American ,0 0  0  ,00 0 0
  Male ,   0 0   0
  Female 0    0   0
  Unknown 0 0 0 0 0 0 0 0
Native Hawaiian or other Pacific Islander        0
  Male        0
  Female     0 0  0
  Unknown 0 0 0 0 0 0 0 0
White ,  0     
  Male ,       
  Female        0
  Unknown 0 0 0 0 0 0 0 0
Multiple Race   0 0    0
  Male   0 0 0   0
  Female   0 0  0  0
  Unknown 0 0 0 0 0 0 0 0
Unknown  0  0    0
  Male  0 0 0    0
  Female  0  0   0 0
  Unknown 0 0 0 0 0 0 0 0
0
Table 18.  Tuberculosis Cases in Foreign-born Persons1 by Hispanic Ethnicity and Non-His-
panic Race, Sex, and Age Group: United States, 2007
Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacific islands.                 
Persons of Hispanic or Latino ethnicity may be of any race or multiple race.            
Indicates two or more races reported for a person. Category first reported in 2003.        
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other 
Pacific Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple race does 
not include persons of Hispanic ethnicity.
See Technical Notes (page 9). 
See Surveillance Slide #13.
Age Group
Race/Ethnicity and Sex All Ages Under 5 5–14 15–24 25–44 45–64 >
Not 
Stated
Total Cases ,0   , ,0 ,0 , 0
  Male , 0 0  , ,0  0
  Female ,    , 0 0 0
  Unknown  0 0 0   0 0
Hispanic or Latino ,    ,   0
  Male ,      0 0
  Female       0 0
  Unknown  0 0 0   0 0
Non-Hispanic
American Indian or Alaska Native  0    0  0
  Male  0    0 0 0
  Female  0 0 0  0  0
  Unknown 0 0 0 0 0 0 0 0
Asian ,0    , ,0  0
  Male ,     0  0
  Female ,  0 0    0
  Unknown 0 0 0 0 0 0 0 0
Black or African American ,00 0  0  0  0
  Male    0    0
  Female     0   0
  Unknown 0 0 0 0 0 0 0 0
Native Hawaiian or Other Pacific Islander   0  0   0
  Male   0 0   0 0
  Female  0 0     0
  Unknown 0 0 0 0 0 0 0 0
White   0   0  0
  Male        0
  Female        0
  Unknown 0 0 0 0 0 0 0 0
Multiple Race  0 0     0
  Male  0 0    0 0
  Female  0 0     0
  Unknown 0 0 0 0 0 0 0 0
Unknown  0 0     0
  Male  0 0  0  0 0
  Female  0 0     0
  Unknown 0 0 0 0 0 0 0 0

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
Eastern Mediterranean Region
Total Cases = 356
Algeria 0 Ethiopia  Niger 0
Angola  Gabon 0 Nigeria 
Benin 0 Gambia  Rwanda 
Botswana  Ghana  Sao Tome and Principe 
Burkina Faso  Guinea  Senegal 
Burundi  Guinea-Bissau  Seychelles 
Cameroon  Kenya  Sierra Leone 
Cape Verde  Lesotho 0 South Africa 
Central African Republic  Liberia  Swaziland 
Chad  Madagascar 0 Tanzania, UR 
Comoros 0 Malawi  Togo 
Congo, Republic of  Mali  Uganda 
Côte d’Ivoire  Mauritania  Zambia 
DR Congo  Mauritius 0 Zimbabwe 
Equatorial Guinea  Mozambique 0   
Eritrea 0 Namibia 
Anguilla 0 Cuba  Panama 
Antigua and Barbuda 0 Dominica  Paraguay 0
Argentina  Dominican Republic 0 Peru 
Bahamas  Ecuador  Puerto Rico 0
Barbados  El Salvador  St. Kitts and Nevis 0
Belize  Grenada  St. Lucia 
Bermuda 0 Guatemala  St. Vincent & Grenadines 
Bolivia  Guyana  Suriname 
Brazil  Haiti  Trinidad and Tobago 
British Virgin Islands  Honduras 0 Turks and Caicos Islands 0
Canada  Jamaica  Uruguay 
Cayman Islands 0 Mexico , U.S. Virgin Islands 
Chile  Montserrat 0 United States of America ,
Colombia  Netherland Antilles 0 Venezuela 
Costa Rica  Nicaragua    
Afghanistan  Lebanon  Sudan 
Bahrain 0 Libyan Arab Jamahiriya 0 Syrian Arab Republic 
Djibouti 0 Morocco  Tunisia 
Egypt  Oman 0 United Arab Emirates 0
Iran, Islamic Republic of  Pakistan  West Bank and Gaza 0
Iraq  Qatar 0 Yemen 
Jordan  Saudi Arabia 
Kuwait  Somalia 
Table 19. Tuberculosis Cases by Country of Origin1: United States, 2007
African Region
Total Cases = 547
Americas Region
Total Cases = 8,683

Albania   Germany  Norway 0
Andorra 0 Greece   Poland 
Armenia  Hungary  Portugal 
Austria 0 Iceland  Romania 
Azerbaijan  Ireland  Russian Federation 
Belarus 0 Israel  San Marino 0
Belguim  Italy  Serbia 
Bosnia and Herzegovina  Kazakhstan 0 Slovakia 0
Bulgaria  Kyrgyzstan  Slovenia 
Croatia  Latvia  Spain 
Cyprus 0 Lithuania  Sweden 
Czech Republic  Luxembourg 0 Switzerland 0
Czechoslovakia  Macedonia, TFYR  Tajikistan 
Denmark  Malta 0 Turkey 
Estonia  Moldova, Republic of  Turkmenistan 0
Finland  Monaco 0 Ukraine 
France  Montenegro 0 United Kingdom 
Georgia  Netherlands  Uzbekistan 
Yugoslavia 
Bangladesh  Korea, DPR  Sri Lanka 
Bhutan  Maldives  Thailand 
India  Myanmar  Timor-Leste 0
Indonesia  Nepal 
American Samoa  Korea, Rep.  Philippines 
Australia 0 Lao, PDR  Samoa 
Brunei Darussalam 0 Malaysia  Singapore 0
Cambodia  Marshall Islands, Republic of  Solomon Islands 0
China  Micronesia, Federated States of  Tokelau 0
China, Hong Kong SAR  Mongolia  Tonga 
China, Macao SAR 0 Nauru 0 Tuvalu 0
Cook Islands 0 New Caledonia 0 Vanuatu 0
Fiji  New Zealand  Vietnam 
French Polynesia 0 Niue 0 Wallis and Futuna 0
Guam  N. Mariana Islands, Commonwealth of 
Japan  Palau, Republic of 0
Kiribati 0 Papua New Guinea 
Country as reported by patient.
Includes country codes currently reported via the National Tuberculosis Surveillance System that are not represented by WHO member 
states.
Note:  Regional composition of countries based on WHO 2008 Report Global Tuberculosis Control, Surveillance, Planning, Financing, 
World Health Organization  (WHO/HTM/TB/2008.393) (http://www.who.int/tb/publications/global_report/en/).
Table 19.  (Cont’d) Tuberculosis Cases by Country of Origin1: United States, 2007
European Region
Total Cases = 288
Other2
Total Cases = 50
Unknown
Total Cases = 56
Southeast Asia Region
Total Cases = 935
Western	Pacific	Region
Total Cases = 2,384

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
Morbidity Tables
States, 2007


United States 13,299 13,754 4.4 4.6 -- -- 301,621,157
Alabama   . .   ,,
Alaska  0 . 0.   ,
Arizona 0  . .  0 ,,
Arkansas 0 0 . .   ,,
California , , . .   ,,
Colorado   . . 0  ,,
Connecticut 0  . .   ,0,0
Delaware   . .   ,
District of Columbia 0  0. . -- -- ,
Florida  ,0 . .   ,,
Georgia  0 .0 .   ,,0
Hawaii   . .   ,,
Idaho  0 0. .   ,,0
Illinois   . .   ,,
Indiana   .0 .0   ,,
Iowa  0 . .   ,,0
Kansas   . .0   ,,
Kentucky 0  . .0   ,,
Louisiana  0 . .   ,,0
Maine   . . 0  ,,0
Maryland 0  . .   ,,
Massachusetts   . .0   ,,
Michigan   . .   0,0,
Minnesota   . .   ,,
Mississippi   . .0   ,,
Missouri  0 .0 .   ,,
Montana   . .   ,
Nebraska   . .  0 ,,
Nevada 0 0 .0 . 0 0 ,,
New Hampshire   0. .   ,,
New Jersey  0 . .   ,,0
New Mexico   . .  0 ,,
New York , , . .   ,,
North Carolina   . .   ,0,0
North Dakota  0 . .   ,
Ohio   . .   ,,
Oklahoma   . .0   ,,
Oregon   . .   ,,
Pennsylvania   . .   ,,
Rhode Island   . .   ,0,
South Carolina   . . 0  ,0,0
South Dakota   . .   ,
Tennessee   . .   ,,
Texas ,0 , . .   ,0,0
Utah   . .   ,,0
Vermont   0. .   ,
Virginia 0  .0 .   ,,0
Washington   . .   ,,
West Virginia   . .   ,,0
Wisconsin 0  . .   ,0,0
Wyoming   0. 0. 0 0 ,0
American Samoa,   . . -- -- ,
Fed. States of Micronesia,   . . -- -- 0,
Guam,   .0 . -- -- ,
Marshall Islands,   . . -- -- ,
N. Mariana Islands,   . . -- -- ,
Puerto Rico,   . . -- -- ,,
Republic of Palau,   . . -- -- 0,
U.S. Virgin Islands, ... ... ... ... -- -- 0,
Table 20. Tuberculosis Cases and Case Rates per 100,000 Population: States, 2007 and 2006
Not ranked with the states. See Table 28, page 50, for District of Columbia ranking among states.
Not included in U.S. totals. 
Note: Denominators for computing 2006 and 2007 rates for states, the District of Columbia, and Puerto Rico were obtained from An-
nual Estimates of the Population for the United States and States, and for Puerto Rico: April 1, 2000–July 1, 2007 (NST-EST2006-01) 
(accessed June 25, 2008)  (http://www.census.gov/popest/states/tables/NST-EST2007-01.xls); for all other areas, from IDB Summary 
Demographic Data (http://www.census.gov/ipc/www/idb/summaries.html).
Ellipses indicate data not available.
See Technical Notes (page 9).
See Surveillance Slide #4.
State
Cases Case Rates Rank According to Rate
Population Estimates
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Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacific islands.
Note: See Surveillance Slide #14.
Table 23. Tuberculosis Cases and Percentages, U.S.-born and Foreign-born Persons: States, 
2007
States
Total
Cases No. No. No.(%) (%) (%)
U.S.-born Persons Foreign-born Persons Unknown Origin
United States 13,299 5,493 (41.3) 7,750 (58.3) 56 (0.4)
Alabama   (78.3)  (21.1)  (0.6)
Alaska   (82.4)  (15.7)  (2.0)
Arizona 0  (37.5)  (61.2)  (1.3)
Arkansas 0 0 (75.5)  (23.6)  (0.9)
California ,  (21.9) ,0 (77.4)  (0.8)
Colorado   (29.7)  (70.3) 0 (0.0)
Connecticut 0  (29.6)  (69.4)  (0.9)
Delaware   (10.5)  (89.5) 0 (0.0)
District of Columbia 0  (60.0)  (40.0) 0 (0.0)
Florida   (53.3)  (46.7) 0 (0.0)
Georgia   (59.3)  (40.7) 0 (0.0)
Hawaii   (34.4)  (63.9)  (1.6)
Idaho   (44.4)  (55.6) 0 (0.0)
Illinois   (40.5) 0 (58.9)  (0.6)
Indiana   (56.3)  (43.0)  (0.8)
Iowa  0 (46.5)  (53.5) 0 (0.0)
Kansas   (37.3)  (62.7) 0 (0.0)
Kentucky 0  (69.2)  (30.8) 0 (0.0)
Louisiana   (83.0)  (16.5)  (0.5)
Maine   (31.6)  (68.4) 0 (0.0)
Maryland 0  (30.7)  (69.3) 0 (0.0)
Massachusetts   (25.9)  (74.1) 0 (0.0)
Michigan  0 (61.9)  (37.6)  (0.4)
Minnesota   (14.7) 0 (85.3) 0 (0.0)
Mississippi   (88.3)  (10.9)  (0.7)
Missouri   (64.7)  (35.3) 0 (0.0)
Montana   (72.7)  (27.3) 0 (0.0)
Nebraska   (4.0)  (96.0) 0 (0.0)
Nevada 0  (37.3)  (62.7) 0 (0.0)
New Hampshire   (18.2)  (81.8) 0 (0.0)
New Jersey   (26.3)  (73.7) 0 (0.0)
New Mexico   (52.9)  (47.1) 0 (0.0)
New York ,  (28.6)  (71.1)  (0.3)
North Carolina  0 (58.8)  (40.9)  (0.3)
North Dakota   (71.4)  (28.6) 0 (0.0)
Ohio   (54.4)  (45.6) 0 (0.0)
Oklahoma   (76.5)  (23.5) 0 (0.0)
Oregon   (27.7)  (72.3) 0 (0.0)
Pennsylvania   (43.8)  (51.4)  (4.7)
Rhode Island  0 (22.2)  (77.8) 0 (0.0)
South Carolina   (74.3)  (25.7) 0 (0.0)
South Dakota   (84.6)  (15.4) 0 (0.0)
Tennessee   (71.4)  (28.6) 0 (0.0)
Texas ,0  (48.7)  (51.3) 0 (0.0)
Utah   (30.8)  (69.2) 0 (0.0)
Vermont   (33.3)  (66.7) 0 (0.0)
Virginia 0  (25.6) 0 (74.4) 0 (0.0)
Washington   (29.9) 0 (70.1) 0 (0.0)
West Virginia   (79.2)  (20.8) 0 (0.0)
Wisconsin 0  (45.7)  (54.3) 0 (0.0)
Wyoming   (50.0)  (50.0) 0 (0.0)

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Table 25. Tuberculosis Cases and Percentages in Foreign-born Persons1 by Number of Years 
in the United States: States, 2007
States
Total
Cases
Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacific islands.
Note: See Surveillance Slide #18.                 
<1 Year 1–4 5–9 10–19 >0 Unknown or 
Missing
No. No. No. No. No. No.(%) (%) (%) (%) (%) (%)
United States 7,750 1,519 (19.6) 1,643 (21.2) 1,150 (14.8) 1,229 (15.9) 1,385 (17.9) 824 (10.6)
Alabama   (32.4)  (21.6) 0 (27.0)  (8.1)  (10.8) 0 (0.0)
Alaska   (25.0)  (37.5) 0 (0.0)  (25.0) 0 (0.0)  (12.5)
Arizona   (25.8)  (19.4)  (15.1)  (11.8)  (19.4)  (8.6)
Arkansas   (36.0)  (28.0)  (12.0)  (12.0)  (8.0)  (4.0)
California ,0  (16.5)  (14.0)  (12.6)  (18.3)  (23.6)  (14.9)
Colorado   (30.8)  (10.3)  (10.3)  (15.4)  (11.5)  (21.8)
Connecticut   (12.0)  (24.0)  (24.0)  (17.3)  (22.7) 0 (0.0)
Delaware   (17.6)  (41.2)  (29.4) 0 (0.0)  (11.8) 0 (0.0)
District of Columbia   (25.0)  (37.5)  (16.7)  (8.3)  (12.5) 0 (0.0)
Florida   (21.2)  (27.3)  (16.7)  (14.3)  (18.2)  (2.4)
Georgia   (18.1)  (23.3)  (22.3)  (20.2) 0 (10.4)  (5.7)
Hawaii   (28.2)  (14.1)  (9.0)  (20.5)  (21.8)  (6.4)
Idaho   (20.0)  (60.0) 0 (0.0)  (20.0) 0 (0.0) 0 (0.0)
Illinois 0  (13.7)  (18.9)  (11.4) 0 (16.3)  (18.2)  (21.5)
Indiana   (20.0)  (20.0)  (3.6)  (3.6) 0 (0.0)  (52.7)
Iowa   (52.2)  (17.4)  (4.3)  (17.4)  (8.7) 0 (0.0)
Kansas   (35.1)  (32.4)  (16.2) 0 (0.0)  (13.5)  (2.7)
Kentucky   (16.2)  (48.6) 0 (27.0)  (2.7)  (5.4) 0 (0.0)
Louisiana   (30.6)  (33.3)  (11.1)  (5.6)  (19.4) 0 (0.0)
Maine   (23.1)  (15.4)  (23.1)  (30.8)  (7.7) 0 (0.0)
Maryland   (19.8)  (35.3)  (19.3)  (12.8)  (11.2)  (1.6)
Massachusetts   (19.9)  (23.5)  (18.7)  (16.9)  (19.9)  (1.2)
Michigan   (21.2)  (22.4)  (12.9)  (14.1)  (22.4)  (7.1)
Minnesota 0  (25.6)  (31.5)  (16.3)  (7.4)  (2.0)  (17.2)
Mississippi   (40.0)  (6.7)  (13.3)  (20.0)  (20.0) 0 (0.0)
Missouri   (19.0)  (33.3)  (7.1)  (21.4)  (14.3)  (4.8)
Montana   (33.3) 0 (0.0)  (33.3) 0 (0.0)  (33.3) 0 (0.0)
Nebraska   (16.7)  (25.0)  (20.8)  (20.8)  (12.5)  (4.2)
Nevada   (26.6) 0 (15.6)  (20.3)  (20.3)  (12.5)  (4.7)
New Hampshire   (22.2)  (11.1) 0 (0.0)  (22.2) 0 (0.0)  (44.4)
New Jersey   (16.0)  (21.5)  (12.2)  (6.1)  (8.4)  (35.8)
New Mexico   (8.3)  (25.0)  (4.2)  (8.3)  (50.0)  (4.2)
New York   (17.4)  (22.6)  (15.2) 0 (18.0)  (19.4)  (7.4)
North Carolina   (17.7)  (27.7)  (22.0)  (11.3)  (8.5)  (12.8)
North Dakota  0 (0.0)  (50.0) 0 (0.0) 0 (0.0) 0 (0.0)  (50.0)
Ohio   (36.5)  (28.7)  (13.9) 0 (8.7)  (7.0)  (5.2)
Oklahoma   (17.1)  (20.0)  (11.4) 0 (28.6)  (22.9) 0 (0.0)
Oregon   (17.6)  (17.6)  (8.8)  (4.4)  (10.3)  (41.2)
Pennsylvania   (19.7)  (22.5) 0 (28.2)  (9.9)  (11.3)  (8.5)
Rhode Island   (25.7) 0 (0.0)  (2.9)  (5.7) 0 (0.0)  (65.7)
South Carolina   (14.3)  (48.2)  (8.9)  (12.5)  (14.3)  (1.8)
South Dakota  0 (0.0)  (50.0) 0 (0.0)  (50.0) 0 (0.0) 0 (0.0)
Tennessee   (26.9)  (26.9)  (22.4)  (11.9)  (10.4)  (1.5)
Texas   (21.2)  (20.2)  (14.5)  (20.0)  (24.2) 0 (0.0)
Utah   (22.2)  (29.6)  (11.1)  (33.3)  (3.7) 0 (0.0)
Vermont   (50.0)  (50.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Virginia 0  (21.3) 0 (30.4) 0 (21.7)  (15.7)  (10.9) 0 (0.0)
Washington 0  (22.1)  (18.1)  (12.3)  (20.1)  (18.1)  (9.3)
West Virginia  0 (0.0)  (40.0)  (40.0) 0 (0.0)  (20.0) 0 (0.0)
Wisconsin   (23.7)  (42.1)  (15.8)  (10.5)  (7.9) 0 (0.0)
Wyoming   (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)

United States 13,299 9,488 (71.3) 2,697 (20.3) 1,102 (8.3) 218
Alabama  0 (80.0)  (16.0)  (4.0) 
Alaska   (92.2)  (7.8) 0 (0.0) 0
Arizona 0  (76.0)  (18.4)  (5.3) 
Arkansas 0  (89.6)  (4.7)  (5.7) 0
California , , (71.1)  (20.0)  (9.0) 
Colorado   (61.3)  (27.9)  (10.8) 
Connecticut 0  (60.2)  (34.3)  (5.6) 
Delaware   (57.9)  (21.1)  (21.1) 
District of Columbia 0  (80.0)  (18.3)  (1.7) 
Florida  0 (81.2)  (14.1)  (4.8) 
Georgia   (69.2) 0 (23.2)  (7.4) 
Hawaii  0 (82.8)  (10.7)  (6.6) 
Idaho   (77.8)  (11.1)  (11.1) 
Illinois   (68.3)  (26.3)  (5.4) 
Indiana   (77.3)  (17.2)  (5.5) 
Iowa   (62.8)  (34.9)  (2.3) 0
Kansas   (62.7)  (25.4)  (11.9) 0
Kentucky 0  (78.3)  (19.2)  (2.5) 0
Louisiana   (79.8)  (15.6) 0 (4.6) 
Maine   (73.7)  (21.1)  (5.3) 0
Maryland 0  (64.8)  (26.3)  (8.9) 
Massachusetts   (61.6)  (24.6)  (13.8) 
Michigan   (70.4)  (23.9)  (5.8) 
Minnesota   (48.3)  (41.6)  (10.1) 
Mississippi   (83.9)  (13.1)  (2.9) 
Missouri   (69.7)  (19.3)  (10.9) 
Montana   (45.5)  (45.5)  (9.1) 0
Nebraska  0 (80.0)  (16.0)  (4.0) 0
Nevada 0  (80.4)  (14.7)  (4.9) 0
New Hampshire   (81.8)  (18.2) 0 (0.0) 0
New Jersey   (63.2) 0 (21.8) 0 (15.0) 0
New Mexico   (64.7) 0 (19.6)  (15.7) 
New York , 0 (68.2) 0 (21.3)  (10.6) 
North Carolina   (72.2)  (16.5)  (11.3) 
North Dakota   (42.9)  (42.9)  (14.3) 0
Ohio   (64.7)  (29.8)  (5.6) 
Oklahoma   (65.8)  (17.4)  (16.8) 0
Oregon   (56.4) 0 (31.9)  (11.7) 
Pennsylvania   (68.5) 0 (21.7)  (6.5) 
Rhode Island   (62.2)  (33.3)  (4.4) 
South Carolina   (67.9)  (19.7)  (12.4) 
South Dakota  0 (76.9)  (23.1) 0 (0.0) 0
Tennessee   (78.2)  (14.5)  (6.8) 
Texas ,0 , (78.4) 0 (15.2)  (6.4) 
Utah   (56.4) 0 (25.6)  (17.9) 
Vermont   (66.7)  (33.3) 0 (0.0) 0
Virginia 0  (74.1)  (17.5)  (8.4) 
Washington   (53.6)  (29.9)  (16.5) 
West Virginia   (70.8)  (20.8)  (8.3) 
Wisconsin 0 0 (57.1)  (32.9)  (10.0) 
Wyoming   (100.0) 0 (0.0) 0 (0.0) 0
American Samoa   (100.0) 0 (0.0) 0 (0.0) 0
Fed. States of Micronesia   (84.8)  (10.6)  (4.5) 0
Guam   (94.6)  (4.3)  (1.1) 
Marshall Islands   (64.1)  (29.9)  (5.1) 
N. Mariana Islands   (90.2)  (7.3)  (2.4) 0
Puerto Rico   (85.7)  (13.3)  (1.0) 0
Republic of Palau   (54.5)  (27.3)  (9.1) 
U.S. Virgin Islands ... ... ... ... ... ... ... ...
Table 26. Tuberculosis Cases and Percentages by Pulmonary and Extrapulmonary Disease: 
Reporting Areas, 2007
States
Total
Cases
Pulmonary Extrapulmonary
Pulmonary and
Extrapulmonary Cases
Total Miliary
No. No. No. No.(%) (%) (%)
Includes cases with pulmonary listed as major site of disease and no additional site of disease.
Includes cases with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, genitourinary, or other site, excluding pulmonary, listed 
as major site of disease.
Includes miliary cases.
Not included in U.S. totals.
Note: 12 cases had missing and/or unknown site of disease.
Ellipses indicate data not available.
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>= 500 cases in 2007
.California  .  . -. -. 
.Texas 0 .  . -. -. 
.New York  .  . -.0 -.0 
.Florida  . 0 . -. -. 
.Illinois  .  . -. -. 
100-499 cases in 2007
.Georgia  .0 0 . -. -. 0
.New Jersey  . 0 . -. -. 
.North Carolina  .  . -. -. 
.Virginia 0 .0  . -. -. 0
.Arizona 0 .  . -. -. 
.Washington  .  . . . 
.Pennsylvania  .  . -. -. 
.Maryland 0 .  . . . 
.Ohio  .  . . . 
.Minnesota  .  . . . 
.Tennessee  .  . -. -. 
.Michigan  .  . . . 
.Massachusetts  .  .0 -. -. 
.Louisiana  . 0 . . . 
.South Carolina  .  . -. -. 
.Alabama  .  . -0. -. 
.Oklahoma  .  .0 . . 
.Mississippi  .  .0 . . 
.Indiana  .0  .0 . . 
.Hawaii  .  . .0 . 
.Kentucky 0 .  .0 . . 
.Missouri  .0 0 . . . 
.Colorado  .  . -0. -. 
.Connecticut 0 .  . . . 
.Arkansas 0 . 0 . . .0 
.Nevada 0 .0 0 . .0 -. 
< 100 cases in 2007
.Oregon  .  . .0 . 0
.Wisconsin 0 .  . -. -. 
.District of Columbia 0 0.  . -. -. 
.Kansas  .  .0 -.0 -. 
.New Mexico  .  . . . 
.Alaska  . 0 0. -. -. 
.Rhode Island  .  . . . 
.Iowa  . 0 . . . 
.Utah  .  . . . 0
.Nebraska  .  . 0.0 -0. 
.West Virginia  .  . . . 
.Delaware  .  . -. -. 
.Maine  .  . . . 
.South Dakota  .  . -. -.0 
.Montana  .  . -. -. 
.New Hampshire  0.  . -. -. 
.Idaho  0. 0 . -.0 -. 
.North Dakota  . 0 . -0.0 -0. 
.Vermont  0.  . -. -. 0
.Wyoming  0.  0. -0.0 -.0 
Total 13299 4.4 13754 4.6 -3.3 -4.2
Table 28.  Tuberculosis Cases and Case Rates per 100,000 Population, Ranked and 
Grouped by Number of Cases: States and the District of Columbia, 2007 and 2006
States
00 00 2006–2007 % Change
No. Rate No. No.
Overall 
Rank by 
00 RateRate Rate
Includes New York City.
Note: Denominators for computing 2006 and 2007 rates for states and the District of Columbia were obtained from Annual 
Estimates of the Population for the United States and States, and for Puerto Rico: April 1, 2000–July 1, 2007 (NST-EST2007-01)  
(http://www.census.gov/popest/states/tables/NST-EST2007-01.xls) (accessed June 25, 2008).
See Table 20, page 37, for ranking of states without the District of Columbia.

Morbidity Tables
Reporting Areas, 2007 and 2005


United States 12,518 12,491 (99.8) 476 (3.8)
Alabama   (100.0)  (3.0)
Alaska   (100.0)  (6.4)
Arizona   (100.0)  (19.4)
Arkansas   (100.0)  (1.1)
California , ,0 (99.9)  (2.9)
Colorado 0 0 (100.0)  (1.9)
Connecticut 0 0 (100.0)  (2.9)
Delaware   (100.0) 0 (0.0)
District of Columbia   (100.0)  (3.4)
Florida   (100.0)  (2.7)
Georgia   (99.5)  (5.5)
Hawaii   (99.2)  (1.7)
Idaho   (100.0)  (11.1)
Illinois 0 0 (99.4)  (3.0)
Indiana   (100.0)  (2.4)
Iowa   (100.0) 0 (0.0)
Kansas   (100.0)  (1.8)
Kentucky   (100.0)  (1.7)
Louisiana 0 0 (99.0) 0 (9.8)
Maine   (100.0)  (5.9)
Maryland   (100.0)  (1.9)
Massachusetts 0 0 (100.0)  (1.9)
Michigan 0 0 (99.0)  (2.5)
Minnesota   (100.0)  (0.9)
Mississippi   (100.0)  (4.7)
Missouri   (100.0)  (2.6)
Montana   (100.0) 0 (0.0)
Nebraska   (100.0) 0 (0.0)
Nevada   (100.0)  (2.2)
New Hampshire   (100.0) 0 (0.0)
New Jersey   (100.0)  (1.4)
New Mexico   (100.0)  (4.1)
New York State   (99.6)  (2.5)
New York City   (100.0)  (1.8)
North Carolina 0 0 (100.0) 0 (3.1)
North Dakota   (100.0) 0 (0.0)
Ohio   (100.0)  (1.3)
Oklahoma   (97.7)  (2.4)
Oregon   (97.7) 0 (0.0)
Pennsylvania  0 (96.4)  (1.3)
Rhode Island   (100.0) 0 (0.0)
South Carolina 0 0 (100.0)  (1.5)
South Dakota   (100.0) 0 (0.0)
Tennessee   (100.0)  (7.6)
Texas ,0 ,0 (100.0)  (9.5)
Utah   (100.0)  (2.7)
Vermont   (100.0) 0 (0.0)
Virginia   (100.0)  (1.7)
Washington   (100.0)  (0.7)
West Virginia   (100.0) 0 (0.0)
Wisconsin   (100.0) 0 (0.0)
Wyoming   (100.0) 0 (0.0)
American Samoa   (100.0) 0 (0.0)
Fed. States of Micronesia   (98.0)  (2.1)
Guam  0 (98.4) 0 (0.0)
Marshall Islands   (98.9)  (5.4)
N. Mariana Islands   (100.0) 0 (0.0)
Puerto Rico   (100.0)  (4.3)
Republic of Palau   (100.0) 0 (0.0)
U.S. Virgin Islands ... ... ... ... ...
Table 29. Tuberculosis Cases and Percentages by Residence in Correctional Facilities, 
Age > 15: Reporting Areas, 2007
Reporting Area
Total 
Cases
Cases with Information on Residence
 in Correctional Facilities
Cases Reported As Residents
 of Correctional Facilities
No. No.(%) (%)
Resident of correctional facility at time of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the Dis-
trict of Columbia). Counts and percentages shown only for reporting areas with information reported for >% of cases.
Excludes New York City.
Not included in U.S. totals.
Note: Ellipses indicate data not available.

United States 12,518 12,364 (98.8) 705 (5.7)
Alabama   (99.4)  (4.2)
Alaska   (97.9)  (23.9)
Arizona   (94.2)  (9.5)
Arkansas   (100.0)  (2.1)
California , ,0 (99.2)  (6.0)
Colorado 0 0 (100.0)  (5.8)
Connecticut 0 0 (99.0)  (5.8)
Delaware   (100.0) 0 (0.0)
District of Columbia   (100.0)  (6.9)
Florida   (99.2) 0 (7.6)
Georgia   (99.3)  (8.3)
Hawaii   (99.2)  (1.7)
Idaho   (88.9)  (12.5)
Illinois 0  (95.4)  (7.1)
Indiana   (99.2) 0 (8.2)
Iowa   (100.0)  (7.1)
Kansas   (100.0)  (5.5)
Kentucky   (100.0)  (9.5)
Louisiana 0 0 (98.1)  (6.9)
Maine   (100.0) 0 (0.0)
Maryland   (100.0)  (7.0)
Massachusetts 0 0 (99.0)  (2.9)
Michigan 0  (95.1)  (2.6)
Minnesota   (99.5)  (2.8)
Mississippi   (97.7)  (7.2)
Missouri   (100.0)  (6.1)
Montana   (100.0)  (9.1)
Nebraska   (100.0)  (4.3)
Nevada   (98.9)  (7.6)
New Hampshire   (81.8) 0 (0.0)
New Jersey   (100.0)  (1.6)
New Mexico   (100.0)  (10.2)
New York State   (95.5)  (3.0)
New York City   (97.3)  (4.9)
North Carolina 0 0 (100.0)  (4.7)
North Dakota   (100.0) 0 (0.0)
Ohio   (100.0)  (6.7)
Oklahoma   (94.5)  (5.0)
Oregon   (96.6)  (6.0)
Pennsylvania  0 (96.4)  (4.6)
Rhode Island   (100.0) 0 (0.0)
South Carolina 0 0 (100.0)  (3.4)
South Dakota   (100.0)  (30.8)
Tennessee   (100.0)  (8.5)
Texas ,0 ,0 (100.0)  (4.5)
Utah   (100.0)  (13.5)
Vermont   (100.0) 0 (0.0)
Virginia   (100.0)  (2.4)
Washington   (100.0)  (7.8)
West Virginia   (100.0)  (4.2)
Wisconsin   (100.0)  (5.9)
Wyoming   (100.0) 0 (0.0)
American Samoa   (100.0) 0 (0.0)
Fed. States of Micronesia   (91.8) 0 (0.0)
Guam   (95.1) 0 (0.0)
Marshall Islands   (97.8)  (1.1)
N. Mariana Islands   (58.5) -- --
Puerto Rico   (100.0)  (4.3)
Republic of Palau   (100.0) 0 (0.0)
U.S. Virgin Islands ... ... ... ... ...
Reporting Area
Total 
Cases
Cases with Information
on Homeless Status
Cases Reported As
Being Homeless 
No. No.(%) (%)
Table 30. Tuberculosis Cases and Percentages by Homeless Status,1 Age >15: Reporting 
Areas, 2007
Homeless within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the District of 
Columbia). Counts and percentages shown only for reporting areas with information reported for >% of cases.
Excludes New York City.
Not included in U.S. totals. 
Note: Ellipses indicate data not available.

United States 12,518 12,483 (99.7) 253 (2.0)
Alabama   (99.4)  (4.2)
Alaska   (100.0)  (2.1)
Arizona   (100.0)  (3.2)
Arkansas   (100.0)  (2.1)
California , , (99.9)  (1.4)
Colorado 0 0 (100.0)  (4.8)
Connecticut 0 0 (100.0)  (1.0)
Delaware   (100.0) 0 (0.0)
District of Columbia   (100.0) 0 (0.0)
Florida   (100.0)  (0.4)
Georgia  0 (98.4)  (2.8)
Hawaii   (99.2)  (2.5)
Idaho   (100.0)  (22.2)
Illinois 0 00 (99.2)  (1.6)
Indiana   (100.0)  (3.3)
Iowa   (100.0) 0 (0.0)
Kansas   (100.0)  (1.8)
Kentucky   (100.0)  (6.0)
Louisiana 0 0 (99.5)  (1.0)
Maine   (100.0) 0 (0.0)
Maryland   (100.0)  (1.9)
Massachusetts 0 0 (100.0)  (4.3)
Michigan 0 0 (99.0)  (3.4)
Minnesota   (100.0)  (0.5)
Mississippi   (100.0) 0 (7.8)
Missouri   (100.0)  (1.7)
Montana   (100.0)  (18.2)
Nebraska   (100.0)  (4.3)
Nevada   (100.0) 0 (0.0)
New Hampshire   (100.0) 0 (0.0)
New Jersey   (100.0)  (1.4)
New Mexico   (100.0) 0 (0.0)
New York State   (98.8)  (2.5)
New York City   (100.0)  (1.7)
North Carolina 0 0 (100.0)  (2.2)
North Dakota   (100.0) 0 (0.0)
Ohio   (100.0)  (3.3)
Oklahoma   (97.7)  (3.2)
Oregon   (98.9)  (1.2)
Pennsylvania  0 (96.4)  (4.6)
Rhode Island   (100.0)  (2.7)
South Carolina 0 0 (100.0)  (2.9)
South Dakota   (100.0)  (7.7)
Tennessee   (100.0)  (2.7)
Texas ,0 ,0 (100.0)  (2.1)
Utah   (100.0)  (2.7)
Vermont   (100.0) 0 (0.0)
Virginia   (100.0)  (0.7)
Washington   (100.0)  (1.5)
West Virginia   (100.0) 0 (0.0)
Wisconsin   (100.0)  (4.4)
Wyoming   (100.0) 0 (0.0)
American Samoa   (100.0) 0 (0.0)
Fed. States of Micronesia   (98.0) 0 (0.0)
Guam   (100.0) 0 (0.0)
Marshall Islands   (98.9) 0 (0.0)
N. Mariana Islands   (100.0) 0 (0.0)
Puerto Rico   (100.0)  (1.1)
Republic of Palau   (100.0) 0 (0.0)
U.S. Virgin Islands ... ... ... ... ...
Reporting Area
Total 
Cases
Cases with Information on
Residence in Long-term Care Facilities
Cases Reported As Residents of
Long-term Care Facilities
No. No.(%) (%)
Table 31. Tuberculosis Cases and Percentages by Residence in Long-term Care Facilities,1 
Age >15: Reporting Areas, 2007
Resident of long-term care facility at time of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the 
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >% of cases.
Excludes New York City.
Not included in U.S. totals. 
Note: Ellipses indicate data not available.

United States 12,518 12,142 (97.0) 256 (2.1)
Alabama   (99.4)  (1.8)
Alaska   (93.6)  (2.3)
Arizona   (87.8)  (3.7)
Arkansas   (100.0)  (2.1)
California , , (97.0)  (1.7)
Colorado 0 0 (98.1)  (1.0)
Connecticut 0 0 (97.1)  (4.9)
Delaware   (100.0) 0 (0.0)
District of Columbia   (100.0)  (8.6)
Florida   (99.6) 0 (2.2)
Georgia   (98.2)  (3.0)
Hawaii   (34.5) -- --
Idaho   (88.9) 0 (0.0)
Illinois 0  (90.3)  (0.7)
Indiana  0 (97.6)  (5.0)
Iowa   (100.0) 0 (0.0)
Kansas   (100.0)  (5.5)
Kentucky   (99.1)  (1.7)
Louisiana 0  (87.4)  (4.4)
Maine   (100.0) 0 (0.0)
Maryland   (99.2)  (2.7)
Massachusetts 0 0 (98.6)  (0.5)
Michigan 0  (95.1)  (4.1)
Minnesota   (99.1)  (0.5)
Mississippi   (100.0)  (0.8)
Missouri   (99.1)  (4.4)
Montana   (100.0) 0 (0.0)
Nebraska   (100.0)  (4.3)
Nevada   (97.8) 0 (0.0)
New Hampshire  0 (90.9) 0 (0.0)
New Jersey   (100.0)  (1.4)
New Mexico   (98.0)  (2.1)
New York State   (96.7)  (1.7)
New York City   (97.0)  (2.4)
North Carolina 0  (99.4)  (1.6)
North Dakota   (100.0) 0 (0.0)
Ohio   (98.7)  (1.3)
Oklahoma   (94.5) 0 (0.0)
Oregon   (96.6)  (2.4)
Pennsylvania   (96.0)  (1.3)
Rhode Island   (97.3)  (2.8)
South Carolina 0 0 (99.0)  (1.5)
South Dakota   (100.0) 0 (0.0)
Tennessee   (100.0)  (2.7)
Texas ,0 ,0 (100.0)  (2.6)
Utah   (100.0)  (5.4)
Vermont   (100.0) 0 (0.0)
Virginia   (100.0)  (1.7)
Washington   (99.6)  (2.2)
West Virginia   (100.0) 0 (0.0)
Wisconsin   (100.0)  (2.9)
Wyoming   (100.0) 0 (0.0)
Amercian Samoa   (100.0) 0 (0.0)
Fed. States of Micronesia   (91.8) 0 (0.0)
Guam   (95.1) 0 (0.0)
Marshall Islands  0 (96.8) 0 (0.0)
N. Mariana Islands   (100.0) 0 (0.0)
Puerto Rico   (100.0)  (13.8)
Republic of Palau   (100.0) 0 (0.0)
U.S. Virgin Islands ... ... ... ... ...
Reporting Area
Total 
Cases
Cases with Information on
Injecting Drug Use
Cases Reporting Injecting Drug Use
No. No.(%) (%)
Table 32. Tuberculosis Cases and Percentages by Injecting Drug Use,1 Age >15: 
Reporting Areas, 2007
Injecting drug use within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the 
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >% of cases.
Excludes New York City.
Not included in U.S. totals. 
Note: Ellipses indicate data not available.

United States 12,518 12,103 (96.7) 965 (8.0)
Alabama   (99.4)  (7.2)
Alaska   (93.6)  (13.6)
Arizona   (87.1)  (8.7)
Arkansas   (100.0)  (4.2)
California , , (97.1)  (6.3)
Colorado 0 0 (98.1)  (4.9)
Connecticut 0 0 (97.1)  (4.9)
Delaware   (100.0) 0 (0.0)
District of Columbia   (100.0)  (12.1)
Florida   (99.7)  (12.2)
Georgia  0 (98.4)  (11.4)
Hawaii   (32.8) -- --
Idaho   (100.0)  (11.1)
Illinois 0  (89.1)  (9.8)
Indiana  0 (97.6)  (10.0)
Iowa   (100.0)  (7.1)
Kansas   (100.0)  (10.9)
Kentucky   (99.1)  (5.2)
Louisiana 0  (86.5)  (24.6)
Maine   (100.0) 0 (0.0)
Maryland   (99.2)  (4.3)
Massachusetts 0 0 (99.0)  (2.9)
Michigan 0  (94.6)  (6.7)
Minnesota   (99.1)  (3.7)
Mississippi   (100.0)  (6.3)
Missouri   (99.1)  (13.2)
Montana   (100.0) 0 (0.0)
Nebraska   (100.0) 0 (0.0)
Nevada   (95.7)  (3.4)
New Hampshire  0 (90.9) 0 (0.0)
New Jersey   (100.0)  (3.2)
New Mexico   (98.0)  (6.3)
New York State   (87.8) 0 (4.7)
New York City  0 (96.8)  (9.5)
North Carolina 0  (99.4)  (13.8)
North Dakota   (85.7) 0 (0.0)
Ohio   (98.7)  (9.7)
Oklahoma  0 (93.8)  (10.8)
Oregon   (94.3) 0 (12.2)
Pennsylvania   (96.0)  (5.9)
Rhode Island   (97.3) 0 (0.0)
South Carolina 0 0 (99.0)  (12.8)
South Dakota   (100.0) 0 (0.0)
Tennessee   (100.0)  (20.1)
Texas ,0 ,0 (100.0)  (6.6)
Utah   (100.0)  (2.7)
Vermont   (100.0) 0 (0.0)
Virginia   (100.0) 0 (3.4)
Washington   (98.9)  (4.1)
West Virginia   (100.0)  (4.2)
Wisconsin   (100.0)  (5.9)
Wyoming   (100.0) 0 (0.0)
American Samoa   (100.0) 0 (0.0)
Fed. States of Micronesia   (71.4) -- --
Guam   (91.8) 0 (0.0)
Marshall Islands  0 (96.8) 0 (0.0)
N. Mariana Islands   (90.2) 0 (0.0)
Puerto Rico   (100.0)  (16.0)
Republic of Palau   (81.8) 0 (0.0)
U.S. Virgin Islands ... ... ... ... ...
Reporting Area
Total 
Cases
Cases with Information on
Noninjecting Drug Use
Cases Reporting Noninjecting Drug Use
No. No.(%) (%)
Table 33. Tuberculosis Cases and Percentages by Noninjecting Drug Use,1 Age >15: 
Reporting Areas, 2007
Noninjecting drug use within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and 
the District of Columbia). Counts and percentages shown only for reporting areas with information reported for >% of cases.
Excludes New York City.
Not included in U.S. totals. 
Note: Ellipses indicate data not available.

United States 12,518 12,177 (97.3) 1,631 (13.4)
Alabama   (99.4)  (12.6)
Alaska   (93.6) 0 (45.5)
Arizona   (86.7)  (13.7)
Arkansas   (100.0)  (3.2)
California , ,0 (96.8)  (9.8)
Colorado 0 0 (100.0)  (11.5)
Connecticut 0 0 (98.1)  (10.7)
Delaware   (100.0)  (5.6)
District of Columbia   (100.0) 0 (17.2)
Florida   (99.7)  (18.9)
Georgia   (97.9)  (13.8)
Hawaii   (72.3) -- --
Idaho   (88.9)  (25.0)
Illinois 0 0 (89.3)  (15.3)
Indiana   (98.4)  (28.1)
Iowa   (100.0)  (9.5)
Kansas   (100.0)  (10.9)
Kentucky   (99.1) 0 (17.4)
Louisiana 0  (89.4)  (26.5)
Maine   (100.0)  (17.6)
Maryland   (99.6)  (6.3)
Massachusetts 0 0 (98.6)  (7.8)
Michigan 0  (94.1)  (9.3)
Minnesota   (99.1)  (5.6)
Mississippi   (100.0)  (16.4)
Missouri   (100.0)  (19.1)
Montana   (100.0)  (18.2)
Nebraska   (100.0)  (4.3)
Nevada   (94.6) 0 (11.4)
New Hampshire   (81.8)  (11.1)
New Jersey   (100.0)  (6.6)
New Mexico   (98.0)  (29.2)
New York State   (96.3)  (6.4)
New York City   (97.1)  (16.7)
North Carolina 0  (99.7)  (13.2)
North Dakota   (85.7) 0 (0.0)
Ohio   (99.6)  (13.0)
Oklahoma   (94.5)  (12.4)
Oregon   (95.4) 0 (12.0)
Pennsylvania   (96.0)  (6.7)
Rhode Island   (97.3)  (2.8)
South Carolina 0 0 (99.0)  (17.7)
South Dakota   (100.0)  (38.5)
Tennessee   (100.0)  (21.9)
Texas ,0 ,0 (100.0)  (17.4)
Utah   (100.0)  (13.5)
Vermont   (100.0) 0 (0.0)
Virginia   (100.0)  (8.6)
Washington   (98.9)  (10.2)
West Virginia   (100.0)  (16.7)
Wisconsin   (100.0)  (19.1)
Wyoming   (100.0) 0 (0.0)
American Samoa   (100.0)  (33.3)
Fed. States of Micronesia   (77.6) 0 (0.0)
Guam   (95.1) 0 (0.0)
Marshall Islands   (84.9)  (13.9)
N. Mariana Islands   (100.0)  (2.4)
Puerto Rico   (100.0)  (16.0)
Republic of Palau   (81.8)  (22.2)
U.S. Virgin Islands ... ... ... ... ...
Reporting Area
Total 
Cases
Cases with Information on
Excess Alcohol Use
Cases Reporting
Excess Alcohol Use
No. No.(%) (%)
Table 34. Tuberculosis Cases and Percentages by Excess Alcohol Use,1 Age >15: 
Reporting Areas, 2007
Excess alcohol use within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the 
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >% of cases.
Excludes New York City.
Not included in U.S. totals. 
Note: Ellipses indicate data not available.

United States 13,299 12,999 12,954 (99.7) (1.1) (4.7) (83.3) (83.3)
Alabama    (100.0) (0.6) (4.2) (85.6) (85.6)
Alaska   0 (98.0) (0.0) (12.0) (86.0) (86.0)
Arizona 0   (99.3) (1.4) (5.2) (79.6) (79.2)
Arkansas 0 0 0 (100.0) (7.7) (38.5) (39.4) (39.4)
California , , , (99.7) (0.9) (2.4) (87.6) (87.5)
Colorado  0 0 (99.0) (0.0) (2.9) (80.4) (80.4)
Connecticut 0 0 0 (99.1) (1.0) (4.8) (84.8) (84.8)
Delaware    (100.0) (0.0) (5.3) (89.5) (89.5)
District of Columbia 0   (98.2) (0.0) (1.8) (98.2) (98.2)
Florida    (100.0) (0.6) (5.9) (84.1) (84.1)
Georgia    (100.0) (0.4) (5.2) (62.5) (62.5)
Hawaii    (100.0) (2.5) (9.9) (79.3) (79.3)
Idaho    (100.0) (0.0) (0.0) (75.0) (75.0)
Illinois    (100.0) (1.0) (3.5) (83.1) (83.1)
Indiana    (100.0) (0.8) (3.3) (92.7) (92.7)
Iowa    (100.0) (0.0) (9.5) (90.5) (90.5)
Kansas    (100.0) (0.0) (8.8) (89.5) (89.5)
Kentucky 0   (100.0) (0.0) (7.6) (65.3) (65.3)
Louisiana    (99.5) (0.0) (2.3) (95.3) (95.3)
Maine    (100.0) (0.0) (0.0) (89.5) (89.5)
Maryland 0   (100.0) (1.1) (4.5) (90.6) (90.6)
Massachusetts    (99.5) (0.9) (1.4) (82.8) (82.8)
Michigan    (98.6) (3.3) (18.9) (74.1) (74.1)
Minnesota    (99.6) (0.9) (7.7) (84.6) (84.6)
Mississippi    (100.0) (3.0) (8.3) (80.3) (80.3)
Missouri    (100.0) (0.0) (7.1) (75.0) (75.0)
Montana    (100.0) (0.0) (0.0) (100.0) (100.0)
Nebraska    (96.0) (0.0) (8.3) (87.5) (87.5)
Nevada 0   (100.0) (0.0) (0.0) (97.9) (97.9)
New Hampshire    (100.0) (0.0) (0.0) (100.0) (100.0)
New Jersey    (99.8) (0.9) (2.8) (86.5) (86.5)
New  Mexico    (100.0) (0.0) (0.0) (92.2) (92.2)
New York State    (100.0) (1.2) (5.2) (86.9) (86.9)
New York City    (100.0) (1.0) (3.0) (85.3) (85.3)
North Carolina    (100.0) (0.3) (3.9) (89.3) (89.3)
North Dakota    (85.7) (0.0) (0.0) (83.3) (83.3)
Ohio    (100.0) (0.0) (5.7) (83.0) (83.0)
Oklahoma    (100.0) (11.0) (19.3) (62.8) (62.8)
Oregon    (98.9) (0.0) (2.2) (93.4) (93.4)
Pennsylvania    (96.7) (0.4) (2.3) (42.4) (42.4)
Rhode Island    (97.8) (6.8) (0.0) (84.1) (84.1)
South Carolina    (100.0) (0.5) (10.3) (82.2) (82.2)
South Dakota    (100.0) (0.0) (15.4) (69.2) (69.2)
Tennessee    (100.0) (0.0) (6.1) (61.0) (61.0)
Texas ,0 , , (99.5) (1.9) (3.1) (88.5) (88.5)
Utah    (100.0) (0.0) (5.1) (89.7) (89.7)
Vermont    (100.0) (0.0) (0.0) (100.0) (100.0)
Virginia 0 0  (98.7) (0.3) (3.7) (89.6) (89.6)
Washington    (100.0) (0.0) (3.8) (88.2) (88.2)
West Virginia    (100.0) (4.8) (4.8) (81.0) (81.0)
Wisconsin 0   (100.0) (0.0) (5.8) (85.5) (85.5)
Wyoming    (100.0) (0.0) (0.0) (100.0) (100.0)
American Samoa    (100.0) (0.0) (0.0) (100.0) (100.0)
Fed. States of Micronesia    (98.5) (0.0) (18.8) (79.7) (79.7)
Guam  0 0 (100.0) (0.0) (20.0) (75.6) (75.6)
Marshall Islands    (99.1) (0.0) (19.8) (78.4) (78.4)
N. Mariana Islands  0 0 (100.0) (0.0) (0.0) (100.0) (100.0)
Puerto Rico    (100.0) (0.0) (3.2) (91.4) (91.4)
Republic of Palau    (100.0) (0.0) (9.1) (72.7) (72.7)
U.S. Virgin Islands ... ... ... ... ... ... ... ...
Table 35. Tuberculosis Cases and Percentages by Initial Drug Regimen: 
Reporting Areas, 2007
Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and the District of Columbia). Counts and percentages 
shown only for reporting areas with information reported for >% of cases.
I=isoniazid; R=rifampin; Z=pyrazinamide; E=ethambutol; S=streptomycin.
 Streptomycin is no longer considered a first-line drug.  CDC.  Treatment of Tuberculosis. American Thoracic Society, CDC, and Infec-
tious Diseases Society of America.  MMWR 2003;52(No.RR-11): 1–77.
Excludes New York City.
Not included in U.S. totals. 
Note: Excluding cases with no information on drug regimen, 127 (0.98%) persons were not started on any drugs, 21 (<0.2%) were 
started on one drug, and 1,272 (9.8%) had an initial multidrug regimen other than IR, IRZ, or IRZ,E/S.
Ellipses indicate data not available.
Reporting Area
Total 
Cases
Cases with Information on
Initial Drug Regimen
Percentage of Cases in Persons with
Initial Drug Regimen,
No. (%) IRZ
Cases in 
Persons 
Alive at 
Diagnosis IR IRZ,E/S IRZE
0
United States 10,426 9,858 (94.6) 762 (7.7) 119 (1.2)
Alabama   (91.8)  (0.7) 0 (0.0)
Alaska   (100.0) 0 (0.0) 0 (0.0)
Arizona   (97.7)  (7.4)  (1.4)
Arkansas 0  (97.1)  (10.3)  (4.4)
California , , (96.9)  (10.9)  (1.3)
Colorado   (100.0)  (12.2)  (1.4)
Connecticut   (100.0)  (12.8)  (3.2)
Delaware   (100.0) 0 (0.0) 0 (0.0)
District of Columbia   (100.0)  (2.1) 0 (0.0)
Florida  0 (93.6)  (8.2)  (0.8)
Georgia  0 (96.8)  (5.8)  (0.6)
Hawaii   (96.9)  (5.3)  (1.1)
Idaho   (100.0)  (14.3) 0 (0.0)
Illinois 0  (94.3)  (8.1)  (1.0)
Indiana 0 0 (100.0) 0 (9.4)  (0.9)
Iowa   (97.0)  (9.4)  (3.1)
Kansas   (89.1)  (2.4) 0 (0.0)
Kentucky 0  (95.1)  (4.1) 0 (0.0)
Louisiana   (90.2)  (2.5) 0 (0.0)
Maine   (100.0) 0 (0.0) 0 (0.0)
Maryland   (100.0) 0 (4.7)  (1.4)
Massachusetts   (84.3)  (6.0)  (0.7)
Michigan   (97.7)  (6.4)  (1.8)
Minnesota   (99.4)  (9.7)  (1.7)
Mississippi   (99.0)  (3.2) 0 (0.0)
Missouri   (98.0)  (4.1)  (1.0)
Montana   (100.0)  (11.1) 0 (0.0)
Nebraska   (90.5) 0 (0.0) 0 (0.0)
Nevada   (95.2)  (7.6)  (1.3)
New Hampshire   (55.6) -- -- -- --
New Jersey 0  (99.5)  (9.5)  (2.2)
New Mexico   (100.0)  (6.8)  (2.3)
New York State   (97.4)  (8.6) 0 (0.0)
New York City   (97.9)  (11.3)  (1.0)
North Carolina   (100.0)  (4.0)  (0.7)
North Dakota   (100.0) 0 (0.0) 0 (0.0)
Ohio   (98.5) 0 (5.2)  (0.5)
Oklahoma   (94.5) 0 (0.0) 0 (0.0)
Oregon   (100.0)  (8.9)  (2.5)
Pennsylvania 0 0 (82.9)  (8.2)  (1.2)
Rhode Island   (100.0) 0 (0.0) 0 (0.0)
South Carolina   (96.1)  (3.5)  (2.3)
South Dakota   (100.0) 0 (0.0) 0 (0.0)
Tennessee  0 (98.2)  (3.1)  (1.9)
Texas , 0 (82.1)  (4.5)  (1.1)
Utah 0 0 (100.0)  (6.7)  (3.3)
Vermont   (100.0) 0 (0.0) 0 (0.0)
Virginia 0 0 (90.0)  (8.2)  (2.4)
Washington   (99.1)  (10.3)  (0.9)
West Virginia  0 (83.3) 0 (0.0) 0 (0.0)
Wisconsin   (95.1)  (15.5)  (10.3)
Wyoming   (100.0) 0 (0.0) 0 (0.0)
American Samoa ... ... ... ... ... ... ...
Fed. States of Micronesia   (20.0) -- -- -- --
Guam   (89.2)  (3.0) 0 (0.0)
Marshall Islands   (81.8)  (5.6)  (5.6)
N. Mariana Islands 0  (70.0) -- -- -- --
Puerto Rico   (98.9)  (6.9)  (3.4)
Republic of Palau ... ... ... ... ... ... ...
U.S. Virgin Islands ... ... ... ... ... ... ...
Patients tested to at least isoniazid and rifampin
Isolates may be resistant to other drugs. Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and the District 
of Columbia). Counts and percentages shown only for reporting areas with information reported for >% of cases.
Excludes New York City.
Not included in U.S. totals. 
Note: Ellipses indicate data not available.
Table 36. Culture-Positive Tuberculosis Cases and Percentages with Drug-Susceptibility 
Results, by Resistance to INH or Multidrug Resistance: Reporting Areas, 2007
Reporting Area
Total 
Culture 
Positive 
Cases
Cases with Initial Drug-
Susceptibility Testing Performed
Resistance
No. (%)
Isoniazid Isoniazid and Rifampin
No. No.(%) (%)

United States 4,317 3,102 (71.9) -- --
Alabama   (87.8)  (22.2)
Alaska   (100.0) 0 (0.0)
Arizona 00  (86.0)  (14.0)
Arkansas   (84.2)  (6.3)
California  0 (0.0) -- --
Colorado   (96.6)  (7.1)
Connecticut   (70.2) -- --
Delaware   (100.0) 0 (0.0)
District of Columbia 0 0 (100.0)  (25.0)
Florida   (88.9)  (24.7)
Georgia 0  (94.7)  (19.9)
Hawaii   (79.2)  (5.3)
Idaho   (75.0) 0 (0.0)
Illinois  0 (88.1)  (10.0)
Indiana   (83.0)  (10.3)
Iowa 0  (95.0)  (5.3)
Kansas   (100.0)  (36.4)
Kentucky   (94.3)  (12.1)
Louisiana   (90.8)  (15.3)
Maine   (80.0)  (25.0)
Maryland   (93.7)  (14.6)
Massachusetts   (70.3) -- --
Michigan   (75.4)  (15.2)
Minnesota   (95.7)  (10.2)
Mississippi   (100.0)  (12.8)
Missouri   (94.1)  (3.1)
Montana   (100.0) 0 (0.0)
Nebraska   (87.5) 0 (0.0)
Nevada   (100.0)  (12.0)
New Hampshire   (100.0) 0 (0.0)
New Jersey   (77.0)  (15.7)
New Mexico   (100.0)  (9.1)
New York State  0 (89.9) 0 (12.5)
New York City   (81.8)  (18.9)
North Carolina   (95.9)  (12.0)
North Dakota   (100.0) 0 (0.0)
Ohio 0  (97.5)  (14.1)
Oklahoma   (94.4)  (8.8)
Oregon   (97.3)  (8.3)
Pennsylvania   (69.6) -- --
Rhode Island   (78.6)  (9.1)
South Carolina   (96.6)  (14.0)
South Dakota   (100.0) 0 (0.0)
Tennessee   (100.0) 0 (24.4)
Texas   (86.1) 0 (20.0)
Utah   (100.0) 0 (0.0)
Vermont -- -- (0.0) -- --
Virginia   (93.7)  (5.9)
Washington 0 0 (89.1)  (5.6)
West Virginia   (85.7) 0 (0.0)
Wisconsin   (91.7)  (22.7)
Wyoming  0 (0.0) -- --
American Samoa ... ... ... ... ...
Fed. States of Micronesia   (64.3) -- --
Guam   (94.7) 0 (0.0)
Marshall Islands 0  (93.3)  (3.6)
N. Mariana Islands   (95.7) 0 (0.0)
Puerto Rico   (100.0)  (44.0)
Republic of Palau   (100.0) 0 (0.0)
U.S. Virgin Islands ... ... ... ... ...
Table 37. Tuberculosis Cases and Percentages Among Persons Aged 25–44 by HIV Status: 
Reporting Areas, 2007
Includes only those cases in persons with negative, positive, or indeterminate HIV test results.
Counts and percentages shown only for reporting areas with information reported for >75% of cases. All 2007 California cases had an 
unknown HIV status because CA HIV data for 2007 were not available at time of publication.
Excludes New York City.
Not included in U.S. totals. 
Note: Ellipses indicate data not available.
See Technical Notes (page 9).
Reporting Area
Total  
Cases
Cases with Information on HIV Status Cases in Persons with HIV-Positive Results
No. (%) No. (%)

United States 12,518 11,969 (95.6) (51.4) (3.2) (0.1) (1.1) (44.0) (0.2)
Alabama   (100.0) (59.5) (2.4) (0.0) (0.0) (38.1) (0.0)
Alaska   (93.6) (70.5) (0.0) (0.0) (0.0) (29.5) (0.0)
Arizona   (87.8) (59.8) (4.1) (0.0) (4.1) (32.0) (0.0)
Arkansas   (37.9) -- -- -- -- -- --
California , , (94.8) (56.0) (3.3) (0.1) (1.9) (38.6) (0.1)
Colorado 0 0 (100.0) (57.7) (3.8) (0.0) (1.0) (37.5) (0.0)
Connecticut 0 0 (100.0) (37.1) (3.8) (1.0) (1.0) (57.1) (0.0)
Delaware   (100.0) (22.2) (5.6) (5.6) (0.0) (66.7) (0.0)
District of Columbia   (100.0) (94.8) (0.0) (0.0) (0.0) (5.2) (0.0)
Florida   (99.8) (47.3) (2.9) (0.2) (2.5) (47.1) (0.0)
Georgia   (85.6) (38.0) (2.4) (0.0) (0.5) (59.1) (0.0)
Hawaii   (77.3) (56.5) (1.1) (0.0) (0.0) (41.3) (1.1)
Idaho   (77.8) (28.6) (0.0) (0.0) (0.0) (71.4) (0.0)
Illinois 0 0 (87.3) (57.0) (4.3) (0.2) (0.2) (38.2) (0.0)
Indiana  0 (97.6) (45.8) (3.3) (0.8) (0.0) (50.0) (0.0)
Iowa   (100.0) (40.5) (0.0) (0.0) (0.0) (57.1) (2.4)
Kansas   (100.0) (63.6) (5.5) (0.0) (1.8) (29.1) (0.0)
Kentucky   (100.0) (55.2) (3.4) (0.9) (6.0) (34.5) (0.0)
Louisiana 0  (84.1) (47.1) (2.9) (0.6) (0.6) (48.3) (0.6)
Maine   (100.0) (29.4) (11.8) (0.0) (5.9) (52.9) (0.0)
Maryland   (99.6) (39.8) (2.3) (0.4) (0.0) (56.3) (1.2)
Massachusetts 0 0 (96.7) (47.5) (6.4) (0.0) (0.5) (45.5) (0.0)
Michigan 0  (94.1) (54.9) (3.1) (0.0) (0.0) (41.5) (0.5)
Minnesota   (99.1) (57.5) (7.0) (0.0) (0.0) (35.0) (0.5)
Mississippi   (99.2) (55.1) (1.6) (0.0) (0.8) (42.5) (0.0)
Missouri   (99.1) (49.1) (1.8) (0.9) (0.9) (46.5) (0.9)
Montana   (100.0) (54.5) (0.0) (0.0) (0.0) (45.5) (0.0)
Nebraska   (100.0) (43.5) (0.0) (0.0) (4.3) (52.2) (0.0)
Nevada   (94.6) (48.9) (1.1) (0.0) (0.0) (48.9) (1.1)
New Hampshire   (100.0) (54.5) (0.0) (0.0) (0.0) (45.5) (0.0)
New Jersey   (100.0) (55.8) (3.4) (0.0) (0.2) (40.3) (0.2)
New Mexico   (95.9) (51.1) (0.0) (0.0) (0.0) (48.9) (0.0)
New York State   (96.3) (41.9) (8.1) (0.0) (0.8) (48.7) (0.4)
New York City   (97.0) (57.1) (3.7) (0.0) (0.0) (38.9) (0.2)
North Carolina 0  (99.7) (46.4) (1.3) (0.0) (1.3) (51.1) (0.0)
North Dakota   (100.0) (28.6) (28.6) (14.3) (0.0) (28.6) (0.0)
Ohio   (97.9) (56.4) (4.3) (0.4) (0.4) (38.5) (0.0)
Oklahoma  0 (93.8) (44.2) (3.3) (0.0) (0.0) (52.5) (0.0)
Oregon   (98.9) (32.6) (3.5) (1.2) (5.8) (57.0) (0.0)
Pennsylvania   (94.4) (31.5) (3.4) (0.0) (0.0) (65.1) (0.0)
Rhode Island   (89.2) (45.5) (6.1) (0.0) (0.0) (48.5) (0.0)
South Carolina 0 0 (99.5) (49.5) (2.0) (0.5) (1.5) (46.6) (0.0)
South Dakota   (100.0) (100.0) (0.0) (0.0) (0.0) (0.0) (0.0)
Tennessee   (100.0) (64.3) (1.3) (0.0) (0.4) (33.9) (0.0)
Texas ,0 ,0 (100.0) (46.4) (2.6) (0.1) (0.6) (50.2) (0.1)
Utah   (100.0) (45.9) (0.0) (0.0) (2.7) (51.4) (0.0)
Vermont   (100.0) (33.3) (0.0) (0.0) (0.0) (66.7) (0.0)
Virginia   (100.0) (50.2) (2.1) (0.0) (0.0) (47.8) (0.0)
Washington   (91.1) (47.8) (4.5) (0.0) (1.2) (46.1) (0.4)
West Virginia   (100.0) (58.3) (12.5) (0.0) (0.0) (29.2) (0.0)
Wisconsin   (100.0) (47.1) (1.5) (0.0) (0.0) (51.5) (0.0)
Wyoming   (100.0) (0.0) (0.0) (0.0) (0.0) (100.0) (0.0)
American Samoa   (100.0) (66.7) (0.0) (0.0) (0.0) (33.3) (0.0)
Fed. States of Micronesia   (87.8) (79.1) (0.0) (0.0) (0.0) (20.9) (0.0)
Guam   (91.8) (55.4) (0.0) (0.0) (0.0) (44.6) (0.0)
Marshall Islands   (98.9) (52.2) (3.3) (0.0) (0.0) (43.5) (1.1)
N. Mariana Islands   (100.0) (12.2) (0.0) (0.0) (0.0) (87.8) (0.0)
Puerto Rico   (98.9) (73.1) (1.1) (0.0) (0.0) (25.8) (0.0)
Republic of Palau  0 (90.9) (20.0) (0.0) (0.0) (0.0) (80.0) (0.0)
U.S. Virgin Islands    ... ... ... ... ... ... ... ... ...
Table 38. Tuberculosis Cases and Percentages by Occupation, Age >15: Reporting Areas, 
2007
Occupation within past 24 months of TB diagnosis. Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and 
the District of Columbia). Percentages shown only for reporting areas with information reported for >% of cases.
Excludes New York City.
Not included in U.S. totals. 
Note: Ellipses indicate data not available.
Reporting Area
Total 
Cases
Cases with
Information on 
Occupation
Percentage of Cases by Occupation
No. (%)
Unemployed 
Past 24 Mos.
Health Care 
Worker
Correctional 
Employee
Migrant 
Worker
Other 
Occupation
Multiple
Occupations

United States 14,065 13,766 13,561 (98.5) (58.7) (18.5) (22.7)
Alabama    (100.0) (72.2) (9.4) (18.4)
Alaska    (100.0) (32.2) (1.7) (66.1)
Arizona    (93.8) (68.0) (22.0) (10.0)
Arkansas    (76.1) (90.7) (9.3) (0.0)
California ,00 , , (98.9) (51.8) (30.7) (17.4)
Colorado 0   (99.0) (62.9) (7.2) (29.9)
Connecticut    (100.0) (14.0) (49.5) (36.6)
Delaware    (100.0) (74.1) (3.7) (22.2)
District of Columbia    (100.0) (63.0) (22.2) (14.8)
Florida ,0 ,0 ,0 (99.9) (72.9) (13.1) (14.1)
Georgia 0 0 0 (95.4) (68.3) (6.0) (25.6)
Hawaii   0 (99.1) (27.3) (18.2) (54.5)
Idaho    (100.0) (47.8) (30.4) (21.7)
Illinois    (99.1) (40.0) (30.3) (29.8)
Indiana    (100.0) (14.0) (8.4) (77.6)
Iowa    (100.0) (1.8) (3.6) (94.5)
Kansas 0   (100.0) (32.2) (13.6) (54.2)
Kentucky  0  (99.2) (58.8) (13.4) (27.7)
Louisiana    (88.3) (62.8) (6.9) (30.3)
Maine    (94.1) (93.8) (6.3) (0.0)
Maryland    (98.9) (87.3) (5.8) (6.9)
Massachusetts    (97.3) (39.0) (8.3) (52.8)
Michigan    (99.6) (55.0) (21.4) (23.5)
Minnesota    (100.0) (58.9) (36.5) (4.6)
Mississippi 0   (100.0) (91.5) (3.2) (5.3)
Missouri 0 0 0 (99.0) (14.7) (17.6) (67.6)
Montana 0   (100.0) (44.4) (0.0) (55.6)
Nebraska    (100.0) (3.0) (36.4) (60.6)
Nevada  0  (89.1) (80.6) (4.1) (15.3)
New Hampshire    (100.0) (0.0) (0.0) (100.0)
New Jersey    (99.1) (69.2) (26.3) (4.5)
New Mexico    (100.0) (51.4) (29.7) (18.9)
New York State 00   (99.0) (63.0) (17.0) (20.1)
New York City    (99.6) (36.4) (21.0) (42.6)
North Carolina    (100.0) (56.2) (4.0) (39.8)
North Dakota    (100.0) (0.0) (66.7) (33.3)
Ohio 0   (99.2) (56.6) (20.1) (23.3)
Oklahoma    (99.3) (96.4) (0.0) (3.6)
Oregon 0 0 0 (100.0) (57.3) (4.9) (37.9)
Pennsylvania 0   (99.4) (78.5) (21.2) (0.3)
Rhode Island    (100.0) (91.3) (4.3) (4.3)
South Carolina   0 (99.2) (83.6) (1.6) (14.8)
South Dakota    (100.0) (68.8) (12.5) (18.8)
Tennessee    (100.0) (61.0) (3.1) (36.0)
Texas , , ,0 (98.6) (71.0) (17.3) (11.7)
Utah    (100.0) (24.1) (0.0) (75.9)
Vermont    (100.0) (12.5) (12.5) (75.0)
Virginia  0  (99.7) (73.1) (15.8) (11.2)
Washington    (99.2) (65.3) (9.8) (24.9)
West Virginia    (96.4) (29.6) (7.4) (63.0)
Wisconsin    (100.0) (0.0) (0.0) (100.0)
Wyoming 0 0 0 . -- -- --
American Samoa    (60.0) -- -- --
Fed. States of Micronesia    (44.6) -- -- --
Guam    (93.7) (93.2) (0.0) (6.8)
Marshall Islands    (83.3) (100.0) (0.0) (0.0)
N. Mariana Islands   0 (89.3) (98.0) (0.0) (2.0)
Puerto Rico  00 00 (100.0) (84.0) (14.0) (2.0)
Republic of Palau 0 0  (90.0) (88.9) (0.0) (11.1)
U.S. Virgin Islands … ... … ... ... ... ...
Most recent year for which data are available.
Health Department: All outpatient care provided by the state or local health department; Private/Other: All care (except contact inves-
tigation and dispensing of medication) provided by non–health department providers; Both Health Department and Private/Other: Both 
sectors involved in the care of the patient. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of 
Columbia). Percentages shown only for reporting areas with information reported for >% of cases.
Excludes New York City.
Not included in U.S. totals. 
Note: Ellipses indicate data not available.
Table 39. Tuberculosis Cases and Percentages by Type of Health Care Provider: Reporting 
Areas, 20051
Reporting Area
Total  
Cases
Percentage of Cases by
Type of Health Care Provider
No. (%)
Health 
Department
Private/
Other
Both Health 
Department and 
Private/Other
Cases in 
Persons 
Alive at 
Diagnosis
Cases with Information on
Type of Health Care Provider

United States 14,065 13,662 13,454 (98.5) (57.6) (29.9)
Alabama    (100.0) (22.2) (77.4)
Alaska    (100.0) (91.5) (8.5)
Arizona    (96.3) (75.6) (13.6)
Arkansas    (82.1) (10.9) (52.2)
California ,00 , , (98.4) (62.1) (21.2)
Colorado 0   (100.0) (91.8) (4.1)
Connecticut    (100.0) (18.3) (48.4)
Delaware    (100.0) (70.4) (29.6)
District of Columbia    (100.0) (46.3) (16.7)
Florida ,0 ,00 ,0 (99.9) (50.7) (44.0)
Georgia 0   (97.6) (82.8) (15.5)
Hawaii  0 0 (98.2) (2.8) (66.7)
Idaho    (95.7) (45.5) (27.3)
Illinois    (99.7) (54.1) (16.2)
Indiana    (100.0) (55.9) (31.5)
Iowa    (98.2) (64.8) (18.5)
Kansas 0   (98.3) (93.1) (6.9)
Kentucky  0  (99.2) (63.9) (30.3)
Louisiana    (87.8) (81.9) (13.5)
Maine    (94.1) (93.8) (0.0)
Maryland    (100.0) (90.2) (8.0)
Massachusetts  0  (98.8) (30.4) (47.1)
Michigan    (99.6) (28.7) (31.2)
Minnesota    (100.0) (84.3) (14.7)
Mississippi 0   (100.0) (30.9) (68.1)
Missouri 0 0 0 (99.0) (30.4) (51.0)
Montana 0   (100.0) (77.8) (22.2)
Nebraska    (100.0) (63.6) (6.1)
Nevada  0  (89.1) (84.7) (10.2)
New Hampshire    (100.0) (75.0) (0.0)
New Jersey    (98.7) (48.6) (22.7)
New Mexico    (97.2) (85.7) (14.3)
New York State 00   (100.0) (15.8) (76.7)
New York City    (99.4) (5.0) (63.4)
North Carolina    (100.0) (91.9) (7.8)
North Dakota    (100.0) (0.0) (100.0)
Ohio 0 0 0 (100.0) (58.4) (28.0)
Oklahoma    (100.0) (99.3) (0.0)
Oregon 0 0 0 (100.0) (65.0) (32.0)
Pennsylvania 0  0 (99.0) (61.0) (29.5)
Rhode Island    (100.0) (8.7) (91.3)
South Carolina   0 (99.2) (94.4) (4.4)
South Dakota    (100.0) (62.5) (12.5)
Tennessee    (100.0) (81.8) (18.2)
Texas , , , (97.1) (64.3) (33.8)
Utah    (100.0) (96.6) (3.4)
Vermont    (100.0) (75.0) (12.5)
Virginia  0  (99.7) (83.7) (14.6)
Washington    (99.2) (78.2) (16.5)
West Virginia    (100.0) (61.5) (30.8)
Wisconsin    (98.7) (33.3) (60.0)
Wyoming 0 0 0 -- -- --
American Samoa    (60.0) -- --
Fed. States of Micronesia    (44.6) -- --
Guam   0 (95.2) (3.3) (96.7)
Marshall Islands    (83.3) (65.5) (30.9)
N. Mariana Islands   0 (89.3) (98.0) (2.0)
Puerto Rico    (100.0) (61.6) (0.0)
Republic of Palau 0 0 0 (100.0) (10.0) (60.0)
U.S. Virgin Islands ... ... ... ... ... ...
Table 40. Tuberculosis Cases and Percentages by Directly Observed Therapy (DOT): 
Reporting Areas, 20051
Most recent year for which data are available.
Includes persons alive at diagnosis with an initial drug regimen of one or more drugs prescribed.
Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia). Percentages shown only for 
reporting areas with information reported for >% of cases.
Excludes New York City.
Not included in U.S. totals. 
Note: Ellipses indicate data not available.
Reporting Area
Total  
Cases
Percentage of Cases by
Directly Observed Therapy
No. (%) DOT Only
Both DOT and 
Self-Administered
Cases with 
Initial Drug 
Regimen 
Prescribed
Cases with Information on
Directly Observed Therapy

Table 41. Tuberculosis Cases and Percentages by Completion of Tuberculosis Therapy 
(COT): Reporting Areas, 20051
Most recent year for which data are available.
Initial isolate susceptible to rifampin (n=9,212) or susceptibility unknown (n=223); culture negative (n=2,346); culture status un-
known (n=561); age unknown (n=0).
Initial isolate rifampin resistant, or pediatric patients (aged <15) with meningeal, bone, joint, or miliary disease.
Number of cases in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed, who did not die during 
therapy. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia). Percentages 
shown only for reporting areas with information reported for >0% of cases.
Excludes New York City.
Not included in U.S. totals. 
Note: Ellipses indicate data not available. See Technical Notes for description of Completion of Therapy calculation (page 9).
Reporting Area
Total  
Cases
All Drug Therapy
No. COT(%) No. COT(%)
Therapy <1 Year Indicated
COT <1 Year(%)
Therapy >1 Year Indicated
No. COT(%)
United States 14,065 12342 (82.7) (91.9) 346 (82.7) 12688 (91.7)
Alabama   (89.7) (94.8)  (33.3)  (93.9)
Alaska   (93.0) (96.5)  (100.0)  (96.6)
Arizona   (83.3) (87.3)  (100.0)  (87.5)
Arkansas  0 -- --  -- 0 --
California ,00  (80.7) (91.9)  (80.3)  (91.6)
Colorado 0  (96.5) (97.6)  (100.0)  (97.8)
Connecticut   (82.8) (97.7)  (100.0)  (97.7)
Delaware   (87.5) (100.0) 0 ...  (100.0)
District of Columbia   (87.8) (93.9)  (33.3)  (90.4)
Florida ,0  (88.6) (94.6)  (95.2)  (94.6)
Georgia 0  (82.0) (93.1)  (72.7) 0 (92.6)
Hawaii   (74.7) (88.4) 0 ...  (88.4)
Idaho   (76.2) (85.7) 0 ...  (85.7)
Illinois   (80.0) (91.4)  (80.0)  (91.3)
Indiana   (91.0) (95.5)  (100.0)  (95.5)
Iowa   (84.6) (94.2) 0 ...  (94.2)
Kansas 0  (86.0) (91.2) 0 ...  (91.2)
Kentucky  0 (87.5) (93.3)  (100.0) 0 (93.5)
Louisiana   -- --  --  --
Maine   (75.0) (75.0)  (100.0)  (76.5)
Maryland   (88.4) (94.8)  (100.0)  (94.9)
Massachusetts   (78.3) (89.8)  (75.0)  (89.1)
Michigan  0 (80.1) (91.5)  (75.0) 0 (90.9)
Minnesota   (92.9) (97.8)  (100.0) 0 (97.9)
Mississippi 0  (84.5) (95.2)  (100.0)  (95.3)
Missouri 0  (85.7) (96.7)  (66.7)  (95.7)
Montana 0  (87.5) (100.0) 0 ...  (100.0)
Nebraska   (75.9) (82.8)  (100.0)  (84.4)
Nevada  0 -- --  -- 0 --
New Hampshire   (75.0) (100.0) 0 ...  (100.0)
New Jersey  0 (85.7) (93.3)  (93.3)  (93.3)
New Mexico   (80.8) (100.0)  (100.0)  (100.0)
New York State 00  (87.2) (97.4)  (77.8)  (96.7)
New York City   (81.9) (90.5)  (77.3)  (89.9)
North Carolina  0 (86.2) (96.6)  (100.0)  (96.6)
North Dakota   (50.0) (83.3) 0 ...  (83.3)
Ohio 0  (87.0) (94.8)  (85.7)  (94.5)
Oklahoma   (84.7) (97.5)  (66.7)  (96.7)
Oregon 0  (93.7) (96.8)  (100.0)  (96.9)
Pennsylvania 0 0 -- --  --  --
Rhode Island   (82.9) (95.1)  (0.0)  (92.9)
South Carolina   (87.1) (96.1)  (71.4)  (95.4)
South Dakota   (53.8) (100.0) 0 ...  (100.0)
Tennessee   (88.8) (96.6)  (85.7)  (96.4)
Texas ,  (80.6) (89.7)  (83.3)  (89.5)
Utah   (96.2) (96.2)  (100.0)  (96.4)
Vermont   (100.0) (100.0) 0 ...  (100.0)
Virginia   (81.9) (90.7)  (100.0)  (90.9)
Washington   (83.2) (92.0)  (83.3)  (91.8)
West Virginia   (58.3) (87.5) 0 ...  (87.5)
Wisconsin  0 (84.3) (90.0)  (100.0)  (90.3)
Wyoming 0 0 -- -- 0 ... 0 --
American Samoa   -- -- 0 --  --
Fed. States of Micronesia   -- --  --  --
Guam   (79.7) (88.1)  (0.0) 0 (86.7)
Marshall Islands   -- -- 0 --  --
N. Mariana Islands   -- --  --  --
Puerto Rico   (87.2) (94.2)  (100.0)  (94.3)
Republic of Palau 0 0 (100.0) (100.0) 0 ... 0 (100.0)
U.S. Virgin Islands 0 0 -- -- 0 -- 0 --

United States 13,662 11,629 (85.1) 336 (2.5) 317 (2.3) 88 (0.6) 974 (7.1) 318 (2.3)
Alabama   (87.3)  (1.4)  (2.4)  (0.9)  (7.1)  (0.9)
Alaska   (94.9) 0 (0.0) 0 (0.0)  (1.7)  (1.7)  (1.7)
Arizona   (81.0)  (0.4)  (5.6)  (0.7) 0 (7.5)  (4.9)
Arkansas   (76.8)  (1.8)  (0.9) 0 (0.0)  (6.3)  (14.3)
California , , (84.8) 0 (3.8)  (1.7)  (0.6) 0 (7.4)  (1.8)
Colorado   (89.7) 0 (0.0)  (1.0) 0 (0.0)  (8.2)  (1.0)
Connecticut   (92.5)  (1.1)  (1.1) 0 (0.0)  (5.4) 0 (0.0)
Delaware   (88.9) 0 (0.0) 0 (0.0) 0 (0.0)  (11.1) 0 (0.0)
District of Columbia   (87.0)  (5.6)  (3.7) 0 (0.0)  (3.7) 0 (0.0)
Florida ,00  (88.2)  (1.8)  (2.4)  (0.5)  (6.8)  (0.4)
Georgia   (86.1)  (1.4)  (3.6)  (0.6)  (7.1)  (1.2)
Hawaii 0  (76.4)  (4.5)  (1.8)  (1.8)  (13.6)  (1.8)
Idaho   (78.3)  (4.3) 0 (0.0)  (4.3)  (8.7)  (4.3)
Illinois   (84.0)  (2.8)  (2.8)  (1.0)  (8.0)  (1.4)
Indiana   (89.5)  (0.7)  (2.1)  (0.7)  (6.3)  (0.7)
Iowa   (89.1) 0 (0.0)  (3.6) 0 (0.0)  (5.5)  (1.8)
Kansas   (88.1)  (1.7)  (1.7)  (1.7)  (3.4)  (3.4)
Kentucky 0 00 (83.3)  (2.5)  (1.7) 0 (0.0)  (10.8)  (1.7)
Louisiana   (71.4)  (2.9)  (4.9)  (0.4)  (9.8)  (10.6)
Maine   (76.5)  (5.9) 0 (0.0)  (5.9) 0 (0.0)  (11.8)
Maryland   (88.4)  (2.5)  (1.1)  (0.4)  (6.9)  (0.7)
Massachusetts 0 0 (84.6)  (6.9)  (1.5)  (0.8)  (5.0)  (1.2)
Michigan  0 (79.8)  (0.8)  (2.5)  (3.8)  (12.2)  (0.8)
Minnesota   (94.4)  (0.5)  (0.5)  (1.0)  (3.6) 0 (0.0)
Mississippi   (87.2)  (4.3) 0 (0.0) 0 (0.0)  (8.5) 0 (0.0)
Missouri 0 0 (87.4)  (1.0)  (1.0)  (1.0)  (8.7)  (1.0)
Montana   (88.9) 0 (0.0) 0 (0.0) 0 (0.0)  (11.1) 0 (0.0)
Nebraska   (81.8)  (6.1)  (9.1) 0 (0.0)  (3.0) 0 (0.0)
Nevada 0  (84.5)  (1.8) 0 (0.0) 0 (0.0)  (2.7)  (10.9)
New Hampshire   0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
New Jersey  0 (87.3) 0 (0.0)  (4.9) 0 (0.0) 0 (6.5)  (1.3)
New Mexico   (77.8) 0 (0.0) 0 (0.0) 0 (0.0)  (22.2) 0 (0.0)
New York State   (91.1)  (0.3)  (1.7)  (0.7)  (5.8)  (0.3)
New York City   (83.3)  (1.8)  (3.4)  (0.8) 0 (7.3)  (3.3)
North Carolina   (89.4)  (0.6)  (2.2) 0 (0.0)  (7.5)  (0.3)
North Dakota   (83.3) 0 (0.0) 0 (0.0)  (16.7) 0 (0.0) 0 (0.0)
Ohio 0  (90.0)  (2.8) 0 (0.0)  (1.6)  (4.8)  (0.8)
Oklahoma   (84.8)  (1.4)  (0.7) 0 (0.0)  (12.3)  (0.7)
Oregon 0  (90.3) 0 (0.0)  (1.9)  (1.0)  (6.8) 0 (0.0)
Pennsylvania  0 (66.2)  (1.6)  (0.3)  (0.6)  (11.3)  (19.9)
Rhode Island   (84.8)  (4.3) 0 (0.0)  (2.2)  (8.7) 0 (0.0)
South Carolina   (90.5)  (0.8)  (0.8)  (1.6)  (5.2)  (1.2)
South Dakota   (81.3) 0 (0.0) 0 (0.0) 0 (0.0)  (18.8) 0 (0.0)
Tennessee   (90.4)  (1.4)  (1.7) 0 (0.0)  (6.2)  (0.3)
Texas , , (83.8) 0 (3.4)  (3.5)  (0.3)  (6.3)  (2.7)
Utah   (93.1) 0 (0.0)  (3.4) 0 (0.0)  (3.4) 0 (0.0)
Vermont   (87.5) 0 (0.0) 0 (0.0) 0 (0.0)  (12.5) 0 (0.0)
Virginia 0  (85.1)  (3.7)  (3.1)  (0.3)  (6.3)  (1.4)
Washington   (86.9)  (5.3)  (0.8)  (0.4)  (5.3)  (1.2)
West Virginia   (80.8)  (7.7) 0 (0.0) 0 (0.0)  (7.7)  (3.8)
Wisconsin   (85.5)  (2.6)  (2.6)  (1.3)  (5.3)  (2.6)
Wyoming 0 0 ... 0 ... 0 ... 0 ... 0 ... 0 ...
American Samoa   (60.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)  (40.0)
Fed. States of Micronesia   (39.2)  (2.7) 0 (0.0)  (1.4)  (1.4)  (55.4)
Guam   (82.5)  (1.6) 0 (0.0) 0 (0.0)  (4.8)  (11.1)
Marshall Islands   (74.2) 0 (0.0)  (4.5) 0 (0.0)  (4.5)  (16.7)
N. Mariana Islands   (78.6)  (8.9) 0 (0.0) 0 (0.0)  (1.8)  (10.7)
Puerto Rico   (82.8)  (1.0)  (4.0) 0 (0.0)  (12.1) 0 (0.0)
Republic of Palau 0 0 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
U.S. Virgin Islands ... ... ... ... ... ... ... ... ... ... ... ... ...
Table 42. Tuberculosis Cases and Percentages by Reason Therapy Stopped: 
Reporting Areas, 20051
Most recent year for which data are available.
Number of cases in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed. Percentage for U.S. based on 52 
reporting areas (50 states, New York City, and the District of Columbia).
Died = Died of any cause.
Includes cases reported as Other, Missing, or Unknown.
Excludes New York City.
Not included in U.S. totals. 
Note: Ellipses indicate data not available.
Reporting Area
Completed Moved Lost Refused Died Unknown
No. No. No. No. No. No.(%) (%) (%) (%) (%) (%)
Cases with 
Initial Drug 
Regimen 
Prescribed

United States 12,342 3,627 (82.5) 121 (80.2) 2,894 (81.5) 3,454 (83.6) 2,156 (83.7) 90 (76.7)
Alabama   (88.0) 0 ...  (100.0)  (92.2)  (86.1) 0 ...
Alaska   (100.0)  (89.3)  (100.0) 0 ...  (80.0)  (100.0)
Arizona   (81.0)  (81.8)  (88.9)  (83.3)  (88.9) 0 ...
Arkansas 0 -- -- -- -- -- -- -- -- -- -- -- --
California , ,00 (83.0)  (80.0) ,0 (79.7) 0 (77.9)  (79.8)  (62.5)
Colorado  0 (97.5) 0 ...  (100.0)  (94.1)  (93.3)  (100.0)
Connecticut   (95.2) 0 ...  (70.8)  (85.7)  (81.0) 0 ...
Delaware   (100.0) 0 ...  (33.3)  (85.7)  (100.0) 0 ...
District of Columbia   (100.0) 0 ...  (100.0)  (85.4) 0 ... 0 ...
Florida   (86.0) 0 ... 0 (83.8) 0 (90.1) 0 (91.4)  (50.0)
Georgia   (72.6) 0 ...  (90.7)  (83.7)  (82.1)  (66.7)
Hawaii  0 ... 0 ...  (73.3) 0 ...  (85.7)  (100.0)
Idaho   (60.0)  (100.0) 0 ...  (100.0)  (75.0)  (100.0)
Illinois   (80.8)  (100.0)  (79.7)  (82.1)  (72.1)  (66.7)
Indiana   (88.9) 0 ...  (91.7)  (97.2)  (87.0) 0 ...
Iowa   (61.5)  (100.0)  (83.3)  (100.0)  (92.0) 0 ...
Kansas   (88.2)  (100.0) 0 (80.0)  (86.7)  (85.7) 0 ...
Kentucky 0  (83.3) 0 ...  (87.5)  (91.7) 0 (88.3) 0 ...
Louisiana  -- -- -- -- -- -- -- -- -- -- -- --
Maine  0 ... 0 ...  (60.0)  (50.0)  (100.0) 0 ...
Maryland   (83.7) 0 ...  (94.4) 0 (88.5)  (81.8) 0 ...
Massachusetts  0 (75.0) 0 ...  (75.3) 0 (80.0)  (83.3) 0 ...
Michigan 0 0 (75.0)  (0.0)  (83.7) 0 (81.1)  (77.3)  (100.0)
Minnesota   (88.9)  (100.0)  (89.8) 0 (94.1) 0 (100.0) 0 ...
Mississippi  0 (90.0)  (100.0) 0 ...  (82.7)  (85.7) 0 ...
Missouri   (66.7) 0 ...  (75.0) 0 (86.7)  (94.6) 0 ...
Montana   (100.0)  (75.0) 0 ... 0 ...  (100.0) 0 ...
Nebraska   (72.7)  (0.0)  (100.0)  (100.0)  (81.8)  (0.0)
Nevada 0 -- -- -- -- -- -- -- -- -- -- -- --
New Hampshire  0 ... 0 ...  (75.0) 0 ... 0 ... 0 ...
New Jersey 0  (88.1) 0 ...  (81.4) 00 (89.0)  (83.9) 0 ...
New Mexico   (87.5)  (40.0)  (100.0)  (100.0) 0 ... 0 ...
New York State  0 (88.9) 0 ...  (88.7) 0 (81.7)  (88.9) 0 ...
New York City   (83.0) 0 ...  (86.9)  (78.5)  (77.0)  (72.7)
North Carolina 0  (86.6)  (87.5)  (84.0)  (85.8)  (87.8) 0 ...
North Dakota  0 ...  (33.3) 0 ...  (0.0)  (100.0) 0 ...
Ohio   (90.5) 0 ...  (85.7) 00 (87.0)  (86.3)  (100.0)
Oklahoma   (94.7)  (81.8)  (90.9)  (72.2)  (82.1)  (100.0)
Oregon   (96.0)  (100.0)  (87.9)  (100.0)  (96.3)  (100.0)
Pennsylvania 0 -- -- -- -- -- -- -- -- -- -- -- --
Rhode Island   (86.7) 0 ...  (88.9)  (75.0)  (76.9) 0 ...
South Carolina   (76.9) 0 ...  (100.0)  (89.9)  (79.2) 0 ...
South Dakota  0 ...  (33.3)  (33.3)  (66.7)  (75.0) 0 ...
Tennessee   (85.3)  (0.0)  (100.0)  (87.3)  (91.6) 0 ...
Texas ,  (80.8)  (50.0)  (80.7)  (79.7)  (81.5) 0 ...
Utah   (91.7)  (100.0)  (100.0)  (100.0)  (100.0) 0 ...
Vermont  0 ... 0 ...  (100.0) 0 ...  (100.0) 0 ...
Virginia   (78.2) 0 ...  (84.0) 00 (81.0)  (86.8)  (100.0)
Washington   (70.6)  (92.3)  (82.0) 0 (80.0)  (93.8)  (100.0)
West Virginia   (100.0) 0 ...  (33.3)  (0.0)  (61.1)  (100.0)
Wisconsin 0  (82.4)  (100.0)  (87.0)  (87.5)  (76.9) 0 ...
Wyoming 0 -- -- -- -- -- -- -- -- -- -- -- --
American Samoa  -- -- -- -- -- -- -- -- -- -- -- --
Fed. States of Micronesia  -- -- -- -- -- -- -- -- -- -- -- --
Guam  0 ... 0 ...  (79.3) 0 ... 0 ...  (100.0)
Marshall Islands  -- -- -- -- -- -- -- -- -- -- -- --
N. Mariana Islands  -- -- -- -- -- -- -- -- -- -- -- --
Puerto Rico   (88.2) 0 ... 0 ...  (0.0) 0 ... 0 ...
Republic of Palau 0 0 ... 0 ... 0 (100.0) 0 ... 0 ... 0 ...
U.S. Virgin Islands 0 -- -- -- -- -- -- -- -- -- -- -- --
Table 43. Completion of Tuberculosis Therapy (COT) Cases and Percentages1 by Hispanic 
Ethnicity and Non-Hispanic Race: Reporting Areas, 20052
Percentages shown only for reporting areas with information reported for >90% of cases, and indicate the percentage of those who completed 
therapy within 1 year. 
Most recent year for which data are available.
Therapy < 1 year indicated in persons alive at diagnosis with an initial regimen of one or more drugs prescribed, who did not die during therapy. 
Persons of Hispanic or Latino origin may be of any race.
Excludes New York City.
Not included in U.S. totals. 
Note: Case counts and percentage for race categories do not include persons of Hispanic ethnicity. Ellipses indicate data not available.
See Technical Notes for description of Completion of Therapy calculation (page 9).
Reporting Area
Total
Cases
Unknown or 
MissingWhiteBlackHispanic
American Indian 
or Alaska Native
Asian or Pacific 
Islander
Non-Hispanic
No. (%) No. No. No. No.(%) (%) (%) (%)No. (%)

United States 13,921 (81.5) 13,128 (82.1) 13,065 (82.8) 12,788 (82.8) 12,342 (82.7)
Alabama  (81.2) 0 (90.0)  (86.2)  (89.9)  (89.7)
Alaska 0 (88.0)  (88.9)  (92.2)  (84.2)  (93.0)
Arizona  (82.1)  (80.2) 0 (79.6)  (74.8)  (83.3)
Arkansas  (92.0)  (86.8)  (87.9)  (88.6) 0 --
California , (80.9) , (82.7) , (81.5) , (81.7) , (80.7)
Colorado  (92.0)  (84.4) 0 (93.1)  (96.6)  (96.5)
Connecticut  (73.2)  (70.8) 00 (76.0)  (77.6)  (82.8)
Delaware 0 (93.3)  (90.9)  (85.7)  (93.1)  (87.5)
District of Columbia  (85.5)  (98.7)  (91.2)  (93.9)  (87.8)
Florida ,00 (81.6)  (82.3)  (85.9)  (85.9)  (88.6)
Georgia 00 (82.6)  (78.9) 0 (79.6)  (83.4)  (82.0)
Hawaii  (74.6)  (69.9)  (78.8) 0 (79.6)  (74.7)
Idaho  --  --  -- 0 (80.0)  (76.2)
Illinois  (78.0)  (77.6)  (80.8) 0 (79.9)  (80.0)
Indiana  (92.8) 0 (96.2)  (95.8)  (93.7)  (91.0)
Iowa  (77.8)  (81.8)  (91.9)  (76.6)  (84.6)
Kansas 0 (72.9)  (83.6)  (78.1)  (84.2)  (86.0)
Kentucky  (87.8)  (85.3) 0 (85.8) 0 (87.3) 0 (87.5)
Louisiana  (74.5) 0 (81.6)  (81.7)  (73.2)  --
Maine  (94.7)  (77.8)  (69.6)  (66.7)  (75.0)
Maryland 0 (90.0)  (87.7)  (87.9)  (90.7)  (88.4)
Massachusetts  (77.3)  (76.8)  (80.2)  (77.0)  (78.3)
Michigan  (81.9)  (82.0) 0 (84.9)  (87.0) 0 (80.1)
Minnesota  (84.9)  (85.3) 00 (89.5)  (91.0)  (92.9)
Mississippi  (83.9)  (83.0) 0 (73.4) 0 (85.1)  (84.5)
Missouri  (84.7)  (86.0) 0 (73.3)  (82.0)  (85.7)
Montana  (94.1) 0 (90.0)  (100.0)  (92.9)  (87.5)
Nebraska  (83.9)  (70.8)  (68.0)  (86.5)  (75.9)
Nevada  (81.6) 0 (98.6)  (91.7)  (90.9) 0 --
New Hampshire  (89.5)  (88.9)  (92.3)  (100.0)  (75.0)
New Jersey  (76.5)  (79.1) 0 (81.8)  (82.3) 0 (85.7)
New Mexico  (86.4)  (83.7)  (86.5)  (84.8)  (80.8)
New York State  (83.2)  (77.1)  (83.4)  (86.3)  (87.2)
New York City ,0 (85.5) 0 (86.2)  (86.5) 0 (84.5)  (81.9)
North Carolina  (88.8)  (90.7)  (89.5)  (92.5) 0 (86.2)
North Dakota  (100.0)  (100.0)  (50.0)  (100.0)  (50.0)
Ohio  (79.7)  (80.4)  (90.7) 0 (87.9)  (87.0)
Oklahoma 0 (80.6)  (85.7)  (70.1)  (80.5)  (84.7)
Oregon  (88.3) 0 (88.1)  (84.4)  (89.7)  (93.7)
Pennsylvania  (76.9)  (75.6)  (79.5) 0 -- 0 --
Rhode Island 0 (73.3)  (68.2) 0 (90.0)  (85.7)  (82.9)
South Carolina  (85.0)  (80.2)  (86.6)  (82.2)  (87.1)
South Dakota  (66.7)  (88.9)  (68.8)  (44.4)  (53.8)
Tennessee  (85.2)  (84.4)  (81.0)  (85.7)  (88.8)
Texas , (76.6) ,0 (76.6) , (77.0) ,0 -- , (80.6)
Utah  (83.9) 0 (93.3)  (97.1)  (96.9)  (96.2)
Vermont  (100.0)  (87.5)  (100.0)  (66.7)  (100.0)
Virginia  (81.6)  (86.7)  (87.6)  (88.4)  (81.9)
Washington 0 (85.0)  (83.2)  (82.5)  (88.1)  (83.2)
West Virginia  (64.0)  (65.4)  (70.6)  (81.0)  (58.3)
Wisconsin  (81.3)  (83.6)  (86.9)  (79.8) 0 (84.3)
Wyoming  (100.0)  (100.0)  (100.0)  (100.0) 0 …
American Samoa 0 (0.0) 0 (0.0) 0 (0.0)  (0.0)  (60.0)
Fed. States of Micronesia 0 (0.0) 0 (0.0) 0 (0.0)  (40.0)  (38.9)
Guam  (75.9)  --  (87.9)  (84.4)  (79.7)
Marshall Islands 0 (0.0) 0 (0.0) 0 (0.0)  (76.3)  (76.2)
N. Mariana Islands 0 (88.0) 0 (70.0)  (78.6)  (87.0)  (81.5)
Puerto Rico  (92.4)  (79.6)  (70.8)  (79.8)  (87.2)
Republic of Palau 0 (0.0) 0 (0.0)  (57.1)  (80.0) 0 (100.0)
U.S. Virgin Islands … … … … … … … … … …
Reporting Area
00 00 00 00 00
Year
No. No. No.No.(%) (%) (%) (%) (%)
Table 44. Tuberculosis Cases and Percentages in Persons Completing Therapy for Whom 
Therapy Was Indicated for One Year or Less: Reporting Areas, 2001–20051
Most recent year for which data are available.
Total cases for which therapy less than 1 year indicated in persons alive at diagnosis, with an initial regimen of one or more drugs pre-
scribed, who did not die during therapy. 
Percentage of total cases in persons who completed therapy for whom therapy less than 1 year was indicated.
Excludes New York City.
Not included in U.S. totals. 
Ellipses indicate data not available.
See Technical Notes for description of Completion of Therapy calculation (page 9).
No.

Morbidity Tables
Cities and Metropolitan Statistical Areas, 2007
0

Albuquerque, NM 0 
Anaheim, CA  
Arlington, TX  
Atlanta, GA  
Austin, TX  
Baltimore, MD  
Birmingham, AL  
Boston, MA  
Buffalo, NY  
Charlotte, NC  0
Chicago, IL  
Cincinnati, OH  
Cleveland, OH  
Colorado Springs, CO  
Columbus, OH  
Corpus Christi, TX  
Dallas, TX  
Denver, CO 0 
Detroit, MI  
El Paso, TX 0 
Fort Worth, TX  
Fresno, CA  
Honolulu, HI  
Houston, TX  
Indianapolis, IN  
Jacksonville, FL  
Kansas City, MO 0 
Las Vegas, NV  
Long Beach, CA  
Los Angeles, CA 0 0
Louisville, KY 0 
Memphis, TN  0
Mesa, AZ  
Miami, FL  
Milwaukee, WI  
Minneapolis, MN  
Nashville, TN 0 
New Orleans, LA  0
New York, NY  
Newark, NJ  
Norfolk, VA  
Oakland, CA  0
Oklahoma City, OK  
Omaha, NE  
Philadelphia, PA  
Phoenix, AZ  00
Pittsburgh, PA  
Portland, OR  
Sacramento, CA  
San Antonio, TX  
San Diego, CA  0
San Francisco, CA  0
San Jose, CA  
Santa Ana, CA  
Seattle, WA  
St. Louis, MO  0
St. Paul, MN 0 
Tampa, FL  
Toledo, OH  
Tucson, AZ  
Tulsa, OK  0
Virginia Beach, VA  
Washington, DC 0 
Wichita, KS  
TOTAL - 64 CITIES , ,0
San Juan, PR  
Table 45. Tuberculosis Cases in Selected Cities: 2007 and 2006
Cases
00 00City
Historical list of cities.
Case counts are based on verified cases in persons residing within city limits. 
Residence within city limits was determined by the health department.

Table 46. Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan 
Statistical Areas with >500,000 Population, 2007 and 2006
Metropolitan 
Statistical Area
Cases Case Rates Population 
Estimates 
0000 0000 00
Akron, OH   (0.7) (0.7) ,
Albany-Schenectady-Troy, NY   (1.9) (1.9) ,
Albuquerque, NM   (1.9) (1.5) ,0
Allentown-Bethlehem-Easton, PA-NJ   (0.2) (2.8) 0,
Atlanta-Sandy Springs-Marietta, GA   (5.2) (5.5) ,,0
Augusta-Richmond County, GA-SC   (6.4) (6.9) ,
Austin-Round Rock, TX   (4.1) (3.4) ,,
Bakersfield, CA 0  (5.1) (5.0) 0,0
Baltimore-Towson, MD 0  (3.9) (3.1) ,,0
Baton Rouge, LA   (3.6) (2.4) 0,0
Birmingham-Hoover, AL   (3.8) (4.0) ,0,0
Boise City-Nampa, ID   (0.7) (0.9) ,
Boston-Cambridge-Quincy, MA-NH   (4.0) (4.3) ,,
Bridgeport-Stamford-Norwalk, CT   (5.8) (3.7) ,0
Buffalo-Niagara Falls, NY 0  (0.9) (1.3) ,,
Cape Coral-Fort Myers, FL   (7.6) (3.3) 0,
Charleston-North Charleston, SC   (7.0) (5.5) 0,00
Charlotte-Gastonia-Concord, NC-SC 0  (3.0) (5.1) ,,
Chattanooga, TN-GA  ... (3.1) ... ,
Chicago-Naperville-Joliet, IL 0  (5.1) (5.4) ,,
Cincinnati-Middleton, OH-KY-IN   (2.1) (1.7) ,,
Cleveland-Elyria-Mentor, OH   (2.9) (2.2) ,0,
Colorado Springs, CO  0 (1.1) (1.7) 0,0
Columbia, SC  0 (4.3) (2.8) ,00
Columbus, OH  0 (4.6) (5.2) ,,
Dallas-Fort Worth-Arlington, TX   (6.2) (7.0) ,,0
Dayton, OH   (1.8) (1.8) ,
Deltona-Daytona Beach-Ormond Beach, FL  ... (3.4) ... 00,
Denver-Aurora, CO   (3.2) (3.5) ,,
Des Moines-West Des Moines, IA   (1.3) (2.8) ,
Detroit-Warren-Livonia, MI   (3.1) (2.9) ,,
El Paso, TX 0  (5.4) (9.9) ,
Fresno, CA   (4.7) (7.0) ,
Grand Rapids-Wyoming, MI   (3.0) (2.8) ,
Greensboro-High Point, NC   (4.4) (6.1) ,
Greenville, SC   (2.9) (1.8) ,
Harrisburg-Carlisle, PA   (2.5) (1.0) ,
Hartford-West Hartford-East Hartford, CT  0 (2.1) (1.7) ,,
Honolulu, HI 0  (12.0) (10.4) 0,0
Houston-Sugar Land-Baytown, TX   (8.7) (8.6) ,,0
Indianapolis-Carmel, IN  0 (2.8) (3.0) ,,0
Jackson, MS   (6.4) (5.8) ,0
Jacksonville, FL   (5.8) (7.5) ,00,
Kansas City, MO-KS  0 (2.5) (2.5) ,,
Knoxville, TN   (2.3) (2.1) ,
Lakeland, FL   (5.0) (5.6) ,
Las Vegas-Paradise, NV   (5.0) (5.0) ,,
Little Rock-North Little Rock-Conway, AR   (4.7) (1.7) ,0
Los Angeles-Long Beach-Santa Ana, CA ,0 , (8.4) (9.0) ,,
Louisville-Jefferson County, KY-IN   (3.2) (2.3) ,,
Madison, WI   (0.7) (2.0) ,
McAllen-Edinburg-Mission, TX   (10.7) (9.9) 0,
Memphis, TN-MS-AR   (6.5) (9.5) ,0,
Miami-Fort Lauderdale-Pompano Beach, FL   (6.2) (6.8) ,,
Milwaukee-Waukesha-West Allis, WI   (2.5) (2.1) ,,
Minneapolis-St. Paul-Bloomington, MN-WI   (5.9) (5.3) ,0,

Modesto, CA   (2.9) (3.2) ,
Nashville-Davidson-Murfreesboro-Franklin, TN   (4.9) (5.5) ,,
New Haven-Milford, CT   (3.0) (2.6) ,
New Orleans-Metairie-Kenner, LA 0 0 (6.8) (8.1) ,00,
New York-Northern New Jersey-Long Island, NY-NJ-PA , , (7.7) (8.3) ,,
Ogden-Clearfield, UT  ... (0.8) ... ,
Oklahoma City, OK   (3.4) (3.8) ,,
Omaha-Council Bluffs, NE-IA   (1.7) (1.6) ,0
Orlando-Kissimmee, FL   (5.7) (7.0) ,0,
Oxnard-Thousand Oaks-Ventura, CA   (7.3) (6.2) ,
Palm Bay-Melbourne-Titusville, FL   (3.5) (1.5) ,
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD   (4.0) (4.9) ,,
Phoenix-Mesa-Scottsdale, AZ  0 (5.0) (5.1) ,,
Pittsburgh, PA 0  (1.3) (1.3) ,,
Portland-South Portland-Biddeford, ME  0 (2.3) (2.0) ,0
Portland-Vancouver-Beaverton, OR-WA   (3.1) (2.4) ,,
Poughkeepsie-Newburgh-Middletown, NY 0  (1.5) (2.0) ,
Providence-New Bedford-Fall River, RI-MA   (3.6) (2.4) ,00,
Raleigh-Cary, NC   (6.1) (5.6) ,0,
Richmond, VA 0  (2.5) (3.5) ,,
Riverside-San Bernardino-Ontario, CA   (3.4) (3.3) ,0,
Rochester, NY   (2.3) (2.4) ,00,
Sacramento-Arden Arcade-Roseville, CA  0 (6.4) (5.3) ,0,0
St. Louis, MO-IL   (2.0) (1.9) ,0,0
Salt Lake City, UT   (1.9) (2.4) ,0,
San Antonio, TX  0 (4.2) (5.6) ,0,
San Diego-Carlsbad-San Marcos, CA 0  (9.4) (10.7) ,,
San Francisco-Oakland-Fremont, CA  00 (10.8) (9.6) ,0,
San Jose-Sunnyvale-Santa Clara, CA   (13.4) (12.9) ,0,
Sarasota-Bradenton-Venice, FL   (4.9) (4.8) ,
Scranton-Wilkes-Barre, PA   (1.6) (1.5) ,0
Seattle-Tacoma-Bellevue, WA 0  (6.3) (5.9) ,0,
Springfield, MA   (1.9) (2.5) ,
Stockton, CA   (7.6) (11.7) 0,0
Syracuse, NY   (2.6) (2.2) ,
Tampa-St. Petersburg-Clearwater, FL   (4.7) (4.6) ,,
Toledo, OH   (1.2) (1.8) 0,
Tucson, AZ 0  (4.1) (3.7) ,0
Tulsa, OK   (3.4) (3.0) 0,
Virginia Beach-Norfolk-Newport News, VA-NC   (2.5) (3.1) ,,
Washington-Arlington-Alexandria, DC-VA-MD-WV  0 (7.9) (8.0) ,0,
Wichita, KS   (2.9) (4.9) ,
Worchester, MA   (2.3) (4.1) ,
Youngstown-Warren-Boardman, OH-PA   (1.4) (1.0) 0,0
Total - 100 Areas 0, 0, (5.3) (5.5) ,,
San Juan-Caguas-Guaynabo, PR   (2.9) (3.2) ,,0
Table 46. (Cont’d) Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan 
Statistical Areas with >500,000 Population, 2007 and 2006
Metropolitan 
Statistical Area
Cases Case Rates Population 
Estimates 
0000 0000 00
Note: In 2007, there were 3 metropolitan statistical areas with a 2006 population of less than 500,000. Ellipses indicate that data not 
shown for those populations less than 500,000.  
2007 and 2006 population case counts and rates updated using U.S. Census Metropolitan Statistical Areas and Components, December 
2006, with Codes (http://www.whitehouse.gov/omb/bulletins/fy2007/b07-01.pdf) (accessed June 6, 2008).
See Technical Notes (page 9) for definition of MSA.

Akron, OH   (40.0)  (60.0) 0 (0.0) 0
Albany-Schenectady-Troy, NY   (43.8)  (37.5)  (18.8) 0
Albuquerque, NM   (56.3)  (12.5)  (31.3) 
Allentown-Bethlehem-Easton, PA-NJ   (50.0)  (50.0) 0 (0.0) 0
Atlanta-Sandy Springs-Marietta, GA   (69.2)  (22.8)  (8.0) 
Augusta-Richmond County, GA-SC   (55.9)  (32.4)  (11.8) 0
Austin-Round Rock, TX   (77.3)  (18.2)  (4.5) 
Bakersfield, CA 0 0 (75.0)  (12.5)  (12.5) 0
Baltimore-Towson, MD 0  (73.1)  (22.1)  (4.8) 0
Baton Rouge, LA   (75.0)  (17.9)  (7.1) 0
Birmingham-Hoover, AL   (90.5)  (9.5) 0 (0.0) 0
Boise City-Nampa, ID   (50.0)  (25.0)  (25.0) 
Boston-Cambridge-Quincy, MA-NH  0 (61.5)  (24.0)  (14.5) 
Bridgeport-Stamford-Norwalk, CT   (67.3)  (30.8)  (1.9) 0
Buffalo-Niagara Falls, NY 0  (40.0)  (20.0)  (40.0) 
Cape Coral-Fort Myers, FL   (75.6)  (17.8)  (6.7) 0
Charleston-North Charleston, SC   (61.4)  (25.0)  (13.6) 
Charlotte-Gastonia-Concord, NC-SC 0  (68.0)  (22.0)  (10.0) 
Chattanooga, TN-GA   (75.0)  (18.8)  (6.3) 0
Chicago-Naperville-Joliet, IL 0  (68.4)  (26.3)  (5.3) 
Cincinnati-Middleton, OH-KY-IN   (81.8)  (15.9)  (2.3) 0
Cleveland-Elyria-Mentor, OH   (57.4)  (34.4)  (8.2) 
Colorado Springs, CO   (85.7) 0 (0.0)  (14.3) 0
Columbia, SC   (83.9)  (9.7)  (6.5) 0
Columbus, OH   (63.0)  (32.1)  (4.9) 0
Dallas-Fort Worth-Arlington, TX   (74.7)  (16.4)  (8.9) 
Dayton, OH  0 (66.7)  (26.7)  (6.7) 0
Deltona-Daytona Beach-Ormond Beach, FL   (76.5)  (23.5) 0 (0.0) 0
Denver-Aurora, CO   (58.2)  (31.6)  (10.1) 
Des Moines-West Des Moines, IA   (71.4)  (14.3)  (14.3) 0
Detroit-Warren-Livonia, MI   (69.1)  (24.5)  (6.5) 
El Paso, TX 0  (72.5)  (20.0)  (7.5) 
Fresno, CA  0 (71.4)  (21.4)  (7.1) 
Grand Rapids-Wyoming, MI   (69.6)  (21.7)  (8.7) 0
Greensboro-High Point, NC   (71.0)  (16.1)  (12.9) 
Greenville, SC   (77.8)  (16.7)  (5.6) 0
Harrisburg-Carlisle, PA   (61.5)  (30.8)  (7.7) 0
Hartford-West Hartford-East Hartford, CT   (56.0)  (36.0)  (8.0) 0
Honolulu, HI 0 0 (82.6)  (11.0)  (6.4) 
Houston-Sugar Land-Baytown, TX   (79.5)  (16.6)  (3.9) 
Indianapolis-Carmel, IN   (79.2)  (12.5)  (8.3) 
Jackson, MS   (94.1)  (5.9) 0 (0.0) 0
Jacksonville, FL   (80.3)  (15.8)  (3.9) 0
Kansas City, MO-KS   (63.3)  (28.6)  (8.2) 0
Knoxville, TN   (75.0)  (25.0) 0 (0.0) 0
Lakeland, FL   (72.4)  (20.7)  (6.9) 
Las Vegas-Paradise, NV   (80.4)  (14.1)  (5.4) 0
Little Rock-North Little Rock-Conway, AR   (90.3)  (6.5)  (3.2) 0
Los Angeles-Long Beach-Santa Ana, CA ,0  (72.9) 0 (19.4)  (7.7) 
Louisville-Jefferson County, KY-IN   (87.2)  (12.8) 0 (0.0) 0
Madison, WI   (75.0) 0 (0.0)  (25.0) 
McAllen-Edinburg-Mission, TX   (73.7)  (15.8)  (10.5) 
Memphis, TN-MS-AR   (75.9)  (13.3)  (10.8) 
Miami-Fort Lauderdale-Pompano Beach, FL   (85.5) 0 (11.8)  (2.7) 
Milwaukee-Waukesha-West Allis, WI   (47.4)  (39.5)  (13.2) 
Minneapolis-St. Paul-Bloomington, MN-WI   (47.3)  (42.0) 0 (10.6) 
Table 47. Tuberculosis Cases by Pulmonary and Extrapulmonary Disease: Metropolitan 
Statistical Areas with >500,000 Population, 2007
Metropolitan 
Statistical Area
Pulmonary Extrapulmonary
No. (%)
Total
Cases
Total
No. (%) No.
Cases in Persons with Both Pul-
monary and Extrapulm. Disease
Miliary
No. (%)

Modesto, CA  0 (66.7)  (26.7)  (6.7) 
Nashville-Davidson-Murfreesboro-Franklin, TN   (86.5)  (10.8)  (2.7) 
New Haven-Milford, CT   (48.0)  (44.0)  (8.0) 0
New Orleans-Metairie-Kenner, LA 0  (84.3)  (8.6)  (7.1) 
New York-Northern New Jersey-Long Island, NY-NJ-PA ,  (67.4) 0 (21.1)  (11.5) 0
Ogden-Clearfield, UT   (25.0)  (50.0)  (25.0) 
Oklahoma City, OK   (65.9) 0 (24.4)  (9.8) 0
Omaha-Council Bluffs, NE-IA   (92.9)  (7.1) 0 (0.0) 0
Orlando-Kissimmee, FL   (75.9)  (14.7)  (9.5) 
Oxnard-Thousand Oaks-Ventura, CA   (81.0)  (8.6)  (10.3) 0
Palm Bay-Melbourne-Titusville, FL   (89.5)  (10.5) 0 (0.0) 0
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD   (66.7)  (20.3)  (9.5) 
Phoenix-Mesa-Scottsdale, AZ   (76.3)  (18.0)  (5.2) 
Pittsburgh, PA 0  (63.3) 0 (33.3)  (3.3) 
Portland-South Portland-Biddeford, ME   (75.0)  (16.7)  (8.3) 0
Portland-Vancouver-Beaverton, OR-WA   (53.7)  (37.3)  (9.0) 
Poughkeepsie-Newburgh-Middletown, NY 0  (60.0)  (30.0)  (10.0) 
Providence-New Bedford-Fall River, RI-MA   (58.6) 0 (34.5)  (6.9) 
Raleigh-Cary, NC   (75.0)  (14.1)  (10.9) 
Richmond, VA 0  (76.7)  (20.0)  (3.3) 0
Riverside-San Bernardino-Ontario, CA   (81.3)  (15.1)  (3.6) 0
Rochester, NY   (62.5)  (29.2)  (8.3) 0
Sacramento-Arden Arcade-Roseville, CA  0 (79.1)  (17.2)  (3.7) 
St. Louis, MO-IL   (66.7)  (21.1)  (12.3) 
Salt Lake City, UT   (57.1)  (23.8)  (19.0) 
San Antonio, TX   (79.8)  (17.9)  (2.4) 
San Diego-Carlsbad-San Marcos, CA 0  (62.9)  (16.1)  (21.1) 
San Francisco-Oakland-Fremont, CA  0 (67.5) 0 (23.2)  (9.3) 
San Jose-Sunnyvale-Santa Clara, CA   (64.7) 0 (29.0)  (6.2) 0
Sarasota-Bradenton-Venice, FL   (79.4)  (14.7)  (5.9) 
Scranton-Wilkes-Barre, PA   (55.6)  (44.4) 0 (0.0) 0
Seattle-Tacoma-Bellevue, WA 0 0 (50.2)  (29.7)  (20.1) 
Springfield, MA   (84.6)  (15.4) 0 (0.0) 0
Stockton, CA   (56.9)  (25.5)  (17.6) 
Syracuse, NY   (76.5)  (23.5) 0 (0.0) 0
Tampa-St. Petersburg-Clearwater, FL  0 (83.7)  (11.6)  (4.7) 0
Toledo, OH   (37.5)  (50.0)  (12.5) 0
Tucson, AZ 0  (77.5)  (17.5)  (5.0) 0
Tulsa, OK  0 (64.5)  (19.4)  (16.1) 0
Virginia Beach-Norfolk-Newport News, VA-NC   (78.0)  (22.0) 0 (0.0) 0
Washington-Arlington-Alexandria, DC-VA-MD-WV   (69.0)  (22.2)  (8.8) 
Wichita, KS   (52.9)  (23.5)  (23.5) 0
Worchester, MA   (72.2)  (22.2)  (5.6) 
Youngstown-Warren-Boardman, OH-PA   (62.5)  (25.0)  (12.5) 
Total - 100 Areas 0, ,0 (70.6) , (20.8)  (8.5) 
San Juan-Caguas-Guaynabo, PR   (87.3)  (11.4)  (1.3) 0
Table 47. (Cont’d) Tuberculosis Cases by Pulmonary and Extrapulmonary Disease: 
Metropolitan Statistical Areas with >500,000 Population, 2007
Metropolitan 
Statistical Area
Total
Cases
Includes cases in persons with pulmonary listed as major site of disease and no additional site of disease.
Includes cases in persons with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, genitourinary, or other site, excluding pulmo-
nary, listed as major site of disease.
Includes miliary cases.
Note: 9 (<0.1%) cases had missing and/or unknown site of disease. 
See Technical Notes (page 9) for definition of MSA.
Pulmonary Extrapulmonary
No. (%)
Total
No. (%) No.
Cases in Persons with Both Pul-
monary and Extrapulm. Disease
Miliary
No. (%)

Table 48. Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with >500,000 
Population, 2007
Akron, OH  0  0    0
Albany-Schenectady-Troy, NY   0     0
Albuquerque, NM  0 0 0    0
Allentown-Bethlehem-Easton, PA-NJ  0 0  0 0  0
Atlanta-Sandy Springs-Marietta, GA     0   0
Augusta-Richmond County, GA-SC  0 0  0   0
Austin-Round Rock, TX     0   0
Bakersfield, CA 0  0     0
Baltimore-Towson, MD 0       0
Baton Rouge, LA        0
Birmingham-Hoover, AL   0   0  0
Boise City-Nampa, ID  0 0 0  0  0
Boston-Cambridge-Quincy, MA-NH        0
Bridgeport-Stamford-Norwalk, CT        0
Buffalo-Niagara Falls, NY 0 0 0     0
Cape Coral-Fort Myers, FL        0
Charleston-North Charleston, SC   0     0
Charlotte-Gastonia-Concord, NC-SC 0  0     0
Chattanooga, TN-GA   0     0
Chicago-Naperville-Joliet, IL 0 0     0 0
Cincinnati-Middleton, OH-KY-IN  0 0     0
Cleveland-Elyria-Mentor, OH        0
Colorado Springs, CO   0     0
Columbia, SC       0 0
Columbus, OH    0   0 0
Dallas-Fort Worth-Arlington, TX    0    0
Dayton, OH   0     0
Deltona-Daytona Beach-Ormond Beach, FL  0 0     0
Denver-Aurora, CO       0 0
Des Moines-West Des Moines, IA  0 0     0
Detroit-Warren-Livonia, MI        0
El Paso, TX 0    0   0
Fresno, CA        0
Grand Rapids-Wyoming, MI        0
Greensboro-High Point, NC        0
Greenville, SC  0      0
Harrisburg-Carlisle, PA  0      0
Hartford-West Hartford-East Hartford, CT   0    0 0
Honolulu, HI 0     0  0
Houston-Sugar Land-Baytown, TX        0
Indianapolis-Carmel, IN   0  0   0
Jackson, MS     0   0
Jacksonville, FL        0
Kansas City, MO-KS   0     0
Knoxville, TN  0 0 0    0
Lakeland, FL  0   0 0  0
Las Vegas-Paradise, NV        0
Little Rock-North Little Rock-Conway, AR   0     0
Los Angeles-Long Beach-Santa Ana, CA ,0   0 0 0  0
Louisville-Jefferson County, KY-IN  0      0
Madison, WI  0 0   0 0 0
McAllen-Edinburg-Mission, TX        0
Memphis, TN-MS-AR        0
Miami-Fort Lauderdale-Pompano Beach, FL      0 0 0
Milwaukee-Waukesha-West Allis, WI  0 0   0  0
Metropolitan 
Statistical Area
Total
Cases Under 5 15 –24
Unknown 
or 
Missing5–14 25–44 45–64 >

Table 48. (Cont’d) Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with 
>500,000 Population, 2007
Metropolitan 
Statistical Area Under 5
Total
Cases 15 –24
Unknown 
or 
Missing
Note: See Technical Notes (page 9) for definition of MSA.
5–14 25–44 45–64 >
Minneapolis-St. Paul-Bloomington, MN-WI       0 0
Modesto, CA  0 0     0
Nashville-Davidson-Murfreesboro-Franklin, TN     0   0
New Haven-Milford, CT  0 0     0
New Orleans-Metairie-Kenner, LA 0       0
New York-Northern New Jersey-Long Island, NY-NJ-PA ,       0
Ogden-Clearfield, UT  0 0    0 0
Oklahoma City, OK   0     0
Omaha-Council Bluffs, NE-IA  0 0     0
Orlando-Kissimmee, FL        0
Oxnard-Thousand Oaks-Ventura, CA     0   0
Palm Bay-Melbourne-Titusville, FL  0 0     0
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD        0
Phoenix-Mesa-Scottsdale, AZ    0    
Pittsburgh, PA 0  0    0 0
Portland-South Portland-Biddeford, ME        0
Portland-Vancouver-Beaverton, OR-WA     0   0
Poughkeepsie-Newburgh-Middletown, NY 0 0 0     0
Providence-New Bedford-Fall River, RI-MA        0
Raleigh-Cary, NC        0
Richmond, VA 0       0
Riverside-San Bernardino-Ontario, CA        0
Rochester, NY   0     0
Sacramento-Arden Arcade-Roseville, CA        0
St. Louis, MO-IL        0
Salt Lake City, UT  0 0     0
San Antonio, TX      0  0
San Diego-Carlsbad-San Marcos, CA 0 0      0
San Francisco-Oakland-Fremont, CA        0
San Jose-Sunnyvale-Santa Clara, CA        0
Sarasota-Bradenton-Venice, FL        0
Scranton-Wilkes-Barre, PA   0     0
Seattle-Tacoma-Bellevue, WA 0       0
Springfield, MA  0 0     0
Stockton, CA       0 0
Syracuse, NY   0     0
Tampa-St. Petersburg-Clearwater, FL       0 0
Toledo, OH  0 0 0    0
Tucson, AZ 0  0   0  0
Tulsa, OK     0   0
Virginia Beach-Norfolk-Newport News, VA-NC  0      0
Washington-Arlington-Alexandria, DC-VA-MD-WV   0     0
Wichita, KS  0 0     0
Worchester, MA        0
Youngstown-Warren-Boardman, OH-PA   0 0    0
Total - 100 Areas 0,  0 , ,0 , , 
San Juan-Caguas-Guaynabo, PR        0

Akron, OH  0 0   0  0 0
Albany-Schenectady-Troy, NY   0   0  0 0
Albuquerque, NM     0 0  0 0
Allentown-Bethlehem-Easton, PA-NJ  0 0 0   0 0 0
Atlanta-Sandy Springs-Marietta, GA   0   0  0 
Augusta-Richmond County, GA-SC   0     0 0
Austin-Round Rock, TX   0   0  0 0
Bakersfield, CA 0     0  0 0
Baltimore-Towson, MD 0  0   0  0 0
Baton Rouge, LA   0   0  0 0
Birmingham-Hoover, AL   0   0  0 0
Boise City-Nampa, ID   0  0 0  0 0
Boston-Cambridge-Quincy, MA-NH   0   0  0 0
Bridgeport-Stamford-Norwalk, CT   0   0  0 0
Buffalo-Niagara Falls, NY 0  0   0  0 0
Cape Coral-Fort Myers, FL      0 0 0 0
Charleston-North Charleston, SC   0      0
Charlotte-Gastonia-Concord, NC-SC 0     0 0 0 0
Chattanooga, TN-GA   0   0  0 0
Chicago-Naperville-Joliet, IL 0  0   0   
Cincinnati-Middleton, OH-KY-IN   0  0 0  0 0
Cleveland-Elyria-Mentor, OH   0   0  0 0
Colorado Springs, CO   0   0  0 0
Columbia, SC   0   0  0 0
Columbus, OH   0   0  0 0
Dallas-Fort Worth-Arlington, TX   0     0 0
Dayton, OH  0 0   0  0 0
Deltona-Daytona Beach-Ormond Beach, FL   0   0  0 0
Denver-Aurora, CO   0   0  0 0
Des Moines-West Des Moines, IA   0 0  0  0 0
Detroit-Warren-Livonia, MI  0 0  0 0   
El Paso, TX 0  0  0 0  0 0
Fresno, CA      0  0 0
Grand Rapids-Wyoming, MI   0   0  0 0
Greensboro-High Point, NC   0 0  0  0 0
Greenville, SC   0     0 0
Harrisburg-Carlisle, PA  0 0   0   0
Hartford-West Hartford-East Hartford, CT   0   0  0 0
Honolulu, HI 0  0  0   0 0
Houston-Sugar Land-Baytown, TX    0  0  0 0
Indianapolis-Carmel, IN   0   0  0 0
Jackson, MS   0   0  0 0
Jacksonville, FL   0   0  0 0
Kansas City, MO-KS   0     0 0
Knoxville, TN  0 0   0  0 0
Lakeland, FL   0 0  0   0
Las Vegas-Paradise, NV   0   0  0 
Little Rock-North Little Rock-Conway, AR   0   0   
Los Angeles-Long Beach-Santa Ana, CA ,0  0      
Louisville-Jefferson County, KY-IN   0   0  0 0
Madison, WI   0  0 0 0 0 0
McAllen-Edinburg-Mission, TX   0  0 0  0 0
Memphis, TN-MS-AR   0   0 0  0
Miami-Fort Lauderdale-Pompano Beach, FL      0   0
Milwaukee-Waukesha-West Allis, WI   0   0 0 0 0
Minneapolis-St. Paul-Bloomington, MN-WI     0 0  0 0
Table 49. Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race: Metropolitan 
Statistical Areas with >500,000 Population, 2007
Metropolitan 
Statistical Area Asian
American 
Indian or 
Alaska 
Native
Total
Cases
Black 
or 
African 
American
Native 
Hawaiian or 
Other Pacific 
Islander White
Multiple 
Race
Unknown
or 
Missing
Hispanic 
or 
Latino

Modesto, CA   0  0 0 0 0 0
Nashville-Davidson-Murfreesboro-Franklin, TN   0 0    0 0
New Haven-Milford, CT   0   0  0 0
New Orleans-Metairie-Kenner, LA 0  0   0 0 0 0
New York-Northern New Jersey-Long Island, NY-NJ-PA ,  0      
Ogden-Clearfield, UT   0  0 0 0 0 0
Oklahoma City, OK      0  0 0
Omaha-Council Bluffs, NE-IA   0  0    0
Orlando-Kissimmee, FL   0   0  0 0
Oxnard-Thousand Oaks-Ventura, CA   0   0  0 0
Palm Bay-Melbourne-Titusville, FL   0   0  0 0
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD  0 0   0   0
Phoenix-Mesa-Scottsdale, AZ      0   0
Pittsburgh, PA 0  0   0  0 0
Portland-South Portland-Biddeford, ME   0   0  0 0
Portland-Vancouver-Beaverton, OR-WA  0 0     0 0
Poughkeepsie-Newburgh-Middletown, NY 0  0   0  0 0
Providence-New Bedford-Fall River, RI-MA   0   0 0 0 0
Raleigh-Cary, NC   0   0   0
Richmond, VA 0  0   0  0 0
Riverside-San Bernardino-Ontario, CA   0     0 
Rochester, NY   0   0  0 0
Sacramento-Arden Arcade-Roseville, CA   0     0 
St. Louis, MO-IL   0   0  0 0
Salt Lake City, UT   0     0 0
San Antonio, TX   0 0  0  0 0
San Diego-Carlsbad-San Marcos, CA 0  0     0 0
San Francisco-Oakland-Fremont, CA         
San Jose-Sunnyvale-Santa Clara, CA  0 0  0   0 
Sarasota-Bradenton-Venice, FL   0   0 0 0 0
Scranton-Wilkes-Barre, PA   0   0  0 0
Seattle-Tacoma-Bellevue, WA 0        0
Springfield, MA   0   0  0 0
Stockton, CA   0   0   0
Syracuse, NY  0 0   0  0 
Tampa-St. Petersburg-Clearwater, FL   0    0  0
Toledo, OH   0 0  0  0 0
Tucson, AZ 0     0  0 0
Tulsa, OK      0  0 0
Virginia Beach-Norfolk-Newport News, VA-NC   0   0  0 0
Washington-Arlington-Alexandria, DC-VA-MD-WV   0   0  0 0
Wichita, KS   0     0 0
Worchester, MA   0   0  0 0
Youngstown-Warren-Boardman, OH-PA  0 0  0 0  0 0
Total - 100 Areas 0, ,0  ,0 ,00  ,  0
San Juan-Caguas-Guaynabo, PR   0   0 0 0 0
Table 49. (Cont’d) Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race: Metro-
politan Statistical Areas with >500,000 Population, 2007
Persons of Hispanic or Latino origin may be of any race or multiple race.
Indicates two or more races reported for a person.
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other 
Pacific Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple Race does 
not include persons of Hispanic ethnicity.
See Technical Notes (page 9) for definition of MSA and Hispanic ethnicity and non-Hispanic race.
Metropolitan 
Statistical Area Asian
American 
Indian or 
Alaska 
Native
Total
Cases
Black 
or 
African 
American
Native 
Hawaiian or 
Other Pacific 
Islander White
Multiple 
Race
Unknown
or 
Missing
Hispanic 
or 
Latino
0
Akron, OH   (80.0)  (20.0) 0 (0.0)
Albany-Schenectady-Troy, NY   (25.0)  (75.0) 0 (0.0)
Albuquerque, NM   (56.3)  (43.8) 0 (0.0)
Allentown-Bethlehem-Easton, PA-NJ   (50.0)  (50.0) 0 (0.0)
Atlanta-Sandy Springs-Marietta, GA   (47.8)  (52.2) 0 (0.0)
Augusta-Richmond County, GA-SC   (85.3)  (14.7) 0 (0.0)
Austin-Round Rock, TX   (33.3)  (66.7) 0 (0.0)
Bakersfield, CA 0  (37.5)  (62.5) 0 (0.0)
Baltimore-Towson, MD 0  (52.9)  (47.1) 0 (0.0)
Baton Rouge, LA   (75.0)  (25.0) 0 (0.0)
Birmingham-Hoover, AL   (85.7)  (14.3) 0 (0.0)
Boise City-Nampa, ID   (25.0)  (75.0) 0 (0.0)
Boston-Cambridge-Quincy, MA-NH   (27.4) 0 (72.6) 0 (0.0)
Bridgeport-Stamford-Norwalk, CT   (32.7)  (67.3) 0 (0.0)
Buffalo-Niagara Falls, NY 0  (40.0)  (60.0) 0 (0.0)
Cape Coral-Fort Myers, FL   (57.8)  (42.2) 0 (0.0)
Charleston-North Charleston, SC   (70.5)  (29.5) 0 (0.0)
Charlotte-Gastonia-Concord, NC-SC 0  (46.0)  (54.0) 0 (0.0)
Chattanooga, TN-GA  0 (62.5)  (37.5) 0 (0.0)
Chicago-Naperville-Joliet, IL 0  (38.6)  (60.6)  (0.8)
Cincinnati-Middleton, OH-KY-IN  0 (68.2)  (31.8) 0 (0.0)
Cleveland-Elyria-Mentor, OH   (62.3)  (37.7) 0 (0.0)
Colorado Springs, CO   (14.3)  (85.7) 0 (0.0)
Columbia, SC   (67.7) 0 (32.3) 0 (0.0)
Columbus, OH   (33.3)  (66.7) 0 (0.0)
Dallas-Fort Worth-Arlington, TX  0 (54.2)  (45.8) 0 (0.0)
Dayton, OH   (33.3) 0 (66.7) 0 (0.0)
Deltona-Daytona Beach-Ormond Beach, FL   (82.4)  (17.6) 0 (0.0)
Denver-Aurora, CO   (24.1) 0 (75.9) 0 (0.0)
Des Moines-West Des Moines, IA   (57.1)  (42.9) 0 (0.0)
Detroit-Warren-Livonia, MI   (65.5)  (33.8)  (0.7)
El Paso, TX 0  (30.0)  (70.0) 0 (0.0)
Fresno, CA   (28.6) 0 (71.4) 0 (0.0)
Grand Rapids-Wyoming, MI   (26.1)  (73.9) 0 (0.0)
Greensboro-High Point, NC   (48.4)  (51.6) 0 (0.0)
Greenville, SC   (27.8)  (72.2) 0 (0.0)
Harrisburg-Carlisle, PA   (53.8)  (46.2) 0 (0.0)
Hartford-West Hartford-East Hartford, CT   (24.0)  (76.0) 0 (0.0)
Honolulu, HI 0  (32.1)  (66.1)  (1.8)
Houston-Sugar Land-Baytown, TX   (50.6)  (49.4) 0 (0.0)
Indianapolis-Carmel, IN   (37.5) 0 (62.5) 0 (0.0)
Jackson, MS   (85.3)  (11.8)  (2.9)
Jacksonville, FL   (71.1)  (28.9) 0 (0.0)
Kansas City, MO-KS   (53.1)  (46.9) 0 (0.0)
Knoxville, TN   (87.5)  (12.5) 0 (0.0)
Lakeland, FL  0 (69.0)  (31.0) 0 (0.0)
Las Vegas-Paradise, NV   (37.0)  (63.0) 0 (0.0)
Little Rock-North Little Rock-Conway, AR   (80.6)  (19.4) 0 (0.0)
Los Angeles-Long Beach-Santa Ana, CA ,0 0 (19.1)  (80.5)  (0.4)
Louisville-Jefferson County, KY-IN   (79.5)  (20.5) 0 (0.0)
Madison, WI  0 (0.0)  (100.0) 0 (0.0)
McAllen-Edinburg-Mission, TX   (34.2) 0 (65.8) 0 (0.0)
Memphis, TN-MS-AR   (77.1)  (22.9) 0 (0.0)
Miami-Fort Lauderdale-Pompano Beach, FL   (34.0)  (66.0) 0 (0.0)
Milwaukee-Waukesha-West Allis, WI  0 (52.6)  (47.4) 0 (0.0)
Table 50. Tuberculosis Cases and Percentages, U.S.-born Persons and Foreign-born Per-
sons: Metropolitan Statistical Areas with >500,000 Population, 2007
Metropolitan 
Statistical Area
U.S.-born Persons
Foreign-born 
Persons Unknown
No. No.(%) (%)
Total
Cases No. (%)

Minneapolis-St. Paul-Bloomington, MN-WI   (13.3)  (86.7) 0 (0.0)
Modesto, CA   (6.7)  (93.3) 0 (0.0)
Nashville-Davidson-Murfreesboro-Franklin, TN   (55.4)  (44.6) 0 (0.0)
New Haven-Milford, CT   (32.0)  (64.0)  (4.0)
New Orleans-Metairie-Kenner, LA 0  (75.7)  (24.3) 0 (0.0)
New York-Northern New Jersey-Long Island, NY-NJ-PA ,  (26.6) ,0 (73.1)  (0.3)
Ogden-Clearfield, UT   (25.0)  (75.0) 0 (0.0)
Oklahoma City, OK   (65.9)  (34.1) 0 (0.0)
Omaha-Council Bluffs, NE-IA   (7.1)  (92.9) 0 (0.0)
Orlando-Kissimmee, FL   (55.2)  (44.8) 0 (0.0)
Oxnard-Thousand Oaks-Ventura, CA   (27.6)  (72.4) 0 (0.0)
Palm Bay-Melbourne-Titusville, FL   (73.7)  (26.3) 0 (0.0)
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD   (39.4)  (58.4)  (2.2)
Phoenix-Mesa-Scottsdale, AZ   (29.9)  (69.2)  (0.9)
Pittsburgh, PA 0  (46.7)  (43.3)  (10.0)
Portland-South Portland-Biddeford, ME   (33.3)  (66.7) 0 (0.0)
Portland-Vancouver-Beaverton, OR-WA   (22.4)  (77.6) 0 (0.0)
Poughkeepsie-Newburgh-Middletown, NY 0  (30.0)  (70.0) 0 (0.0)
Providence-New Bedford-Fall River, RI-MA   (20.7)  (79.3) 0 (0.0)
Raleigh-Cary, NC   (39.1)  (59.4)  (1.6)
Richmond, VA 0  (60.0)  (40.0) 0 (0.0)
Riverside-San Bernardino-Ontario, CA   (33.1)  (61.2)  (5.8)
Rochester, NY   (25.0)  (75.0) 0 (0.0)
Sacramento-Arden Arcade-Roseville, CA   (29.1) 0 (67.2)  (3.7)
St. Louis, MO-IL   (66.7)  (33.3) 0 (0.0)
Salt Lake City, UT   (23.8)  (76.2) 0 (0.0)
San Antonio, TX   (54.8)  (45.2) 0 (0.0)
San Diego-Carlsbad-San Marcos, CA 0  (20.0)  (80.0) 0 (0.0)
San Francisco-Oakland-Fremont, CA  0 (24.3)  (75.7) 0 (0.0)
San Jose-Sunnyvale-Santa Clara, CA   (7.9)  (90.9)  (1.2)
Sarasota-Bradenton-Venice, FL   (50.0)  (50.0) 0 (0.0)
Scranton-Wilkes-Barre, PA   (55.6)  (44.4) 0 (0.0)
Seattle-Tacoma-Bellevue, WA 0  (27.8)  (72.2) 0 (0.0)
Springfield, MA   (38.5)  (61.5) 0 (0.0)
Stockton, CA   (37.3)  (60.8)  (2.0)
Syracuse, NY   (47.1)  (52.9) 0 (0.0)
Tampa-St. Petersburg-Clearwater, FL   (57.4)  (42.6) 0 (0.0)
Toledo, OH   (75.0)  (25.0) 0 (0.0)
Tucson, AZ 0  (57.5)  (40.0)  (2.5)
Tulsa, OK   (71.0)  (29.0) 0 (0.0)
Virginia Beach-Norfolk-Newport News, VA-NC   (51.2) 0 (48.8) 0 (0.0)
Washington-Arlington-Alexandria, DC-VA-MD-WV   (18.9) 0 (81.1) 0 (0.0)
Wichita, KS   (29.4)  (70.6) 0 (0.0)
Worchester, MA   (16.7)  (83.3) 0 (0.0)
Youngstown-Warren-Boardman, OH-PA   (62.5)  (37.5) 0 (0.0)
Total - 100 Areas 0, , (35.9) , (63.6)  (0.4)
San Juan-Caguas-Guaynabo, PR   (87.3) 0 (12.7) 0 (0.0)
Table 50. (Cont’d) Tuberculosis Cases and Percentages, U.S.-born Persons and Foreign-born 
Persons: Metropolitan Statistical Areas with >500,000 Population, 2007
Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacific islands. 
Note: See Technical Notes (page 9) for definition of MSA.
Metropolitan 
Statistical Area
U.S.-born Persons
Foreign-born 
Persons Unknown
No. No.(%) (%)
Total
Cases No. (%)

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Tuberculosis in the United States
National Tuberculosis Surveillance System Highlights from 2007
Slide 1 (title slide). Tuberculosis in the United States—National Tuberculosis Surveillance System, High-
lights from 2007.  This slide set was prepared by the Division of Tuberculosis Elimination, Centers for Dis-
ease Control and Prevention (CDC), Department of Health and Human Services (DHHS).  It provides trends 
for the recent past and highlights from data collected through the National Tuberculosis Surveillance System 
for 2007.  Since 1953, through the cooperation of state and local health departments, CDC has collected infor-
mation on the newly reported cases of tuberculosis (TB) disease in the United States.  The data presented here 
were primarily collected via the expanded TB case report introduced in 1993.  Currently, each individual TB 
case report (Report of Verified Case of Tuberculosis, or RVCT) is submitted electronically to CDC.  The data 
for this slide set are based on updates received by CDC as of April 23, 2008.  All case counts and rates for 
years 1993–2006 have been updated.
Slide 2. Reported TB Cases, United States, 1982–2007.  The resurgence of TB in the mid-1980s was 
marked by several years of increasing case counts until its peak in 1992.  Case counts began decreasing 
again in 1993, and 2007 marked the fifteenth year of decline in the total number of TB cases reported in the 
United States since the peak of the resurgence.  From 1992 until 2002, the total number of TB cases decreased 
5%–7% annually.  From 2002 to 2003, however, the total number of TB cases decreased by only 1.4%.  In 
2007, a total of 13,299 cases were reported from the 50 states and the District of Columbia.  This represents a 
decline of 3.3% from 2006 and of approximately 50% from 1992.  
Slide 3. TB Morbidity, United States, 2002-2007.   This slide provides the total number of reported U.S. TB 
cases and the associated TB rates for each of the past 6 years.  Rate is defined as cases per 100,000 popula-
tion.  The number of TB cases decreased from 15,056 in 2002 to 13,299 in 2007, and the TB rate also de-
creased, from 5.2 in 2002 to 4.4 in 2007. 
Slide 4. TB Case Rates, United States, 2007.  This map shows TB rates for 2007.  Twenty-six states had a 
rate of less than or equal to 3.5 TB cases per 100,000, the interim goal for the year 2000 established by the 
Advisory Council for the Elimination of Tuberculosis.  This group of states has remained fairly constant over 
the last decade; five states (CT, MI, NM, OR, and PA) joined the group in 2000, one state (MO) joined the 
group in 2001 (also in 1998 for one year only), and one state (KY) joined the group in 2003. Fifteen states and 
the District of Columbia (DC) reported a rate above the 2007 national average of 4.4 cases per 100,000: AK, 
AZ, CA, FL, GA, HI, LA, MD, MN, MS, NJ, NY, SC, TX, and WA.  These 15 states and DC accounted for 
67% of the national total and experienced substantial overall decreases in cases and rates from 1992 through 
2007. 
Slide 5. TB Case Rates by Age Group, United States, 1993–2007.  This slide shows the declining trend 
in TB rates by age group over the last 15 years.  The largest declines occurred in persons 65 years and older 
(from 17.7 per 100,000 in 1993 to 6.8 in 2007), in adults aged 45 to 64 years (from 12.4 to 5.3), in adults aged 
25 to 44 years (from 11.5 to 5.2), and in children under 15 years of age (from 2.9 to 1.3), each group having 
decreased more than 50%.  The rate declined by 26% in those 15 to 24 years of age (from 5.0 to 3.7).
Slide 6. Reported TB Cases by Age Group, United States, 2007.  This pie chart shows the age distribution 
of persons reported with TB in 2007.  Six percent were children under 15 years of age and 12% were 15- to 
24-year-olds, whereas 33% were 25 to 44 years of age, 30% were 45- to 64-year-olds, and 19% were at least 
65 years old.
Slide 7. TB Case Rates by Age Group and Sex, United States, 2007.  This slide graphs the TB rates in 2007 
by age group and sex.  It shows that rates tended to increase with age, ranging from a low of less than 2 per 
100,000 in children to a high of approximately 10 per 100,000 in men 65 years and older.  The rates in men 45 
years and older were more than twice those in same-age women.
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Slide 8. TB Case Rates by Race/Ethnicity, United States, 1993–2007.  This slide shows the declining trend 
in TB rates by race/ethnicity during the last 15 years.  Asians and Pacific Islanders had the highest TB rates, 
which declined from 44.1 per 100,000 in 1993 to 26.2 in 2007, and had the smallest percentage decline over 
the time period (41%).  Rates declined by approximately 50% or more over the time period in the other racial/
ethnic groups: among non-Hispanic blacks or African-Americans, from 28.5 in 1993 to 9.4 in 2007; among 
Hispanics, from 19.9 to 8.5; among American Indians and Alaska Natives, from 13.9 to 5.9; and among 
non-Hispanic whites, from 3.6 to 1.1.  Since 2003, the Asian and Pacific Islander race category has included 
persons who reported race as either 1) Asian only or 2) Native Hawaiian or Other Pacific Islander only.  Al-
though these categories were reported separately beginning in 2003, they were merged for this slide to allow 
for continuity in reporting trends.
Several important factors likely contribute to the disproportionate burden of TB in minorities.  In persons who 
were born in countries where TB is common, TB disease may result from infection acquired in the country of 
origin.  Unequal distribution of TB risk factors, such as HIV infection, may also contribute to increased expo-
sure to TB or to an increased risk of developing TB once infected with M. tuberculosis. 
Slide 9. TB Case Rates by Age Group and Race/Ethnicity, United States, 2007.  This slide presents TB 
rates in 2007 by age group and race/ethnicity.  Risk increased with age across racial and ethnic groups, and 
rates were consistently higher in minority racial and ethnic groups than in non-Hispanic whites.  Rates were 
the highest in Asians and Native Hawaiians and Other Pacific Islanders, particularly in adult age groups.  The 
impact of foreign birth is a consideration in interpreting rate variations by race/ethnicity.  For example, 96% 
of cases in the Asian group occurred in foreign-born persons, compared with 77% of cases in Hispanics and 
32% of cases in non-Hispanic blacks or African-Americans.  Persons reporting two or more races totaled less 
than 1% of all cases.  
Slide 10. Reported TB Cases by Race/Ethnicity, United States, 2007.  In 2007, 83% of all reported TB 
cases occurred in racial and ethnic minorities (29% in Hispanics, 26% in non-Hispanic blacks or African-
Americans, 26% in Asians, 1% in American Indians or Alaska Natives, and  <1% in Native Hawaiians or 
Other Pacific Islanders), whereas 17% of cases occurred in non-Hispanic whites.  Persons reporting two or 
more races totaled less than 1% of all cases.  This is the fourth year that Hispanics have constituted the single 
largest percentage of TB cases among all racial/ethnic groups. 
Slide 11. Number of TB Cases in U.S.-born vs. Foreign-born Persons, United States, 1993–2007.  This 
graph plots the number of U.S.-born vs. foreign-born persons reported with TB each year, from 1993 through 
2007.  It illustrates the increase in the percentage of cases occurring in foreign-born persons during this 
period, from 29% in 1993 to 58% in 2007.  Overall, the number of cases in foreign-born persons remained 
virtually level, with approximately 7,000–8,000 cases each year, whereas the number in U.S.-born persons 
decreased from more than 17,000 in 1993 to less than 5,500 in 2007.
Slide 12. Trends in TB Cases in Foreign-born Persons, United States, 1987–2007.  This slide shows trends 
in TB cases in foreign-born persons in the United States from 1986, when information on country of birth was 
first reported by all areas submitting reports to CDC, through 2007. The number of TB cases in foreign-born 
persons increased from nearly 5,000 in 1986 to 7,000–8,000 each year since 1991.  The percentage of TB 
cases accounted for by foreign-born persons increased from 22% in 1986 to 58% in 2007.
Slide 13. Reported TB Cases by Origin and Race/Ethnicity, United States, 2007.  Among U.S.-born 
persons with TB in 2007, 45% were non-Hispanic black or African-American, 33% were non-Hispanic white, 
16% were Hispanic or Latino, 3% were American Indian or Alaska Native, 2% were Asian, and 1% were 
Native Hawaiian or Other Pacific Islander.  Among the foreign-born, 43% were Asian, 38% were Hispanic or 
Latino, 13% were non-Hispanic black or African-American, and 5% were non-Hispanic white.  Cases among 
American Indians or Alaska Natives and among Native Hawaiians or Other Pacific Islanders constituted less 
than 1%, respectively, of the cases among the foreign-born and are not shown.  Persons reporting two or more 
races totaled less than 1% of all cases. 

Slide 14. Percentage of TB Cases Among Foreign-born Persons, United States, 1997 and 2007.  The 
percentage range of the total number of TB cases that occurred in foreign-born persons in each state is high-
lighted for 1997 and 2007 in these side-by-side maps.  The number of states with at least 50% of cases in 
foreign-born persons increased from 14 in 1997 to 28 in 2007. The number of states with at least 70% of cases 
in foreign-born persons increased from two (HI and MN) in 1997 to thirteen (CA, CO, DE, MA, MN,NE, NH, 
NJ, NY, OR, RI, VA, and WA) in 2007 (not shown on slide). 
Slide 15. TB Case Rates in U.S.-born vs. Foreign-born Persons, United States, 1993–2007.  TB rates in 
foreign-born persons remain higher than those in the U.S.-born population.  From 1993 through 2007, the 
rates in U.S.-born persons decreased from 7.4 per 100,000 to 2.1, whereas the rates in foreign-born persons 
decreased from 34.0 per 100,000 to 20.7.
Slide 16. TB Case Rates in U.S.-born vs. Foreign-born Persons, United States, 1993–2007.  This is the 
same as Slide 15, but the rates are presented on a logarithmic scale to better illustrate the trend in TB rates 
among the U.S.-born and foreign-born. The lines show a greater rate of decline among the U.S.-born com-
pared with the foreign-born during this period.
Slide 17. Countries of Birth of Foreign-born Persons Reported with TB, United States, 2007.  This slide 
shows the overall distribution of the countries of birth of foreign-born persons reported with TB in 2007, with 
the top seven highlighted.  The list of countries has remained relatively constant since 1986, when informa-
tion on country of birth was first reported by all areas submitting reports to CDC. The seven top countries 
accounted for 62% of the total, with Mexico accounting for 24%; the Philippines, 12%; Viet Nam, 7%; India, 
8%; China, 5%; Haiti, 2%; and Republic of Korea, 3%.  Persons from more than 135 other countries each 
accounted for 2% or less of the total, but altogether accounted for 39% of foreign-born persons reported with 
TB.
Slide 18. Percent of Foreign-born with TB by Time of Residence in U.S. Prior to Diagnosis, 2007.  The 
length of U.S. residence among foreign-born persons prior to their TB diagnosis in 2007 is shown in these 
stacked bars.  Overall, 20% had been in the United States for less than 1 year, 21% between 1 and 4 years, 
and 49% for at least 5 years.  The distribution is also shown for the top three countries of birth: Mexico, the 
Philippines, and India.  Among persons born in Mexico, 13% had been in the United States for less than 1 
year, 21% between 1 and 4 years, and 54% for at least 5 years. Among persons born in the Philippines, 29% 
had been in the United States for less than 1 year, 12% between 1 and 4 years, and 47% for at least 5 years.  
Among persons born in India, 23% had been in the United States for less than 1 year, 26% between 1 and 4 
years, and 40% for at least 5 years.
Slide 19. Primary Anti-TB Drug Resistance, United States, 1993–2007.  Primary drug resistance is shown 
for the past 15 years.  The graph starts in 1993, the year in which the individual TB case reports submitted to 
the national surveillance system began collecting information on initial susceptibility test results for patients 
with culture-positive TB.  Data were available for more than 85% of culture-positive cases for each year.  
Primary resistance was calculated by using data from persons with no reported prior TB episode. Resistance 
to at least isoniazid remained between 7.0% and 8.4%.  However, resistance to at least isoniazid and rifampin 
combined, known as multidrug-resistant TB (MDR TB), decreased from 2.4% in 1993 to 1.1% in 1997, and 
remained at approximately 1.1 % up to and including 2007.
Slide 20. Primary MDR TB, United States, 1993–2007.  This graph focuses on trends in primary MDR TB 
(based on initial isolates from persons with no prior history of TB) in the United States from 1993 through 
2007.  The number of MDR TB cases, represented by bars, steadily declined from 410 in 1993 to 116 in 2001. 
Since then the total number of MDR TB cases has fluctuated from 91 to 126 cases, with 98 cases reported for 
2007.  The percentage of primary MDR TB, shown by the line, decreased from 2.4% in 1993 to approximate-
ly 1.1% in 1997, and remained approximately at 1.1% up to and including 2007.
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Slide 21. Primary Isoniazid Resistance in U.S.-born vs. Foreign-born Persons, United States, 1993–2007.  
This graph shows primary isoniazid resistance in U.S.-born vs. foreign-born persons.  Based on initial isolates 
from persons with no prior history of TB, the percentage of isoniazid resistance was approximately two times 
higher among foreign-born persons than among U.S.-born persons.  In foreign-born persons, the percentage 
declined from 12.3% in 1993 to 9.4% in 2007.  In U.S.-born persons, the percentage decreased from 6.8% in 
1993 to 4.4% in 2007. 
Slide 22. Primary MDR TB in U.S.-born vs. Foreign-born Persons, United States, 1993–2007.  This graph 
highlights primary MDR TB in U.S.-born versus foreign-born persons.  The percentage with primary MDR TB 
has declined among both groups, although the decline in the U.S.-born has been greater.  As a result, the pro-
portion of primary MDR TB cases reported in foreign-born persons increased from approximately 25% of all 
MDR TB cases in 1993 to approximately 70% of all MDR TB cases in 1999, and continued to increase to ap-
proximately 80% in 2007 (not shown on slide).  Among the U.S.-born, the percentage with MDR TB remained 
between 0.5% and 0.7% from 1998 through 2004 and dropped to 0.5% in 2007.  The percentage among for-
eign-born persons has fluctuated year by year, while averaging approximately 1.4% from 1998 through 2007.
Slide 23. Extensively Drug Resistant (XDR) TB, as Defined on Initial Drug Susceptibility Testing (DST), 
United States, 1993–2007.  This graph shows the annual number of counted XDR TB cases as defined on 
initial DST from 1993-2007, reported as of April 23, 2008. Two XDR TB cases were reported in 2007. The 
most reported in a single year was 10 in 1993, while there were no cases reported in 2000 and 2003. There is 
no apparent trend in the number of cases over time. 
Slide 24. Reporting of HIV Test Results in Persons with TB by Age Group, United States, 1993–2006.  
This slide shows the completeness of reporting of HIV test results in persons with TB by age group from 
1993 through 2006.  The percentage of TB patients for whom test results were reported increased from 30% 
among all ages in 1993 to 60% in 2006, the latest year with available data.  Among adults aged 25–44 years, 
the percentage increased from 46% to 69% in 2006.  The numerator includes TB patients with positive, nega-
tive, or indeterminate HIV test results and persons from California reported with AIDS (HIV test results are not 
reported to CDC from California).
Slide 25. Estimated HIV Coinfection in Persons Reported with TB, United States, 1993–2006.  This slide 
provides minimum estimates of HIV coinfection among persons reported with TB from 1993 through 2006, 
the latest year with available data.  Since the addition of the request for HIV status to the individual TB case 
report in 1993, incomplete reporting has provided a challenge to calculating reliable estimates.  Results from 
the cross-matching of TB and AIDS registries have been used to supplement reported HIV test results.  For 
all ages, the estimated percentage of HIV coinfection in persons reported with TB decreased from 15% to 7% 
overall and from 29% to 12% in persons aged 25 to 44 years during this period. 
Slide 26. Mode of Treatment Administration in Persons Reported with TB, United States, 1993–2005.  In 
1993, the reporting areas began providing information about mode of treatment administration on the individu-
al TB case report form.  Treatment administered as only directly observed therapy (DOT) increased from 21% 
in 1993 to 57% in 2005, the latest year with available data.  There was also an increase in the proportion of 
patients who received at least some portion of their treatment as DOT (based on combining the percentage of 
patients who received only DOT and the percentage for whom some portion was self-administered).  In 2005, 
86% of patients received at least some portion of their treatment as DOT.
Slide 27. Completion of TB Therapy, United States, 1993–2005.  The reporting areas began providing infor-
mation on completion of therapy in 1993 through the individual TB case report form.  The calculations exclude 
patients with an initial isolate resistant to rifampin as well as children with meningeal, bone or joint, or miliary 
disease.  Overall completion of therapy has remained at approximately 92% from 1998 through 2005. Comple-
tion in 1 year or less increased from 64% in 1993 to approximately 83% in 1998—2005, the latest year with 
available data.  The current DHHS Healthy People 2010 objective is completion of therapy in 1 year or less in 
90% of patients.  CDC is working with state and local health departments to determine and evaluate reasons 
for apparently delayed completion of therapy, which may vary by jurisdiction.
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Tuberculosis Case Definition for Public Health Surveillance1
Tuberculosis (Revised 9/96)
Clinical description
A chronic bacterial infection caused by Mycobacterium tuberculosis, characterized pathologically by 
the formation of granulomas. The most common site of infection is the lung, but other organs may be 
involved. 
Clinical case definition
A case that meets all of the following criteria:
• A positive tuberculin skin test result; and
• Other signs and symptoms compatible with tuberculosis, such as an abnormal, unstable (i.e., 
worsening or improving) chest radiograph, or clinical evidence of current disease; and
• Treatment with two or more antituberculosis medications; and
• A completed diagnostic evaluation.
Laboratory criteria for diagnosis
• Isolation of M. tuberculosis from a clinical specimen,* or
• Demonstration of M. tuberculosis from a clinical specimen by nucleic acid amplification test,† or
• Demonstration of acid-fast bacilli in a clinical specimen when a culture has not been or cannot be 
obtained.
Case classification
Confirmed:  a case that meets the clinical case definition or is laboratory confirmed.
Comment
Only one case should be counted in a person within any consecutive 12-month period. However, a 
case in a patient who had previously had verified disease should be reported again if more than 12 
months have elapsed since the patient was discharged from treatment. A case should also be re-
ported again if the patient was lost to supervision for >12 months and disease can be verified again. 
Mycobacterial diseases other than those caused by M. tuberculosis complex should not be counted 
in tuberculosis morbidity statistics unless there is concurrent tuberculosis.
                                                                                                                  
1CDC. Case definitions for infectious conditions under public health surveillance. Morbid Mortal Weekly Report 
1997;46(No. RR-10):40- 41.
*Use of rapid identification techniques for M. tuberculosis (e.g., DNA probes and mycolic acid 
high-pressure liquid chromatography performed on a culture from a clinical specimen) are accept-
able under this criterion.
†Nucleic acid amplification (NAA) tests must be accompanied by culture for mycobacteria species. 
However, for surveillance purposes, CDC will accept results obtained from NAA tests approved by 
the Food and Drug Administration (FDA) and used according to the approved product labeling on 
the package insert.  
Appendix A
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Appendix B
Recommendations for Counting Reported Tuberculosis Cases
(Revised July 1997)
Since publication of the “Recommendations for Counting Reported Tuberculosis Cases”
1 in 
January 1977, numerous changes have occurred and many issues have been raised within the 
field of tuberculosis (TB) surveillance.  This current version updates and supersedes the previous 
version; it clarifies the parameters for counting TB cases among (a) immigrants, resident aliens, 
and border crossers, (b) military personnel stationed in the United States and abroad, and (c) 
persons diagnosed within the Indian Health Service and correctional facilities.
A distinction should be made between reporting TB cases to a health department and counting 
TB cases for determining incidence of disease.  Throughout each year, TB cases and suspected 
cases are reported to public health authorities by sources such as clinics, hospitals, laboratories, 
and health care providers.  From these reports, the state or local TB control officer must deter-
mine which cases meet the current surveillance definition for TB disease.  These verified TB 
cases are then counted and reported to the Centers for Disease Control and Prevention (CDC).
I. Reporting TB Cases. CDC recommends that health care providers and laboratories be 
required to report all TB cases or suspected cases to state and local health departments 
based on the current “Case Definition for Public Health Surveillance.”
2
 This notification 
is essential in order for TB programs to
• Ensure case supervision,
• Ensure completion of appropriate therapy,
• Ensure completion of timely contact investigations,
• Evaluate program effectiveness, and
• Assess trends and characteristics of TB morbidity.
II. TB Surveillance. For purposes of surveillance, a case of TB is defined on the basis of   
 laboratory and/or clinical evidence of active disease due to M. tuberculosis complex.*
________________________________
*Because most laboratories use tests that do not routinely distinguish Mycobacterium tuberculosis from very closely 
related species, these laboratories report culture results as being positive or negative for “Mycobacterium tuberculo-
sis complex.” Although in almost all cases of human disease, isolates in the M. tuberculosis complex are, in fact, M. 
tuberculosis, other species are possible. For example, one study in San Diego found that 6% of human tuberculosis was 
caused by Mycobacterium bovis; cultures from these cases would be reported by most laboratories as being positive for 
M. tuberculosis complex. Other species in the Mycobacterium tuberculosis complex include M. africanum, M. microti, 
M. canetii, M. caprae, and M. pinnipedii. Although M.  microti,  M. canetii,  M. caprae, and M. pinnipedii are newly 
described species, their inclusion in M. tuberculosis complex should not impact public health laboratories or programs 
because only a few laboratories identify to the species level. These seven species are almost identical in DNA homology 
studies. In terms of their ability to cause clinical disease and be transmissible from person to person, M. bovis, M. afri-
canum, M. microti, and M. canetti behave like M. tuberculosis; therefore, disease caused by any of the organisms should 
be reported as TB, using the Report of Verified Case of Tuberculosis (RVCT). The only exception is the BCG strain of 
M. bovis, which may be isolated from persons who have received the vaccine for protection against TB or as cancer 
immunotherapy; disease caused by the BCG strain of M. bovis should not be reported as TB because the transmission is 
iatrogenic (treatment-induced), rather than person-to-person or communicable.
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a. Laboratory Case Definition
• Isolation of M. tuberculosis complex from a clinical specimen.  The use of rapid identi-
fication techniques for M. tuberculosis performed on a culture from a clinical specimen, 
such as DNA probes and high-pressure liquid chromatography (HPLC), is acceptable 
under this criterion.
OR
• Demonstration of M. tuberculosis from a clinical specimen by nucleic acid amplifica-
tion (NAA) test.  NAA tests must be accompanied by cultures of mycobacterial species.  
However, for surveillance purposes, CDC will accept results obtained from NAA tests 
that are approved by the Food and Drug Administration (FDA).  
   
OR   
• Demonstration of acid-fast bacilli (AFB) in a clinical specimen when a culture has not 
been or cannot be obtained; historically this criterion has been most commonly used to 
diagnose TB in the postmortem setting.  
b. Clinical Case Definition. In the absence of laboratory confirmation of M. tuberculosis com-
plex after a diagnostic process has been completed, persons must have all of the following 
criteria for clinical TB:
• Evidence of TB infection based on a positive tuberculin skin test result
AND
• One of the following:
(1) Signs and symptoms compatible with current TB disease, such as an abnormal, 
unstable (worsening or improving) chest radiograph, or
(2) Clinical evidence of current disease (e.g., fever, night sweats, cough, weight 
loss, hemoptysis)
AND
• Current treatment with two or more anti-TB medications 
NOTE: The case definition described herein was developed for use in this document and is not intended 
to replace the case definition for TB as stated in the current “Case Definitions for Infectious Conditions 
Under Public Health Surveillance.”  
In addition, the software for TB surveillance developed by CDC includes a calculated variable called “Ver-
crit,” for which one of the values is “Provider Diagnosis.”  “Provider Diagnosis” is selected when the user 
chooses to override a “Suspect” default value in the case verification screen as “Verified by Provider Diag-
nosis.”  Thus, “Provider Diagnosis” is not a component of the case definition for TB in the current “Case 
Definitions for Infectious Conditions Under Public Health Surveillance” publication.  CDC’s national mor-
bidity reports have traditionally included all cases that are considered verified by the reporting areas, without 
a requirement that cases meet the published case definition.
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III. Counting TB Cases. Cases that meet the current CDC surveillance case definition for 
verified TB are counted by 52 reporting areas with count authority (50 states, District of 
Columbia, and New York City) to determine annual incidence for the United States.  The 
remaining 7 reporting areas (American Samoa, Federated States of Micronesia, Guam, 
Northern Mariana Islands, Puerto Rico, Republic of Palau, and U.S. Virgin Islands) report 
cases to CDC, but are not included in the annual incidence for the United States. The 
laboratory and clinical case definitions are the two diagnostic categories used by the CDC 
“Case Definitions for Infectious Conditions Under Public Health Surveillance.”
Most verified TB cases are accepted for counting based on laboratory confirmation 
of M. tuberculosis complex from a clinical specimen.
A person may have more than one discrete (separate and distinct) episode of TB.  
If disease recurs in a person within any 12-consecutive-month period, count only 
one episode as a case for that year.  However, if TB disease recurs in a person, and 
if more than 12 months have elapsed since the person was discharged from or lost 
to supervision, the TB is considered a separate episode and should be counted as a 
new case.  Note: Discharged from supervision implies completion of therapy.  
Mycobacterial diseases other than those caused by M. tuberculosis complex should 
not be counted in TB morbidity statistics unless there is concurrent TB. 
a. Verified TB Cases
COUNT
Count only verified TB cases that meet the laboratory or clinical case definitions 
(see Section II).  The diagnosis of TB must be verified by the TB control officer 
or designee.  The current CDC surveillance case definition for TB describes and 
defines the criteria to be used in the case definition for TB disease. 
DO NOT COUNT
If diagnostic procedures have not been completed, do not count; wait for confirma-
tion of disease.  Do not count a case for which two or more anti-TB medications 
have been prescribed for preventive therapy for exposure to multidrug- resistant 
(MDR) TB, or while the diagnosis is still pending.
b. Nontuberculous Mycobacterial Diseases (NTM)
COUNT
An episode of TB disease diagnosed concurrently with another nontuberculous my-
cobacterial disease should be counted as a TB case.
DO NOT COUNT
Disease attributed to or caused by nontuberculous mycobacteria alone should not be 
counted as a TB case.
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c. TB Cases Reported at Death
COUNT
TB cases first reported to the health department at the time of a person’s death are 
counted as incident cases, provided the person had current disease at the time of 
death.  The TB control officer should verify the diagnosis of TB.
DO NOT COUNT
Do not count as a case of TB if there is no evidence of current disease at the time of 
death or at autopsy.
d. Immigrants, Refugees, Permanent Resident Aliens, Border Crossers,* and Foreign Visi-
tors3
COUNT
Immigrants and refugees who have been screened overseas for TB and
• have been classified as Class B (B1, B2, or B3)
4 or resident aliens,
• are not already on anti-TB medications for treatment of TB disease, and
• are examined after arriving in the United States and diagnosed with clini-
cally active TB requiring anti-TB medications, and
• should be counted by the locality of their current residence at the time of 
diagnosis regardless of citizenship status.
Border crossers* and permanent resident aliens who are diagnosed with TB and 
plan to receive anti-TB therapy from a locality in the United States for 90 days or 
more should be counted by the locality where they receive anti-TB therapy.
Foreign visitors (e.g., students, commercial representatives, and diplomatic person-
nel) who are diagnosed with TB, are receiving anti-TB therapy, and plan to remain 
in the United States for 90 days or more should be counted by the locality of current 
residence.
*Border crosser — defined, in part, by the U.S. Citizenship and  Immigration 
Services (USCIS)
3  as “a nonresident alien entering the United States across the 
Mexican border for stays of no more than 72 hours.”  Border crossers may go back 
and forth across the border many times in a short period.
DO NOT COUNT
TB cases in immigrants or refugees who have been classified as Class A with a 
waiver (TB, Infectious, Noncommunicable for travel purposes)4 should not be 
counted as new cases even if the persons receive routine initial work-ups in the 
United States.  TB in persons who are temporarily (<90 days) in the United States, 
for whom therapy may have been started but who plan to return to their native 
country to continue therapy, should not be counted in the United States.
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e. Out-of-State or Out-of-Area Residents 
COUNT 
A person’s TB case should be counted by the locality in which he or she resides at 
the time of diagnosis.  TB in a person who has no address should be counted by the 
locality that diagnosed and is treating the TB.  The TB control officer should notify 
the appropriate out-of-state or out-of-area TB control officer of the person’s home 
locality to (1) determine whether the case has already been counted to avoid “dou-
ble counting,” and (2) agree on which TB control office should count the case if it 
has not yet been counted. 
DO NOT COUNT 
Do not count a case in a newly diagnosed TB patient who is an out-of-area resident 
and whose TB has already been counted by the out-of-area TB control office.
f. Migrants and Other Transients 
COUNT
Persons without any fixed U.S. residence are considered to be the public health 
responsibility of their present locality and their TB case should be reported and 
counted where diagnosed.
DO NOT COUNT
Cases in transient TB patients should not be counted when there is evidence that 
they have already been counted by another locality.
g. Federal Facilities (e.g., Military and Veterans Administration Facilities)  
COUNT
Cases in military personnel, dependents, or veterans should be reported and counted 
by the locality where the persons are residing in the United States at the time of 
diagnosis and initiation of treatment.
However, if military personnel or dependents are discovered to have TB at a mili-
tary base outside the United States but are referred elsewhere for treatment (e.g., a 
military base located within the United States), the TB case should be reported and 
counted where treated and not where the diagnosis was made.
DO NOT COUNT
Do not count if the case was already counted by another locality in the United 
States.
h. Indian Health Service
COUNT
TB should be reported to the local health authority (e.g., state or county) and count-
ed where diagnosed and treatment initiated.  However, for a specific group such as 
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the Navajo Nation, which is geographically located in multiple states, health depart-
ments should discuss each case and determine which locality should count the case.
DO NOT COUNT
Do not count if the case was already counted by another locality.
i. Correctional Facilities (e.g., Local, State, Federal, and Military)
COUNT
Persons who reside in local, state, federal, or military correctional facilities may 
frequently be transferred or relocated within and/or between various correctional 
facilities. TB in these persons should be reported to the local health authority and 
counted by the locality where the diagnosis was made and treatment plans were 
initiated.
DO NOT COUNT
Do not count correctional facility residents’ TB cases that were counted elsewhere 
by another locality or correctional facility, even if treatment continues at another 
locale or correctional facility.
j. Peace Corps, Missionaries, and Other Citizens Residing Outside the United States
DO NOT COUNT
TB in persons diagnosed outside the United States should not be counted.  TB in 
these persons should be counted by the country in which they are residing regard-
less of their plans to return to the United States for further work-up or treatment.
IV. Suggested Administrative Practices
To promote uniformity in TB case counting, the following administrative procedures 
are recommended:
(a) All TB cases verified by the 52 reporting areas with count authority (50 states, District 
of Columbia, and New York City) during the calendar year (by December 31) will be 
included in the annual U.S. incidence count for that year.  All tuberculosis cases verified 
during the calendar year by a reporting area with count authority from one of the remain-
ing 7 reporting areas (American Samoa, Federated States of Micronesia, Guam, Northern 
Mariana Islands, Puerto Rico, Republic of Palau, and U.S. Virgin Islands) are also count-
ed but are not included in the annual incidence for the United States.  Cases for which 
bacteriologic results are pending or for which confirmation of disease is questionable 
for any other reason should not be counted until their status is clearly determined; they 
should be counted at the time they meet the criteria for counting.  This means that a case 
reported in one calendar year could be included in the morbidity count for the follow-
ing year.  The reporting area with count authority should ensure that there is agreement 
between final local and state TB figures reported to CDC. Currently, some reporting areas 
may not use this suggested protocol.  Some of these areas may wait until the beginning of 
the following year when they have received and processed all of the TB cases for inclu-
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sion in the annual case count for the previous year.  If reporting areas decide to revise 
their protocols, they should be aware that their TB trends may change.
(b) TB is occasionally reported to health departments over the telephone, by letter or fax, or 
on forms other than the Report of Verified Case of Tuberculosis (RVCT).  Such informa-
tion should be accepted as an official morbidity report if sufficient details are provided; 
otherwise, the notification should be used as an indicator of a possible TB case (suspect) 
which should be investigated promptly for confirmation.
V. TB Surveillance Definitions
Case - an episode of TB disease in a person meeting the laboratory or clinical cri-
teria for TB as defined in the document “Case Definitions for Infectious Conditions 
Under Public Health Surveillance”
2 (see Section II for criteria).
Suspect - a person for whom there is a high index of suspicion for active TB (e.g., 
a known contact to an active TB case or a person with signs or symptoms consistent 
with TB) who is currently under evaluation for TB disease.
Verification of a TB case - the process whereby a TB case, after the diagnostic 
evaluation is complete, is reviewed at the local level (e.g., state or county) by a TB 
control official who is familiar with TB surveillance definitions; if all the criteria for 
a TB case are met, the TB case is then verified and eligible for counting. 
Counting of a TB case - the process whereby a reporting area with count author-
ity evaluates verified TB cases (e.g., assesses for case duplication).  These cases 
are then counted for morbidity in that locality (e.g., state or county) and reported to 
CDC for national morbidity counting.
Mycobacterium tuberculosis complex (M. tuberculosis complex) - Because most 
laboratories use tests that do not routinely distinguish Mycobacterium tuberculosis 
from very closely related species, these laboratories report culture results as being 
positive or negative for “Mycobacterium tuberculosis complex.” Although in almost 
all cases of human disease, isolates in the M. tuberculosis complex are, in fact, M. 
tuberculosis, other species are possible. For example, one study in San Diego found 
that 6% of human tuberculosis was caused by Mycobacterium bovis; cultures from 
these cases would be reported by most laboratories as being positive for M. tuber-
culosis complex. Other species in the Mycobacterium tuberculosis complex include 
M. africanum, M. microti, M. canetii, M. caprae, and M. pinnipedii. Although M.  
microti, M. canetii, M. caprae, and M. pinnipedii are newly described species, their 
inclusion in M. tuberculosis complex should not impact public health laboratories or 
programs because only a few laboratories identify to the species level. These seven 
species are almost identical in DNA homology studies. In terms of their ability to 
cause clinical disease and be transmissible from person to person, M. bovis, M. 
africanum, M. microti, and M. canetti behave like M. tuberculosis; therefore, dis-
ease caused by any of the organisms should be reported as TB, using the Report of 
Verified Case of Tuberculosis (RVCT). The only exception is the BCG strain of M. 
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bovis, which may be isolated from persons who have received the vaccine for pro-
tection against TB or as cancer immunotherapy; disease caused by the BCG strain 
of M. bovis should not be reported as TB because the transmission is iatrogenic 
(treatment-induced), rather than person-to-person or communicable.
 
Nontuberculous mycobacteria (NTM) - mycobacteria other than Mycobacterium 
tuberculosis complex that can cause human infection or disease.  Common nontu-
berculous mycobacteria include M. avium complex or MAC (M. avium, M. intracel-
lulare), M. kansasii, M. marinum, M. scrofulaceum, M. chelonae, M. fortuitum, and 
M. simiae.  Other terms have been used to represent NTM, including MOTT (myco-
bacteria other than TB) and “atypical” mycobacteria.
Reporting area - areas responsible for counting and reporting verified TB cases to 
CDC.  Currently there are 60 reporting areas: the 50 states, District of Columbia, 
New York City, American Samoa, Federated States of Micronesia, Guam, Northern 
Mariana Islands, Marshall Islands, Puerto Rico, Republic of Palau, and U.S. Virgin 
Islands.  The annual incidence of tuberculosis for the United States is based on 52 
reporting areas (the 50 states, District of Columbia, and New York City).
Alien - defined by the U.S. Citizenship and Immigration Services (USCIS)3  as “any 
person not a citizen or national of the United States.”
Border crosser - defined, in part, by the USCIS3 as “a nonresident alien entering 
the United States across the Mexican border for stays of no more than 72 hours.”  
Border crossers may go back and forth across the border many times in a short 
period.
No TB Classification - Applicants with normal tuberculosis screening examina-
tions.
Class A TB with waiver - All applicants who have tuberculosis disease and have 
been granted a waiver.
Class B1 TB, Pulmonary - 
No treatment
• Applicants who have medical history, physical exam, HIV, or CXR findings 
suggestive of pulmonary tuberculosis but have negative AFB sputum smears 
and cultures and are not diagnosed with tuberculosis or can wait to have 
tuberculosis treatment started after immigration.
Completed treatment
• Applicants who were diagnosed with pulmonary tuberculosis and success-
fully completed directly observed therapy prior to immigration. The cover 
sheet should indicate if the initial sputum smears and cultures were positive 
and if drug susceptibility testing results are available.
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Class B1 TB, Extrapulmonary - Applicants with evidence of extrapulmonary 
tuberculosis. Document the anatomic site of infection.
Class B2 TB, LTBI Evaluation - Applicants who have a tuberculin skin test ≥10 
mm but otherwise have a negative evaluation for tuberculosis. The size of the TST 
reaction, the applicant’s status with respect to LTBI treatment, and the medication(s) 
used should be documented. For applicants who had more than one TST, whether 
the applicant converted the TST should be documented (i.e., initial TST <10 mm 
but subsequent TST ≥10 mm).
Class B3 TB, Contact Evaluation - Applicants who are a recent contact of a 
known tuberculosis case. The size of the applicant’s TST reaction should be docu-
mented. Information about the source case, name, alien number, relationship to 
contact, and type of tuberculosis should also be documented.
Immigrant - defined by the USCIS3  as “an alien admitted to the United States as 
a lawful permanent resident.  Immigrants are those persons lawfully accorded the 
privilege of residing permanently in the United States.  They may be issued immi-
grant visas by the Department of State overseas or adjusted to permanent resident 
status by the USCIS of the United States.”
Permanent Resident Alien - see Immigrant. 
Waivers - A provision allows applicants undergoing pulmonary or laryngeal tuber-
culosis treatment to petition for a Class A waiver. Waivers should be pursued for 
any immigrant or refugee who has a complicated clinical course and would benefit 
from receiving treatment of their tuberculosis in the United States. Applicants diag-
nosed with tuberculosis disease who are both smear- and culture-negative and will 
be traveling to the United States prior to start of treatment do not need to complete 
the waiver process.
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Notes 
1. Reference to details of FDA-approved labeling for NAA (IIa) was deleted from this 
document in September 2002.
2. A note of clarification was added to Section III, Counting TB Cases, in September 
2003.
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